Modifying T cell differentiation via protein based delivery of signalling attenuators by Veldhoen, Marc
Open Research Online
The Open University’s repository of research publications
and other research outputs
Modifying T cell differentiation via protein based
delivery of signalling attenuators
Thesis
How to cite:
Veldhoen, Marc (2003). Modifying T cell differentiation via protein based delivery of signalling attenuators.
PhD thesis. The Open University.
For guidance on citations see FAQs.
c© 2003 Marc Veldhoen
Version: Version of Record
Copyright and Moral Rights for the articles on this site are retained by the individual authors and/or other copyright
owners. For more information on Open Research Online’s data policy on reuse of materials please consult the policies
page.
oro.open.ac.uk
LA Aj C-'TeJ
Modifying T cell differentiation 
via protein based delivery of 
signalling attenuators
Submitted by 
Marc Veldhoen
for the degree of Doctor of Philosophy 
Open University
Division of Molecular Immunology 
National Institute for Medical Research 
London 
2003
ProQuest Number: C814845
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest C814845
Published by ProQuest LLO (2019). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLO.
ProQuest LLO.
789 East Eisenhower Parkway 
P.Q. Box 1346 
Ann Arbor, Ml 48106- 1346
Acknowledgements
Acknowledgements
First of all I wish to express my gratitude to my supervisor Brigitta Stockinger 
for allowing me to start in the lab as an undergraduate student (immense gratitude for 
letting me clone C5), allowing me to stay and start my PhD, support and assistance 
throughout the years and to keep having faith in me when things didn’t go as planned. 
Thanks to my second supervisor Anthony Magee for coming onboard during the 
project with helpful advice and discussion, and suburb editing of this manuscript. A 
special thanks to Phil Walker for helpful discussion and suggestions regarding the 
seemingly impossible task of getting those proteins soluble!
Thanks to all the people in the lab throughout the years for technical support, 
discussion, but more importantly: coffee and fun! Thanks for extra assistance to Chris 
Atkins and Graham Preece for the help with FACS sorting and the LSR, and to Trisha 
Norton and Keith Williams for always taking good care of the mice.
Last, a great thank you to the Boehringer Ingelheim Foundation for basic 
research in biomedicine, Hermann Frohlich, Monika Beutelspacher and Claudia 
Walther for excellent financial support and great hiking tours in the Alps!
__________________________________________________________________ Abstract
Abstract
In recent years, evidence has accumulated that hierarchical thresholds for 
proliferation and differentiation may determine the generation of various effector T 
cell modes. It is as yet poorly understood, however, how changes in TCR-mediated 
signalling and its downstream signalling cascades drive the differentiation of the 
naive T cell into different response modes. This project aims to study whether 
manipulation of the signalling pathways directly downstream of the TCR/CD28 
receptor can result in distinct functional differentiation of monoclonal CD4^ T cell 
populations with known antigenic specificity.
To this end, two potential protein transfer mechanisms were tested for their 
suitability to act as inert delivery vehicles to deliver proteins into ex vivo naive T 
cells. The B subunit pentamer of enterotoxin B induced high levels apoptosis in naive 
T cells, which precluded its use as an inert delivery vehicle. The protein transduction 
domain of the HIV-1 protein Tat, however, did not influence T cell physiology and 
was subsequently successfully tested for its ability to transduce ex vivo T cells 
genetically fused to large proteins.
Two fusion partners, the kinase truncated forms of ZAP-70 and Lck, were 
tested for their ability to interfere with TCR-mediated signalling. The kinase- 
truncated form of ZAP-70 showed a concentration dependent effect on calcium 
mobilisation, which was reliant on the strength of CD3 crosslinking. The kinase- 
truncated form of Lck also altered calcium mobilisation in a concentration dependent 
manner, but independent of TCR strength. In addition, it was shown to influence T 
cell activation, to be capable of altering the signal transduction cascade after T cell 
priming, and to dramatically change the cytokine profile.
“From the moment I  picked up your 
book until I  laid it down, I  was convulsed 
with laughter. Some day I  intend to read 
it. ” (Groucho Marx)
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Introduction
1. Introduction
1.1 The Immune System
Our bodies are constantly at war, under assault 24-hours a day from infection 
and toxins. The fact that we survive and most of the times not even give way to 
infection is due to our immune system, a network of cells and chemicals that protect 
the body. Two sub-groups of the immune system, the innate and the adaptive immune 
system, are responsible for protection and elimination of pathogens such as bacteria, 
viruses, parasites and fungi.
1.1.1 Innate Immunity
The immediate defence of the body against an invasion must be in the hands 
of preformed molecules present constitutively. Proteins, such as lysozyme, c-Reactive 
Protein, interferons and the complement system, are present in the body secretions 
and fluids and attack different microorganisms in a variety of ways, often by 
dissolving their protective layer. The strategy of innate immunity is based on the 
detection of constitutive and conserved products of microbil metabolism. Many 
metabolic pathways and gene products are unique to microorganisms of a certain 
class and absent from host cells. Therefore, these products are molecular signatures of 
invaders, and their recognition by the innate immune system signals the presence of 
infection.
Most of the white blood cells, called granulocytes (including neutrophils, 
basophils and eosinophils), alongside others called macrophages, mast cells and 
natural killer (NK) cells, have a role in initial defence. Their action does not depend 
upon prior exposure to the pathogen and it does not generate immunological memory. 
Consequently, these cells react the same way when a second encounter with the same 
antigen takes place.
Because the targets of the innate immune system are conserved molecular 
patterns, they are called pathogen-associated molecular patterns (PAMP). PAMPs are 
produced by microbes and not by host cells, allowing the innate immune system to 
discriminate between self and non-self. Since PAMPs are invariant between
16
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microorganisms of a given class, this allows a limited number of receptors to detect 
the presence of any microbial infection. Importantly, PAMPs are essential for the 
microorganism and mutation or loss is either lethal or results in greatly reduced 
fitniss. Accordingly, the receptors of the innate immune system that recognise 
PAMPs are the pattem-recognition receptors (PRR). These receptors recognise for 
example carbohydrate structures that are not present on host cells, including certain 
mannose linkages and lipopolysaccharide (LPS) on gram-negative bacteria. Various 
PRRs are expressed on the cell surface, in intracellular compartments, or secreted into 
tissue fluids. The principal functions of PRRs include: opsonisation, activation of 
complement and coagulation cascades, phagocytosis, activation of pro-inflammatory 
signalling pathways and induction of apoptosis (Janeway Jr, 1989).
PRRs that have a unique and essential function in immunity are the Toll-like 
receptors (TLR). TLRs comprise a family of at least ten receptors in mammalian 
species, each one with a distinct function in innate immune recognition. The TLR 
ligands are PAMPs, and many TLRs can recognise several structurally unrelated 
ligands; some TLRs, however, require accessory proteins to recognise their ligand. 
TLR4 was the first characterised mammalian Toll receptor (Medzhitov et al., 1997). It 
is expressed in a variety of cell types, predominantly macrophages and Dendritic cells 
(DC). It functions as a signal transduction receptor for LPS, but requires accessory 
molecules to do so. TLR2 is involved in the recognition of an unusually broad range 
of microbial products, including cell wall products of gram-positive bacteria and 
yeast, and is only found expressed by antigen-presenting cells (APCs) and endothelial 
cells.
The secondary effect of recognition of microbial pathogens via either the 
PRRs or the complement receptors is to activate cells to synthesise cytokines. In 
particular, inflammatory cytokines and chemokines such as Tumour Necrosis Factor 
(TNF)-a, Interleukin (II)-12,11-6 and II-Ip play an important role in the second phase 
response. In addition, interferon (IFN)a and IFNP are produced by a variety of cells 
in response to viral infection. They have an important role in limiting viral infection 
in the early phase. They act on a wide variety of cell types to induce the synthesis of a 
series of proteins that interfere with viral replication both by degrading ribonucleic 
acid (RNA) and by inhibiting protein synthesis. They also potently activate NK cells.
17
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NK cells are another component of the innate immune response and have the 
ability to both lyse target cells and provide an early source of cytokines. NK receptors 
are crucial for distinguishing normal cells from transformed or foreign cells, thereby 
eliminating the latter. In more recent years several lines of evidence have shown that 
besides yS T cells and «P T cells a separate lineage of NK T cells exists, which co­
express NK receptors such as N K l.l and the aP  T cell receptor (TCR). NK T cells 
recognise a glycosphingolipid presented by cluster of differentiation (CD) Id with a 
highly skewed TCR repertoire (Bendelac et al., 1997). The precise origin of the NK T 
cell remains unknown, but many gene defects influencing NK T cell development 
also affect NK cells, suggesting a common precursor. Several studies have indicated a 
thymic dependency for the development of NK T cells (Bendelac et al., 1994; 
Bendelac, 1995; Coles and Raulet, 2000), but it is as yet poorly understood which role 
these cells play in immune responses.
1.1.2 Adaptive Immunity
Protection against the enormous variety of microorganisms, continuously 
changing and evolving, cannot be achieved by the innate system alone. Adaptive 
immune recognition relies on the generation of a random and highly diverse repertoire 
of antigen receptors, followed by clonal selection and expansion of receptors with 
relevant specificities. This mechanism accounts for the generation of immunological 
memory, which provides a significant adaptive fitness. However, these randomly 
generated receptors are unable to determine the source and biological context of the 
antigen for which they are specific. The clonal distribution of antigen receptors also 
requires that specific clones expand and differentiate into effector cells before they 
can contribute to host defence. This requires time, typically 4-7 days, which is too 
much of a delay to combat quickly replicating microbial invaders. This illustrates that 
the adaptive immune system operates in the context of the innate immune system. 
Almost every aspect of the adaptive immune system is controlled by a combination of 
permissive and instructive signals, provided by the evolutionarily ancient and more 
universal innate system. Thus, the innate system detects the presence and the nature of 
infection, provides the first line of defence and controls the initiation of the effector 
cells of the adaptive immune response. Conversely, the adaptive system is able to 
change and adapt, resulting in a more swift and efficient response upon subsequent 
encounters with the same antigen.
18
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1.2 Lymphocytes
The two major types of lymphocytes, B and T cells, generated in the bone 
marrow and thymus respectively, are both capable of producing an almost unlimited 
number of receptors. Both B and T cells are derived from a common hematopoietic 
stem cell. The B cell receptor (BCR) and the TCR are encoded by a finite number of 
genes, each of which encodes a part of the antigen receptor (Tonegawa, 1976).
1.2.1 B lymphocytes
The differentiation of precursors along the pathway of B cell development has 
been well characterised. The BCR, an immonoglobulin (Ig), is composed of four 
polypeptide chains; two identical light (L) chains, associated with two identical heavy 
(H) chains. The genes encoding for the L chain are organised in multiple variable (V), 
joining (J) and constant (C) segments; the H chain genes have diversity (D) segments 
in addition. During B cell development any V gene segment can be joined to any J or 
DJ gene segment by somatic recombination, resulting in an enormous diversity of 
receptor specificities. Different gene segments are joined in different B cells, 
generating a variety of Ig chains, during a process known as rearrangement, driven by 
enzymes encoded by recombination activating genes (RAG). In this way a few 
hundred gene segments can combine in different ways to form thousands of different 
receptor chains. Finally, the light and heavy chain are assembled together, to form a 
functional receptor increasing variety even more.
The recognition of proteins by the BCR and its secreted counterpart, the 
antibody (Ab), involves direct binding to the native protein structure. As a result of 
the gene rearrangements generating the broad repertoire of BCRs, B cells will also be 
capable of recognising self-antigen. Those immature B cells that express autoreactive 
receptors have a chance to survive by undergoing secondary L chain gene 
rearrangements (Gay et al., 1993). As soon as a non-autoreactive receptor is expressed 
the recombination mechanisms are turned off ensuring that each B cell produces only 
one type of receptor. This mechanism is known as allelic exclusion. Remaining 
autoreactive cells are deleted by accelerated apoptosis.
19
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Mature B cells may be stimulated by foreign antigen to enter the cell cycle, 
differentiate to Ig-secreting plasma cells or become long-lived memory B cells. T 
cell-independent antigen will not induce longevity and memory. With the help of T 
cells, however, B cells can become long-lived, can switch the expression of the H 
chain they express and can hypermutate the V regions of their IgH and IgL chain 
genes. A germinal center (GC)-specific activator-induced cytidine deaminase, a 
potential RNA editing enzyme, is a key factor controlling the two GC-specific events, 
somatic hypermutation and class switch recombination of immunoglobulins 
(Muramatsu et al., 2000).
Antigen is bound by B cells, internalised, processed and returned to the cell 
surface in association with a molecule known as major histocompatibility complex 
(MHC) class II. The MHC/peptide complex is then recognised by activated T cells 
carrying a specific TCR (Lanzavecchia, 1985). The T cells express additional cell 
surface molecules that interact with receptors on B cells providing important 
activation signals. The immediate effect of activation by T cells is to trigger B cell 
proliferation. However, another important effect can be observed when CD40 ligand 
(CD40L), a molecule expressed by activated T cells (Armitage et al., 1992), binds 
CD40. CD40L/CD40 interactions, in synergy with the effects of cytokines such as II- 
4,11-5 and 11-6 that are secreted by the T cell, induce B cell differentiation into plasma 
cells and isotype switching (Jabara et al., 1990).
High-affinity Igs are produced through a process of maturation and selection 
in the GCs. The germline antibody repertoire is selected during evolution and permits 
the low-affinity recognition of antigens. It would be difficult and inefficient to select 
for specialised high-affinity receptors at that stage. However, to control invaders and 
provide better protection in the future, a more fitted repertoire is generated during 
maturation of an immune response by a specific mechanism that introduces single 
point mutations within specific V genes. This process of hypermutation permits 
selection of high-affinity clones in a locally controlled microenvironment (Liu et al., 
1992). The antigen is trapped on the surface of specialised follicular dendritic cells 
(FDC), and the BCRs of the surrounding B cells compete for it. Consequently, 
antigen can select the better binding mutant B cells in GCs and expand them 
selectively over other mutants that have not improved their specificity for the antigen.
20
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After contact with the specific antigen, B cells differentiate into plasma cells 
producing and secreting large amounts of the soluble form of their Igs called 
antibodies. These circulating antibodies can bind to the pathogen protecting the host 
in three major ways. They facilitate antigen recognition and uptake by phagocytes, 
they activate the complement system and they neutralise pathogenic effects by coating 
the microbial surface. Phagocytes in their turn process and present the endocytosed 
pathogen to T cells.
1.2.2 T lymphocytes
T lymphocytes are the other pillar of the adaptive immune response. Although 
the thymus is the major anatomical site of T cell development, a distinct lineage of 
extrathymically-derived T cells is present in the adult gut mucosa. However, the 
majority of T cells arise from a lymphoid progenitor that develops in the thymus by 
cell-intrinsic and lineage-specific differentiation programs, guided by cell-cell 
interactions and soluble factors.
T and B cells share many developmental properties, including rearrangement 
of their receptor genes. In contrast to B cells, however, most T cells need their antigen 
to be presented in the context of MHC molecules (Zinkemagel and Doherty, 1979). 
These are glycoproteins, of which the two main classes, I and II, bind largely non­
overlapping sets of peptides that are generated in distinct intracellular locations. Their 
function is to collect peptides inside the cell and transport them to the cell surface, 
where the peptide/MHC complex can then be recognised by the TCR. MHC class I 
molecules consist of a membrane-inserted heavy chain and a non-covalently attached 
light chain, also known as Pi-microglobulin (p2m). The structure of the class I 
molecule has been resolved, and resembles a linear groove surrounded by a wall on 
each side (Stem and Wiley, 1994). Class II molecules resemble class I molecules in 
stmcture, but both a  and p chains are membrane inserted. Intriguingly, MHC genes 
are characterised by their polymorphism; dozens or hundreds of alleles can be present 
in a species.
The TCR itself is also a glycoprotein, formed by two polypeptide chains, a  
and P or alternatively y and Ô. Each chain consists of two Ig-like domains, a 
transmembrane part and a short cytoplasmic tail, yô T cells and a p  T cells are not just
21
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similar lymphocytes with subtly different receptors. The cell types differ in the type 
of antigen they recognise, the mechanism of antigen presentation and recognition and 
the mechanism and kinetics of downstream signalling events. Antigen recognition by 
yS T cells, which represent about 5% of peripheral blood T cells, resembles 
recognition by B cells, because they recognise intact protein antigens and small 
phosphate- or amine-containing compounds (Hayday, 2000). Although MHC- 
presentation of these antigens is not required, cell-cell contact seems to be crucial for 
stimulation, suggesting that co-stimulation is required or that non-MHC molecules 
play a role in presentation (Morita et al., 1995). yÔ T cells have been implicated in 
several immunological roles, including immediate responses to pathogenic invasion 
and long-term modulation of inflammation (Carding and Egan, 2000).
The two main populations of a p  T cells, named according to the expression of 
the co-receptor molecules CD4 and CDS, are restricted to one class of MHC. CD4 
and CDS are non-clonally distributed proteins that, because they recognise the ligands 
of the TCR, are often referred to as co-receptors. The CD4 subset, also known as 
helper T cells (Th) recognises antigen in context of MHC class II, expressed 
constitutively by professional APCs like DCs and B cells. The CDS subset, also 
known as cytotoxic T cells (CTL), recognise antigen in the context of the MHC class 
I molecule, generally expressed in every nucleated cell.
1.2.2.1CD4T cells
CD4 T cells have a central role in the immune system, and their activation is 
often a prerequisite for responses by other types of cells, including CDS T cells and B 
cells. CD4 T cells themselves, however, are phenotypically heterogeneous, and the 
different subsets are involved in markedly diverse immunological functions. They are 
primarily responsible for providing help to other immune cells through direct cell-cell 
interactions or the secretion of cytokines. CD4 T cells recognise their specific antigen 
in the context of MHC class II, and differentiate into different subsets of effector cells 
most noticeably Thl, Th2 and possibly T regulatory (Treg) cells, characterised by their 
cytokine profile.
MHC class II molecules can be expressed by DCs, macrophages and B cells, 
the so-called APCs. They are generally involved in initiating the adaptive immune 
response by presenting peptides mostly derived from extracellular origin, such as
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pathogens and bacterial toxins. These APCs have an array of receptors enabling them 
to engulf pathogens and their products to classify the invader. Once internalised, the 
antigen ends up first in endosomal vesicles, and later in lysosomes. It is between these 
compartments where a progressively decreasing pH activa:tes proteases, specifically 
targeted to the endosomal-lysosomal compartments from the endoplasmic reticulum 
(ER) and Golgi system, leading to degradation of the antigens. Class II molecules also 
start their existence in the ER. The two chains assemble and are bound by a 
chaperone-like molecule, the invariant chain (li) (Cresswell, 1994). li serves two 
functions; it directs the class II molecule to the class II loading compartment, a 
specialised vesicle characterised by the presence of high amounts of MHC II. In 
addition, it prevents premature peptide occupancy of the groove of the class II 
molecules. A stretch of the li binds into the groove and thereby, competitively 
prevents the binding of peptides. This class Il-associated invariant chain peptide 
(CLIP) is removed from the heterodimer in the class II loading compartment, giving 
the opportunity to fill the groove with peptide fragments present there. Finally, the 
peptide-loaded class II proteins are translocated to the cell surface. The protein loaded 
onto MHC II is under normal circumstances from endogenous origin due to a constant 
process of endocytosis. These include especially membrane-bound proteins, which 
co-localise in the coated vesicles together with proteins from serum and the 
extracellular matrix, but in the case of an ongoing infection, exogenous protein is 
presented this way to CD4 T cells.
As described, an essentially common pathway achieves MHC class II- 
restricted antigen presentation to CD4 T cells. This is, however, subject to variation 
with regard to the location and extent of degradation of protein antigens and the site 
of peptide binding to MHC class II molecules (Griffin et al., 1997; Fernandes et al., 
2000). These subtle variations reveal flexibility in the ways a diverse peptide 
repertoire is displayed on the APC surface. This diversity has profound consequences 
for the induction of immunity, and leads to the differentiation of CD4 T cells into 
subsets of T helper cells, Thl and Th2, and possibly Treg. Thl cells are important for 
the eradication of intracellular pathogens like some bacteria and parasites, and 
viruses, Th2 cells are targeting extracellular parasites and soluble toxins, while Treg 
are reported to inhibit immune responses.
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1.2.2.2 CDS T cells
In contrast to CD4 T cells, CDS T cells recognise antigen in the context of 
class I MHC molecules (Townsend et al., 1986), which are expressed not only on 
APCs but also on every nucleated cell. Class I molecules are synthesised in the ER, 
but unlike class II molecules this is also where they get loaded with peptide. Cytosolic 
proteins are degraded by the proteasome, a multiunit structure with several activities 
located in the cytosol (Rock et al., 1994). The endopeptidase specificity of the 
proteasome is such that a protein is in principle cut after a hydrophobic residue. At 
least two proteasome subunits, LMP2 and LMP7 influence the fine-tuning of the 
specificity and endopeptidase activity, and are regulated by IFNs. Protected from 
complete degradation by the chaperone Heat Shock Protein (HSP)70, the resulting 
peptides are transported into the lumen of the ER by the Transporter Associated with 
Processing (TAP) (NeeQes et al., 1993). Once inside the ER, and with the help of 
several other molecules, peptide fragments are loaded onto class I molecules. Upon 
peptide loading, the MHC class I is released by calnexin for transport to the cell 
surface.
Thus, peptides loaded onto class I molecules and presented to CDS T cells are 
derived from cytosolic proteins, under normal circumstances produced by the cell 
itself. When a cell is infected, however, the pathogen’s deoxyribonucleic acid (DNA) 
is transcribed, RNA translated, and the protein synthesised in the host cytosol. 
Fragments derived from this invader are presented via the described MHC class I, 
resulting in presentation to CDS T cells. Upon recognition by CDS T cells, the T cells 
differentiate into effector cells and are able to specifically kill infected cells, 
presenting the specific peptide, by apoptosis. As a result, the apoptotic bodies left 
behind are internalised by phagocytes.
The described loading of class I and class II MHC molecules suggests a strict 
separation of the processing pathways. However, there is strong evidence for 
considerable cross-talk between the two pathways. Peptides derived from cytosolic 
proteins can be loaded onto class II molecules (Pinet et al., 1994). On the other hand, 
exogenous antigens can also be presented by class I MHC molecules by a process 
called cross-presentation (Sevan, 1976). This pathway is less well defined but can 
overlap those pathways operating in classical MHC class I presentation. Protein 
antigens that are synthesised in one cell can be captured as exogenous antigens by
24
Introduction
APCs and processed into the MHC class I presentation pathway for priming CTL 
immunity. This may, however, not be a common property, and limited to a subset of 
DCs (den Haan et al., 2000; Pooley et al., 2001).
Concurrent with the initiation of proliferation is the start of a program of gene 
expression that arms the CDS T cell with an arsenal of effector mechanisms to combat 
the infection. The capacity to mobilize these effector mechanisms, which include 
cytolysis of infected cells and the production of cytokines, chemokines, or 
microbicidal molecules, develops over time after the initial stimulation of naive CDS 
T cells and manifests upon subsequent encounter of the effector CDS T cells with 
infected cells. Activated CDS T cells are able to induce cytolysis of infected cells by 
two distinct molecular pathways: the granule exocytosis pathway, dependent on the 
pore-forming molecule perforin, or by the upregulation of FasL (CD95L), which can 
initiate programmed cell death by aggregation of Fas (CD95) on target cells (Berke, 
1995).
1.3 T Cell development
Like other cells of the blood-forming system, T lymphocytes are derived from 
pluripotent hematopoietic stem cells (HSC) present in the fetal liver or adult bone 
marrow (BM). T lymphocyte development depends on interactions between 
differentiating progenitor cells and a complexity of supportive stromal cells in 
primary lymphoid organs. Although the thymus is the major site of T cell 
development, a distinct lineage of extrathymically-derived T cells is present in the 
adult gut mucosa. These T cells are derived from precursors present in specialised 
structures in the lamina propria (Saito et al., 1998).
HSCs give rise to a common lymphoid precursor (CLP), which has lost the 
erythroid and myeloid potential but is capable of giving rise to lymphocytes (B, T and 
NK cells) and possibly thymic DCs (Ardavin et al., 1993). Since B and T cells share a 
remarkable number of developmental properties, it has been suggested that they 
originate from a common precursor. However, more recent results challenge this 
view, and indicate that commitment to T cell and B cell lineages occurs instead 
through myeloid/T and myeloid/B bipotential stages, respectively (Kawamoto et al., 
2000). Notch-1, a transmembrane receptor, is thought to play an important role in this
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lineage decision between B and T cell (Pui et al., 1999; Radtke et al., 1999). CLPs 
committed to a T cell fate thereafter migrate from the BM to the thymus or gut.
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Figure 1. Overall scheme of T cell development in the thymus. Committed 
lymphoid progenitors in the bone marrow migrate to the thymus. Early committed T 
cells lack expression of CD4, CD8 and TCR, termed double negative (DN) 
thymocytes. As cells progress through the four DN stages, they express the pre-TCR. 
Successful expression results in proliferation during the DN4 to double positive (DP) 
transition, and the mature TCR is expressed. Interactions with cortical epithelial cells, 
expressing a high density of MHC molecules, associated with self-antigens, results in 
positive and negative selection. Thymocytes that express TCRs that interact with 
MHC class I molecules become CD8 single positive (SP) T cells, whereas those that 
express TCRs that bind MHC class II become CD4 SP T cells, ready to be exported to 
the peripheral lymphoid organs. Derived from Germain, 2002.
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Following definitive commitment to the T cell lineage, intrathymic precursors 
express CD25 and begin to rearrange and express their TCR p, y and Ô genes. Cells 
that successfully rearrange their y and Ô genes express a yÔ TCR and can proceed 
along the yô lineage. Similarly, successful P rearrangement leads to cells expressing a 
pre-TCR, formed together with the invariant preToc chain. It is currently ill 
understood what leads to ap/yÔ lineage commitment. ap/y5 lineage decision seems to 
occur independently of the TCR, as shown by analysis of the developmental potential 
of pro-T cells. These T cells are characterised by a very limited P, y and Ô gene 
Drearrangement and heterogeneous expression of the surface marker CD 127. The 
CD I27I0  subset was found biased towards ocp T cell development, whereas the 
CDI27hi subset gave rise preferentially to y5 T cells (Kang et al., 2001).
Mature a p  T cells are comprised of two lineages, CD4 and CDS T cells, the 
antigen recognition of which is focused on either MHC class II- or class I-associated 
peptides and whose functions are tuned to these recognition biases.
1.3.1 Selection events
Following successful TCR production and surface expression, CD4 and CDS 
double positive (DP) thymocytes are subject to a rigorous selection process. They are 
tested for recognition of peptide/MHC complexes through the mechanisms known as 
positive and negative selection. The procedure of removing overt self-reactivity while 
imparting self-MHC restriction to the mature TCR repertoire is thought to operate via 
selective processes regulated primarily by the affinity/avidity of the TCR for thymic 
ligands (self-MHC and self-peptide) and the resulting TCR-mediated signals.
1.3.1.1 Positive selection
After the rearrangement of the a  and p chains, most DP thymocytes express 
TCRs that interact with available self-peptide-MHC ligands at very low affinity, or do 
not interact at all. Intracellular signals that are required to sustain viability in these 
circumstances are thought not to be generated, leading to death by neglect and 
ensuring that the T cells that survive the process are able to interact with self-MHC- 
peptide complexes (Huesmann et al., 1991). Selected cells then down-regulate 
expression of RAG and proceed to the next stage of development in the medulla.
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How cortical epithelial cells drive efficient positive selection is currently 
unknown. It is clear however that thymic-epithelial cells play a key role by providing 
peptide-MHC ligands for the apTCR. Several studies have shown that the ability of 
the epithelium to promote positive selection is neither due to provision of a 
specialised repertoire of peptide-MHC complexes (Bevan, 1997), nor merely to 
maintenance of thymocyte viability by the production of survival promoting signals 
(Anderson et al., 1997). It is likely that thymic epithelial cells express unique, or a 
unique combination of, cell surface molecules that provide accessory signals during 
selection (McGargill et al., 2000). This idea is supported by the observation that under 
normal circumstances thymic epithelial cells lack the ability to provide co-stimulation 
for peripheral T cells (Jenkinson et al., 1994).
1.3.2.2 Negative selection
A generally accepted model of thymocyte selection is the “strength of signal” 
hypothesis. In this quantitative model, “strong” activation signals result in cell death 
(negative selection) and “moderate” activation signals result in survival (positive 
selection). Extremely low or no signal at all subsequently leads to death by neglect. 
The fate of a developing T cell is thus critically determined by the interaction between 
the TCR and its ligands (Grossman and Singer, 1996). Therefore, in contrast to 
thymocytes with lower affinity TCRs, if at this stage of development the thymocyte 
expressed a TCR with high affinity, it was thought that the cell would be deleted 
(Kisielow et al., 1988). However, more recent data suggest that thymocytes with high 
affinity TCRs get a second chance and are allowed to continue to rearrange the a- 
locus until a TCR is displayed that is successful in interacting with self-MHC with 
moderate affinity (McGargill et al., 2000).
It was also thought that the most efficient mediators of negative selection in 
the thymus were BM-derived DCs, residing at the corticomedullary junction. 
However, lately the medullary epithelium has also been implicated in the process. It 
has been shown to express many proteins that were previously thought to be tissue 
specific, suggesting a role in tolerance (Klein et al., 1998; Klein et al., 2000). 
Additional results suggest that the origin of the ARC that is encountered by the 
thymocyte might play an important role. If a strong interaction takes place with a BM- 
derived ARC, the thymocyte is eventually deleted when failing to express a proper 
TCR, but when the encounter is with an epithelial cell the thymocyte might be
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diverted to a subset of immunoregulatory CD4+CD25+ T cells (Jordan et al., 2001). 
The end result however is that the TCR repertoire expressed by mature T cells is 
largely devoid of autoreactivity, due to negative selection and is restricted to 
recognising foreign peptides in the context of self-MHC molecules, due to positive 
selection. In addition, and the focus of recent interest, expression of self-antigens by 
thymic epithelium may encourage peripheral tolerance by the promotion of Treg, 
which might more actively prevent autoimmunity.
1.3.1.3 Lineage commitment
The final stage of differentiation is the down-regulation of one of the co­
receptors, so that single positive (SP) T cells, either CD4 or CDS can leave the 
thymus as mature cells. Successful maturation of DP thymocytes seems to be 
restricted to those that maintain expression of the co-receptor molecule that has a 
MHC class specificity that matches the TCR. How the commitment to one or the 
other lineage is made is still poorly understood. The debate on the mechanism 
responsible focuses on whether the commitment decision is the result of instructive or 
stochastic signals (Jameson et al., 1995; von Boehmer, 1996).
In brief, the instructive model proposes that the interaction of a TCR and co­
receptor with a MHC ligand instructs the cell, by a unique biochemical event, as to 
which path to take and which co-receptor to down-regulate and stop transcribing. The 
stochastic model proposes random down-regulation of one of the co-receptors, after 
which the survival of the thymocyte depends on the signal of a matching TCR and co­
receptor. Silencing the transcription of one co-receptor locus is accompanied by other 
genetic events that determine the effector potential of the mature T cell.
DP thymocytes do not simply extinguish transcription of one co-receptor; 
instead it was shown that TCR signalling first leads to some loss of both co-receptors 
irrespective of the recognised MHC class (Lucas and Germain, 1996). This loss seems 
to correlate with the strength of TCR signalling whereby stronger TCR signals result 
in more down-regulation of both co-receptors. Thereafter, first CD4 and shortly after 
CDS are re-expressed, followed by the loss of expression of CD4 for cells committed 
to the CDS lineage and loss of CDS for cells committed to the CD4 lineage.
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Although not all available data is interpreted in the same way, and elements of 
both hypotheses have been found to contribute to the final result, currently an 
instructive model for lineage commitment is favoured (Itano and Robey, 2000). 
Exchanging cytoplasmic tails of CD4 and CDS indicated that lineage fate was largely 
dictated by the signalling part of the co-receptors, rather than by the class of MHC 
recognised (Seong et al., 1992; Itano et al., 1994; Itano et al., 1996). In addition it was 
demonstrated that MHC class Il-restricted thymocytes became CDS SP T cells in the 
absence of CD4, suggesting that a weak signal leads to the CDS fate (Matechak et al., 
1996).
The above observations also led to a ‘strength of signalling’ hypothesis 
whereby strong signals drive the lineage fate to CD4 and weak signals to CDS SP T 
cells. The hypothesis was later reinforced by showing that varying the concentration 
and duration of exposure of pre-selection DP thymocytes to phorbol ester and 
ionomycin led to the selective production of either CD4 or CDS SP T cells (Ohoka et 
al., 1997). In addition, crosslinking TCR and the co-receptor together gave rise to 
CD4 T cells, and crosslinking the TCR alone resulted in CDS SP T cells (Bommhardt 
et al., 1997; Basson et al., 199S). A key signalling component proposed is the tyrosine 
kinase Lck, engaged with co-receptors, both CD4 and CDS. CD4 molecules isolated 
from DP thymocytes are associated with more Lck than CDS molecules (Veillette et 
al., 19S9). Therefore, co-engagement of CD4 and TCR with MHC class II promotes 
the recruitment of more Lck into the signalling complex than CDS and TCR 
engagement with MHC class I.
The strength of signal hypothesis, however, could not fully explain why 
duration of a stimulus influences the lineage fate, and was accordingly adjusted to a 
signal duration concept (Ohoka et al., 1997; Basson et al., 199S). Experiments in 
mature T cells have shown that Lck coupling to the co-receptors influences the quality 
of receptor signalling, consequently effecting desensitisation and duration of 
signalling (Madrenas et al., 1997). Thus, strong sustained activation of Lck is 
correlated with CD4 commitment, and weaker more transient Lck activation with 
CDS commitment (Legname et al., 2000).
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1.3.2 SP thymocytes
After positive and negative selection and following lineage commitment, DP 
thymocytes become SP thymocytes, either CD4^CD8 or CD4 CD8^. However, 
development does not stop there, and functional competence still needs to be 
acquired. SP thymocytes have been shown to reside in medullary areas for up to two 
weeks, during which they undergo changes in expression of a variety of cell-surface 
molecules (Gabor et al., 1997), and several rounds of cell division (Ernst et al., 1995), 
before they are exported to the periphery. The acquisition of full T cell functions is 
believed to take place during these later cell divisions, reflected by the change of cell- 
surface molecules, and in close contact with thymic epithelial cells.
Despite at least six rounds of cell division, the number of SP thymocytes is 
very low (about 2% of total thymocytes). This could be attributed predominantly to 
the low efficiency of successful rearrangements of the a-locus and to a lesser extent 
the frequency of DP cells expressing self-reactive TCRs, which would then be 
negatively selected (Surh and Sprent, 1994). However, even in TCR transgenic mice 
where most DP thymocytes express a pre-selected TCR only 20% of the DP 
thymocytes cells become mature SP thymocytes (Huesmann et al., 1991). This is 
thought to be due to limiting stromal cell microenvironments that can sustain the DP 
to SP transition, at least in a TCR transgenic scenario (Merkenschlager et al., 1994).
1.4 Peripheral T cells
The capacity o f the peripheral immune system to deal with a broad range o f 
antigens in an adequate way relies on the ability of the system as a whole to recognise 
virtually all antigens. The thymus serves its function in creating a vast array o f  TCRs 
and exporting naive T cells displaying unique TCRs. Mature thymocytes leaving the 
thymus contribute to a heterogeneous pool o f peripheral lymphocytes adding their 
unique receptor to an existing collection. However, with such a vast array o f TCRs, 
the frequency o f T cells capable of responding to each antigen is very low. To deal 
efficiently with antigenic challenges, naive cells recognising their respective antigen 
have to be expanded to overcome the numeric disadvantage at the start o f a response. 
On the other hand, naive T cell numbers need to be maintained since they form as a 
collective the basis o f specific antigen recognition. In order to deal more efficiently
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with any subsequent encounters with the same antigen, T cells that have been proven 
useful must also be maintained. Thus, the peripheral pool of T cells consists of 
different subsets at various stages o f activation and differentiation generally divided 
into three simplified sub-populations: naive cells, effector cells and memory cells.
1.4.1 Naive T cells
Naive T cells are the cells that have never encountered their specific antigen, 
and continuously recirculate through the body. Their mobility enables them to access 
the secondary lymphoid tissues (lymph nodes and spleen) where they scan the present 
APCs for their specific antigen, thus surveying the body for the presence of intruders. 
Despite its complexity and the variety of challenges that it is subject to, the immune 
system maintains a dynamic equilibrium in terms of size and subset composition 
throughout much of normal adult life. For the purpose of maintaining cell numbers 
the T cell population seems to be divided into two major compartments: a naive pool 
consisting of recent thymic emigrants and T cells that have yet to encounter their 
antigen, and a memory pool consisting of antigen-experienced T cells (Freitas and 
Rocha, 2000). This separation may form the basis of ensuring that the TCR diversity 
in the naive pool is not compromised by proliferation of cells in the memory 
compartment, which has a much-reduced diversity (Arstila et al., 1999). Vice versa it 
prevents the displacement of memory cells by new thymic emigrants, thus protecting 
T cells essential for a fast reactivation of the immune system.
Maintaining numbers consists of two aspects, compensating for newly derived 
thymic emigrants and the loss of cells from the naive pool. The constant arrival of 
thymic emigrants suggests that space has to be created to accommodate them in the 
naive T cell pool, and subsequently that naive T cells have a limited life span. Upon 
recognition of an antigen naive T cells are activated and differentiate into effector 
cells, thus disappearing from the pool of naive T cells. The loss of cells is primarily 
counterbalanced by the new thymic output, but it is thought that this is insufficient to 
replenish the loss of T cells in immune-compromised situations as in HIV infection or 
old age. An important contribution toward restoring T cell numbers is made by the 
proliferation of peripheral T cells (Rocha et al., 1989; Dummer et al., 2001), known as 
homeostatic proliferation. Expansion of peripheral T cells cannot regenerate the TCR 
diversity found in the full naive compartment, but it creates more diversity than 
expansion of the memory pool.
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The survival of peripheral T cells and the mechanism behind homeostatic 
proliferation has been investigated in many different systems. Several groups have 
now shown that the spontaneous proliferation of naive cells as well as survival of 
mature naive T cells seems to depend on interactions between TCR and peptide-MHC 
in the periphery (Takeda et al., 1996; Kirberg et al., 1997; Freitas and Rocha, 2000); 
these results are however still disputed and a molecular mechanism has yet to be 
found (Dorfman et al., 2000). In addition to T cell homeostasis regulated by cell-cell 
contact, cytokines are also known to regulate the T cell compartment. Among the 
many cytokines that influence T cell survival and proliferation, 11-7 has been shown to 
be an important factor (Maraskovsky et al., 1996; Schluns et al., 2000).
1.4.2 Effector T cells
After naive T cells have encountered their antigen, they become activated and 
differentiate into effector cells, ready to neutralise invading pathogens. Initially the 
activated cells go through many rounds of cell division, generating a pool of effector 
cells. However, following the peak of expansion, there is a rapid decline in the 
number of antigen-specific cells. Although effector cells are generally thought not to 
belong to either the naive or the memory compartment, and thus not to comply with 
mechanisms of T cell homeostasis in either of these pools, numbers of T cells need to 
be controlled (Freitas and Rocha, 2000). The death of effector T cells ensures T cell 
homeostasis, preventing an accumulation of effector cells with a certain specificity 
that would compromise the capacity to respond properly to new pathogens, and 
reducing the metabolic costs to the organism. If the immune response unfolds in the 
absence of inflammatory stimuli the extent of T cell death is so profound that the 
animal contains fewer antigen-specific cells than before the response occurred (Chen 
et al., 1995; Mondino et al., 1996). As a result the organism is tolerised for future 
responses against the same antigen. If the response is accompanied by inflammatory 
stimuli, such as provided by infectious agents, the immune response results in more 
antigen-specific T cells than before the encounter occurred, although less than present 
at the peak of the response.
At least two separate types of cell death control the number of effector T cells; 
activation-induced cell death (AICD) and cytokine withdrawal. There is some 
confusion with the term AICD, and under different circumstances, for example in vivo 
and in vitro, the underlying mechanism is likely to differ. AICD was first used in the
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context of T cell hybridomas and thymocytes shown to die by apoptosis following 
CD3 stimulation in vitro (Shi et al., 1989). It was thereafter shown that Fas (CD95), 
and possibly TN Fa receptors drive the in vitro death after CD3/TCR stimulation 
(Lenardo et al., 1999). These death receptors when engaged activate signalling 
pathways by recruiting adapter molecules through their death domain (DD), which 
lead to caspase activation and eventually to cell death by apoptosis. In contrast, 
primary T cells are resistant to AICD because they express high levels of Fas- 
associating protein with death domain-like interleukin-ip converting enzyme 
(FLICE)-like inhibitory protein (FLIP), an enzymatic caspase-8 homologue and 
inhibitor of the Fas signalling pathway (Algeciras-Schimnich et al., 1999; Himeji et 
al., 2002). However, upon activation, T cells produce the cytokine 11-2, and this is 
responsible for a decrease in FLIP levels and subsequent sensitisation of primary T 
cells to AICD (Algeciras-Schimnich et al., 1999). Low levels of TGF-p may also 
increase AICD susceptibility because T cells deficient in TGF-p have increased 
sensitivity to Fas mediated death, possibly due to a failure in elevating FLIP levels 
(Chen et al., 2001).
There are additional mechanisms to those driven by death receptors, illustrated 
by showing that activated T cells die in vivo in the absence of death receptors 
(Lohman et al., 1996; Van Parijs et al., 1998). An alternative pathway leading to death 
by apoptosis was found earlier and described as cytokine withdrawal (Duke and 
Cohen, 1986). Despite its importance in maintaining T cell numbers, the molecular 
mechanism behind cytokine withdrawal is poorly understood. Cytokine withdrawal 
has been shown to involve members of the Bcl-2 family, and to be responsible for the 
majority of activated T cell death in vivo. At the peak of T cell activation Bcl-2 levels 
within activated T cells are decreased compared with resting T cells (Marrack et al., 
1999).
Several studies have shown that Bcl-2, a proto-oncogene, is involved in a 
separate pathway compared with Fas, controlling death in activated T cells (Strasser 
et al., 1995; Van Parijs et al., 1998). Overexpression of Bcl-2 does not protect against 
Fas-driven cell death nor does the absence of Fas protect cells from death otherwise 
prevented by Bcl-2 overexpression. Since the discovery of Bcl-2, a whole family of 
related proteins has been found. These molecules have either anti- or pro-apoptotic 
activity and it is generally thought that anti-apoptotic proteins like Bcl-2 form
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heterodimers with pro-apoptotic proteins thereby preventing homodimerisation, 
which is essential for their pro-apoptotic function (Cheng et al., 2001).
1.4.3 Memory T cells
An important aspect of the immune system is that upon reencounter of a 
pathogen, the immune response is faster and more vigorous compared with the 
primary response. This implies that after initial contact with antigen, for B as well as 
T cells, some of the cells involved form memory cells (Ahmed and Gray, 1996). As 
stated above, most activated T cells participating in a primary response die by 
apoptosis, and it is largely unresolved how a small proportion of activated cells 
survive and become long-lived memory cells. It seems that at least for CD8+ T cells, 
the memory cells are established at the end of a primary response (Sourdive et al., 
1998) and that there is a correlation between the size of the initial pool of effector 
cells and the size of the resulting memory pool (Hou et al., 1994). This suggested that 
memory cells are derived from fully differentiated effector cells, but did not exclude 
that they arise from partially differentiated cells. It is well established now that naive 
T cells need to undergo several rounds of division before long-term memory arises 
(Swain, 1994; Garcia et al., 1999; Opferman et al., 1999). More evidence that 
memory cells are directly derived from effector cells came with the observations that 
they descend from cells which synthesise 11-2 and express perforin (Opferman et al., 
1999; Saparov et al., 1999).
Although it appears that T cell-dependent immune responses culminate in 
memory cell generation, it has been shown that in cases where T cells undergo 
proliferation after encountering high doses of antigen or a superantigen, although 
there is a marked expansion of specific T cells, this is subsequently followed by their 
disappearance (Webb et al., 1990; Moskophidis et al., 1993). The end result is clonal 
deletion of the specific TCRs from the repertoire and tolerance by exhaustion. It 
implies that prolonged contact with antigen drives all effector cells to programmed 
cell death. Accordingly, memory cells may be derived from effector cells expressing a 
full range of effector functions, but which have not engaged their antigen at a high 
frequency or for a period of time long enough to drive them into apoptosis. In 
accordance, it has been shown that death and survival are greatly determined by the 
particular conditions encountered during the interactions with APCs. Many co­
stimulatory molecules play a role in priming T cell responses, and influence the size
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of the effector and ultimately the memory population (Whitmire and Ahmed, 2000). 
Either directly or indirectly these co-stimulatory molecules induce the up- and down- 
regulation of pro- and anti-apoptitic molecules like the previously mentioned Bcl-2 
family (Garcia et al., 1999; Grayson et al., 2000).
Memory cells differ generally from naive cells in terms of function and 
surface markers; for example they display a CD44^‘ phenotype. They are hyper- 
responsive to antigen and synthesise large quantities of cytokines (Lanzavecchia and 
Sallusto, 2000). The particular cytokines secreted are determined by the conditions 
encountered during T cell priming. On basis of their activation status memory T cells 
have been divided into two categories. Resting or central memory cells closely 
resemble naive T cells, they express the lymph-node homing receptors CD62L and 
CCR7 (Sallusto et al., 1999), but they have a faster turnover rate than their naive 
counterparts (Tough and Sprent, 1994). Activated or effector memory cells display 
many features of effector cells and lack CD62L and CCR7 expression which results in 
exclusion from the lymph-nodes. They are thus mainly found in spleen and gut 
mucosa and in non-lympoid tissues like liver, lung and kidneys (Kim et al., 1999; 
Masopust et al., 2001). There is continuing debate on the importance of resting and 
activated memory cells and on whether they represent subsets with a different role in 
immunity or whether effector memory cells reflect an intermediate state of activation 
(Ochsenbein et al., 1999; Tough and Sprent, 1999; Appay et al., 2002).
Immunological memory depends on the maintenance of T cells proven to 
possess a useful TCR, in a higher frequency than in the naive pool, which can respond 
quicker and stronger upon subsequent encounter of their antigen. In comparison to 
naive T cells, the long-term survival of memory T cells does not seem to be a passive 
process, but memory cells divide slowly even in a full T cell compartment. In contrast 
to naive T cells, where most, but not all, available data indicate a requirement of 
MHC molecules, memory cells seem to survive in the absence of MHC molecules 
(Murali-Krishna et al., 1999; Swain et al., 1999; Kassiotis et al., 2002). In accordance, 
loss of contact with MHC ligands does not interfere with the high rate of memory T 
cell proliferation (Murali-Krishna et al., 1999). Although most results implicate that 
neither survival nor homeostatic proliferation depends on TCR ligation, the functional 
ability of at least CD4+ memory T cells to adequately respond to their specific 
antigen is impaired when denied access to MHC class II molecules (Kassiotis et al..
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2002). Accordingly, MHC may not be an absolute necessity for survival, but is 
essential for maintenance of the functional quality of the secondary immune response.
These findings suggest that other non-MHC ligands provide the stimulus for 
cell division. Currently the emphasis of memory T cell survival and proliferation is on 
cytokines, but although 11-7 plays an important role in naive T cell homeostasis, only 
a partial requirement was demonstrated for memory cells in lymphopénie hosts 
(Schluns et al., 2000). Most data is, however, obtained using CD8+ memory T cells, 
and consequently much less is know about the factors controlling CD4+ memory T 
cells. There is now strong evidence that the cytokine 11-15 acts directly on CD8+ 
memory cells (Kennedy et al., 2000; Nishimura et al., 2000); it is, however, only a 
poor stimulator of CD4+ memory cells (Zhang et al., 1999; Tan et al., 2002). The 
explanation probably lies in the selective expression of the 11-15 receptor on CD8+ 
memory cells, it being very low on CD4+ memory cells and absent on naive T cells 
(Ku et al., 2000).
Over the course of a lifetime, the impact of infections on existing memory cell 
populations constantly reshapes the memory pool. Reoccurring infections 
quantitatively delete and qualitatively alter the memory pool of T cells specific to a 
previously encountered virus (Selin et al., 1999; Appay et al., 2002), ultimately 
providing the organism with an up to date and highly effective system to fight off 
pathogens.
1.5 Antigen presentation
The sophisticated adaptive immune system depends on instructions by cells 
capable of trapping, processing and efficiently presenting antigens. The first step 
towards an adaptive immune response is undertaken by professional APCs such as 
macrophages, B lymphocytes and DCs. These cells have the potential to sense foreign 
antigens and non-specific inflammatory tissue damage and acquire the cellular 
specialisation to select and activate naive antigen-specific T cells. Following 
recognition and uptake of antigen, an array of antigen-derived peptides is displayed 
on the surface on MHC molecules. Subsequently, T lymphocytes, the executioners of 
the adaptive immune response, are activated through direct contact with APCs.
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The central role for APCs in immune responses is also illustrated by their 
capacity to recognise conserved pathogen-associated molecular patterns by way of 
their TLRs, identifying the species of pathogen. Efficient priming of T cells requires 
not only the presentation of antigen in the context of a MHC molecule, but also the 
induction of accessory molecules on APCs and the local production of cytokines 
(Fearon and Locksley, 1996; Ito et al., 2002). Depending which TLRs are triggered, 
APCs secrete appropriate cytokines and thus determine the milieu in which the T cells 
are primed (Schnare et al., 2001).
Each of the APC groups varies in their location in the organism, in the 
mechanism of antigen uptake, the expression of MHC molecules and the availability 
of accessory molecules. This equips the organism with optimal detection methods for 
invading pathogens and their subsequent processing and presentation to T 
lymphocytes.
1.5.1 Macrophages
Macrophages originate in the bone marrow and migrate to body tissues via the 
blood stream. In adult life, the bone marrow releases macrophage precursors 
(immature myeloid cells) and monocytes into peripheral blood, but only upon 
entering the various tissues through the endothelial lining of blood vessels do 
precursor cells undergo their final differentiation. Myeloid cells become residential 
macrophages through stimulation with macrophage differentiation or growth factors, 
such as macrophage colony-stimulating factor (M-CSF) and granulocyte-macrophage 
colony-stimulating factor (GM-CSF), produced in situ and/or supplied humorally. 
Monocytes only migrate into tissues in response to inflammatory stimuli and 
differentiate there into macrophages. Like monocytes, the monocyte-derived 
macrophages have no proliferative potential and are short-lived, whereas the resident 
macrophages are long-lived in tissue, possess proliferative capacity and can be 
sustained by self-renewal (Naito et al., 1996). In order to become activated and fully 
functional, macrophages need to interact with either the cytokine IFNy, released by 
activated T lymphocytes, or microorganism-derived components (Celada and Nathan, 
1994).
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Antigen uptake is achieved mainly by phagocytosis and is mediated through 
specific receptors expressed on the surface, which among others include Fcy-receptors 
(Ravetch and Holland, 2001), complement receptors and scavenger receptors (SR) 
(Hughes et al., 1995). SRs play an important role in uptake and clearance not only of 
pathogens but also of modified host molecules and apoptotic cells. The complexity of 
endocytosis, in which many receptors and signalling molecules are involved, was 
shown when purified macrophage phagosomes where found to contain more than 140 
proteins (Garin et al., 2001).
A critical feature for an effective immune response is the production of 
cytokines and chemokines during phagocytosis. Some phagocytic receptors alone 
trigger the production of chemokines and cytokines, but often engagement of TLRs is 
required. Several TLRs are actively recruited to the phagosomes during internalisation 
of microbes where they sample the phagosomes content to determine the nature o f the 
ingested pathogen (Underhill et al., 1999).
1.5.2 B cells
While macrophages are the scavengers of the immune system, B cells are non- 
phagocytic. However, B cells are unique in binding, internalising and presenting 
specific soluble antigens. This is due to their unique Ig receptor, assembled after a 
process of rearrangements and expressed at the cell surface. After binding to the BCR, 
the antigen is internalised and processed in intracellular vesicles. These are the same 
vesicles where newly synthesised MHC class II molecules are directed, and 
subsequently loaded with internalised peptides (Lanzavecchia, 1985). Due to 
constitutive expression of MHC class II molecules, they are capable of displaying 
peptides derived from specific antigens at high levels and with high density on the 
cell surface.
Like macrophages, triggering of the BCR also up-regulates the expression of 
accessory molecules (Lenschow et al., 1994), which can also be induced by 
microbial-specific products like LPS (Hathcock et al., 1994), allowing full activation 
of T lymphocytes. Although activation of T lymphocytes by B lymphocytes is clearly 
demonstrated in vitro (Lanzavecchia, 1985) and is shown to be vital for the 
production of antibodies, for T cell expansion and for systemic responses to low
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antigen concentrations (Rivera et al., 2001), it appears to be less important in 
initiating T cell responses.
Studies of early events in T cell activation in vivo have shown that naive CD4 
T cells are found primarily, if not exclusively, in secondary lymphoid tissues (spleen, 
lymph nodes and Peyer’s patches) (Reinhardt et al., 2001). Naive T cells express a 
unique set of receptors, which bind ligands only expressed on the high endothelial 
venules (HEV) in secondary lymphoid organs. Once inside, the T cells are restricted 
to T cell-rich areas known as the paracortex in the lymph nodes and Peyer’s patches 
and the periartiolar lymphoid sheath (PALS) in the spleen. B cells reside in 
specialised B cell follicles and are thus anatomically separated from naive T cells in 
the secondary lymphoid organs. Accordingly it was shown that labelled adoptively 
transferred T cells stay in the paracortex of the lymph nodes without the presence of 
macrophages or B cells (Ingulli et al., 1997). Only after initial activation and 
proliferation do T cells migrate to the border region to make contact with B cells 
(Gulbranson-Judge and MacLennan, 1996; Garside et al., 1998; Reinhardt et al., 
2001). This suggests that the importance of B cells as APCs in vivo is small, and that 
the presentation of peptides in the context of MHC class II molecules on antigen 
specific B cells mainly serves to obtain help from primed CD4 T cells for antibody 
production.
1.5.3 Dendritic cells
Dendritic cells represent a heterogeneous cell population, distributed 
throughout the body in all tissues, particularly at sites of contact with the surrounding 
environment, like skin and mucosae. This indicates their central role in antigen 
capture and initiation of immune responses (Steinman et al., 1997). In the absence of 
ongoing inflammatory and immune responses, immature DCs, representing 1-2% of 
the total cell numbers, constitutively patrol the tissues (Banchereau and Steinman,
1998). They are potent in antigen uptake and efficiently capture invading pathogens. 
This is achieved by sampling the surrounding tissue by macro-pinocytosis (Sallusto et 
al., 1995), internalising self and non-self antigens, which are subsequently processed 
and loaded onto MHC molecules. Immature DCs express low amounts of accessory 
molecules and MHC class II; as a result they are inefficient in activating naive T cells.
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After antigen uptake, immature DCs rapidly cross the endothelium of 
lymphatic vessels and migrate to the draining secondary lymphoid organs. During this 
migration, DCs undergo the maturation process that is characterised by 
downregulation of the capacity to capture antigens and upregulation of antigen 
processing and presentation, of expression of costimulatory molecules and of 
dendritic morphology. Mature DCs no longer capture antigens, but are powerful 
initiators of the adaptive immune system by their antigen processing and presenting 
capacity. The signal for DCs to mature is often referred to as a danger signal. In this 
respect, DCs form a bridge between innate and adaptive immunity, since the danger 
signal often results from the innate arm o f the immune system.
DCs sense danger with a wide variety of receptors constitutively expressed on 
their surface. They express a subset o f TLRs, allowing them to respond to various 
conserved pathogenic compounds (Visintin et al., 2001). When these compounds have 
triggered TLR on other cell types, DCs sense danger indirectly through inflammatory 
mediators such as TNFa, IL -lp and prostaglandin E2 (Banchereau and Steinman, 
1998). Ongoing immune responses are sensed by the presence o f antibodies, which 
bind to their Fc-receptors (Regnault et al., 1999), or by triggering o f their complement 
receptors (Reis e Sousa et al., 1993). Activated CD4 T cells can also induce DC 
maturation, potentially for initiating cytotoxic T cells, by triggering o f CD 40,0X 40 
and CD95 (Ohshima et al., 1997; Rescigno et al., 2000; Schuurhuis et al., 2000). 
Although the nature of the activating compound is still unclear, cell death is also 
sensed by DCs and results in enhanced T cell responses (Shi et al., 2000).
The T cell areas are occupied by at least two subsets of DCs (Shortman et al.,
1998), possibly originating from different precursor cells. For example, precursors in 
the skin, Langerhans cells (LC) and myeloid monocytes, both migrate into T cell 
areas of draining lymph nodes (Silberberg-Sinakin et al., 1976; Randolph et al.,
1999), where LCs display DEC205 while myeloid monocytes lack DEC205 and 
CD 8a expression (Inaba et al., 1995; Randolph et al., 1999). This led to the division 
of DC populations in lympoid DCs (CDl lc^CD 8a^EC205^CDl lb  ), derived from 
migrating LCs, and myeloid DCs (CDl lc^CD8a'DEC205'CDl Ib^), derived from 
migrating monocytes (Shortman and Wu, 2001). However, demonstrating that both 
common myeloid and lymphoid precursors can give rise to both DC subsets recently 
challenged this distinction of origin (Manz et al., 2001).
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As well as their stimulatory functions, there is growing evidence that DCs also 
maintain and regulate T cell tolerance in the periphery (Jonuleit et al., 2001). They 
capture antigen from dying cells during normal cell turnover; however, this does not 
result in an immune response against self-antigens. It was shown that damaged cells 
are handled differently by DCs, depending on how they die. Necrotic cells promote 
the maturation of DCs and strong CD4 and CDS T cell stimulatory activity, whereas 
apoptotic cells fail to activate DCs (Gallucci et al., 1999; Sauter et al., 2000). In 
addition, it was demonstrated that the absence of an immune response is not due to 
lack of presentation, since DCs constitutively transport apoptotic cells to the T cell 
areas of lymph nodes and present the self-peptides there (Huang et al., 2000). The 
mechanism behind the induction of tolerance is poorly understood; however, there is 
increasing evidence that a subpopulation of T cells exert regulatory functions (Treg). 
DCs might present certain exogenous self-antigens that are recognised by Treg cells, 
which subsequently block the activation activity of the DC (Kurts et al., 1997; Adler 
et al., 1998; McGuirk et al., 2002).
1.6 Cytokines
Another key role in the multi-factorial network of an immune response is 
played by cytokines. They are initially produced by the innate immune response 
(inflammatory cytokines) and can profoundly influence subsequent adaptive 
immunity. Their effects are pleiotropic and influenced by dose as well as presence or 
absence of other cytokines. Once produced, the factors, individually or in 
combination, can act directly on infected cells, activate cellular constituents of the 
innate system, and promote T and B cell adaptive responses to mediate defence.
T lymphocytes are one of the richest sources of protein mediators. Many of 
their effects, such as T cell help, growth stimulation, macrophage activation or 
suppression are caused by the release of these molecular mediators, which include the 
interleukins 11-2,11-3,11-4,11-5,11-6, IFNa and p, TNF, Lymphotoxin (LT), GM-CSF 
and transforming growth factor (TGF) p. These molecules are only produced 
transiently after activation of the cells, and the CD4+ cells are the richest sources of 
cytokines. 11-2, secreted principally by activated helper T cells, plays a pivotal role in 
the generation and regulation of the immune response. It supports the growth and 
effector function of a wide array of immunologically relevant cells, including
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macrophages, B cells and NK cells, as well as a variety of different T cell 
subpopulations. It has a short half-life and is secreted in apposition to the cell with 
which the T cell interacts.
Induced after antigen activation of resting T-cells, 11-2 plays an important role 
in regulating effector cell numbers. The triggering of the TCR and additional 
accessory molecules not only results in 11-2 secretion, but also in the expression of its 
high affinity receptor (CD25). 11-2 serves as an autocrine growth factor, and is 
responsible, although not solely, for clonal expansion (Schorle et al., 1991). However, 
11-2 serves a dual role, since it is also responsible for the elimination of activated T 
cells by AICD. As previously mentioned cytokines, like 11-7 and 11-15, play an 
important role in the maintenance of peripheral T cell numbers.
Studies of infections have shown a polarisation of CD4 T cell cytokine 
responses as either Thl or Th2 (Heinzel et al., 1989). Each subset produces a wide 
variety of cytokines of which 11-2, IL-3, TNF-a and GM-CSF are found in common. 
Thl cells specifically synthesise cytokines like, IFN-y and TNF-p, which are not 
produced by Th2 cells. On the other hand, IL-4, IL-5, and IL-6 are examples of 
cytokines exclusively made by Th2 cells. The different cytokine profiles reflect the 
differentiation in fiinction between both subsets, and their specialisation for different 
pathogens. Thl cells, targeted to peripheral sides o f infection, interact mainly with 
macrophages by stimulating their microbicidal activity. Their repertoire o f cytokines 
is optimised for dealing with pathogens that have gained access to intracellular 
compartments, such as viruses and intracellular bacteria. Th2 cells on the other hand, 
mostly targeted to B cell-rich areas, secrete cytokines that help B cells to differentiate 
and produce antibodies, thus offering protection against extracellular antigens, like 
toxins and parasites.
There is accumulating evidence that the development of protective Thl or Th2 
cells is driven through the effects of microbes on DCs (d'Ostiani et al., 2000; Dabbagh 
et al., 2002; de Jong et al., 2002). Upon activation by signals released from the 
microorganisms or from infected tissues, DCs undergo maturation and migrate 
towards the T cell areas of draining lymphoid organs. Here, DCs activate naive CD4 
T cells with pathogen-specific (MHC-peptide complexes) and accessory signals. In 
addition, it seems that a third signal determines the polarisation of naive CD4 T cells 
into Thl or Th2 (Kalinski et al., 1999). This third signal is heterogeneous and is
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mediated by soluble as well as membrane-bound molecules, including 11-4,11-12 , II- 
18, IFNa and OX40L (Flynn et al., 1998; de Jong et al., 2002; MacDonald and 
Pearce, 2002). Importantly, the exact combination and expression levels of these 
polarising molecules by mature DCs strongly depend on the conditions during their 
initial activation. For example, tissue-derived factors such as IFNy and prostagladin 
E2, present during DC activation, promote respectively the generation of DCs that 
produce high amounts of 11-12 upon subsequent engagement with naive T cells, or the 
generation of DCs that are II-12-deficient and drive the development of Th2 (Kalinski 
et al., 1998; Vieira et al., 2000).
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Figure 2. Model of CD4 T cell differentiation. After encountering pathogens in 
peripheral organs, DCs migrate to the T cell-rich zones in lymphoid organs. The 
interactions with the pathogen, its products (PAMPs) and the local inflammatory 
milieu result in differential expression of cytokines, chemokines and co-stimulatory 
molecules. As a result, naive CD4 T cells differentiate into Thl effector cells under 
the influence of Thl cytokines like 11-12, or Th2 effector cells under the influence of 
11-4. Autocrine secretion of IFNy expands and stabilises the Thl response while 
inhibiting a Th2 response and, vice versa, 11-4 expands and stabilises the Th2 response 
while inhibiting the generation of Thl cells.
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In addition to their distinct roles in disease, Thl and Th2 cells cross-regulate 
each other’s expansion and functions with their respective repertoire of cytokines 
(Figure 2). Besides polarising and maintaining the Th2 response, 11-4 is involved in 
silencing the expression of the Thl cytokine IFNy (Tanaka et al., 1993). IFNy on the 
other hand, enhances the effect of 11-12, a dominant factor inducing the development 
of Thl cells, by upregulating the I1-12R, while inhibiting the growth of Th2 cells 
(O'Garra, 1998). 11-18 has also been shown to synergise with 11-12 to stimulate the 
production of IFNy by Thl cells, and thus indirectly suppressing the generation of 
Th2 cells (Okamura et al., 1995).
The Treg cytokine profile is distinct from that of classical Thl or Th2 cells, but 
heterogeneous, depending on the tolerance protocol or the site of isolation. Besides II- 
10, some produce TGFP, IFNy, 11-5, but no or only low levels of 11-2 and no to 
variable amounts of 11-4 are reported (Chen et al., 1994; Groux and Powrie, 1999). 
Although they cannot produce it, in \itro  and in vivo these cells seem to be critically 
dependent on 11-2 for differentiation and survival (Papiemik et al., 1998). The distinct 
T cell sub-populations that secrete 11-10 and/or TGFp are considered to play a role in 
the maintenance of self-tolerance.
1.7 T cell activation
Engagement of the TCR on mature peripheral T cells initiates multiple signals 
that can lead to cellular proliferation and the differentiation into specialised effector 
cells. The basis for this activation is formed by the recognition through the TCR of a 
ligand loaded on a MHC molecule.
1.7.1 The TCR
The complexity of molecular associations involved in TCR signalling begins 
with the TCR itself. It is composed of six different polypeptide chains thought to be 
organised into an eight-chain structure (Weissman, 1994). The TCR itself consists of 
two different polypeptide chains, termed a  and P chain, bound to one another by a 
disulphide bond. These a:P  heterodimers account for antigen recognition. Neither 
chain of the TCR heterodimer has a large cytoplasmic domain that might serve to 
signal the cell that the TCR has bound antigen. The signal transduction pathway starts
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instead with a complex of proteins, known as the CD3-complex, which is stably 
associated with the TCR on the surface of T cells. These include the non-polymorphic 
CD3e, CD3y, CD3Ô, and TCRÇ chains, which are all essential for receptor assembly, 
cell-surface expression and signalling (Ashwell and Klusner, 1990).
The cytoplasmic domains of the signalling components contain tyrosine 
residues in conserved motifs termed immunoregulatory tyrosine activation motifs 
(ITAM). Many receptors that participate in immune responses feature multiple 
subunits and/or motifs that mediate signal transduction. Intriguingly, multiple copies 
of these motifs can be found in virtually all receptors that utilise ITAMs for signal 
transduction (Reth, 1989). The receptors contain no inherent kinase activity but, upon 
crosslinking by ligand binding, the tyrosines within the receptor ITAMs become 
phosphorylated by Src-family kinases, thus initiating signal cascades.
ITAMs consist of semi-conserved sequences of amino acids that contain two 
appropriately spaced tyrosines (YXXL/IXe-gYXXL/I; where X denotes non-conserved 
residues) (Reth, 1989). These ITAMs appear as a single copy on the CD3y, 6, and e 
chains and as a triplicate repeat on the Ç chains (Cambier, 1995). This motif is crucial 
for TCR coupling to intracellular tyrosine kinases and hence absolutely required for 
all subsequent TCR signalling responses.
1.7.2 Anatomy of T cell signalling
The earliest recognisable event after TCR engagement by antigen is the 
induction of tyrosine phosphorylation by the Src kinases Lck and Fyn. How these Src 
kinases are activated exactly is unclear, but it involves additional recruitment to the 
cell membrane (Shaw et al., 1995).
1.7.2.1 Raft hypothesis
A clue as to how the TCR is brought into association with signal-initiating Src 
kinases came from the characterisation of lipid rafts. Cell membranes are comprised 
of a complex mixture of cholesterol, glycerophospholipids and sphingolipids. These 
constituents exhibit distinct biophysical properties; sphingolipids have longer and 
more saturated fatty acid chains and exhibit stronger lateral cohesion than 
glycerophospholipids, and cholesterol preferentially interacts with sphingolipids
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rather than with unsaturated glycerophospholipids. Thus, these lipids behave in 
different ways when forming a bilayer, with sphingolipids showing a tendency to 
form distinct ‘liquid-ordered’ phases dispersed in the ‘liquid-disordered’ matrix 
formed by glycerophospholipids (Simons and Toomre, 2000).
Although lipid rafts, rich in cholesterol and glycosphingolipids, were 
identified initially because of their peculiar biophysical properties, they have been 
directly visualised in living cells (Friedrichson and Kurzchalia, 1998; Varma and 
Mayor, 1998; Schütz et al., 2000). Rafts are now defined as dispersed liquid-ordered 
phase domains to which specific proteins are sequestered but from which others are 
excluded (Simons and Toomre, 2000). Thus rafts float in a sea of phospholipids 
providing a mechanism for the lateral sorting of membrane proteins.
Under resting condition, the TCR-CD3Ç complex seems to be excluded from 
or only weakly associated with the raft signalling platforms (Montixi et al., 1998), 
skewing the equilibrium of the receptor toward the non-raft regions of the membrane. 
Engagement of the TCR by its ligand induces TCR translocation into raft domains, 
shifting the equilibrium towards rafts, where the accumulation of supramolecular 
signalling complexes occurs, moved around by the actin cytoskeleton (Montixi et al., 
1998; Lanzavecchia et al., 1999). These events, as well as T cell activation, can be 
suppressed by disrupting raft structure, indicating that membrane 
compartmentalisation is a pre-requisite for TCR signal transduction (Xavier et al., 
1998).
Any factor that affects the process of receptor translocation into rafts could be 
predicted to have the potential to promote or dampen signalling. Indeed, access of 
receptors is altered during both T cell and B cell development, reflecting changes in 
the outcome of antigen engagement by the receptors. In DN T cells, the pre-TCR 
appears to localise into rafts without the need for ligation, providing a mechanism for 
receptor signalling for further development (Guo et al., 2000; Saint-Ruf et al., 2000). 
In contrast, in DP T cells, the crosslinked receptors fail to translocate into rafts, 
possibly providing a structural basis for different outcomes of signalling in mature 
and immature lymphocytes (Ebert et al., 2000).
The post-translational addition of lipids (by myristoylation, palmitoylation and 
prénylation) is an essential requirement for the targeting of many proteins to
47
Introduction
membrane rafts, as well as for their correct functioning. Several molecules are 
associated with raft domains in T cells. Lck, the Src kinase responsible for initial 
tyrosine phosphorylation events following TCR ligation, is targeted to membrane rafts 
by the dual acylation of its N-terminus (Resh, 1994). Targeting to raft domains is 
crucial for Lck function, as shown by the fact that Lck mutants that are not acylated 
and do not localise to the plasma membrane are unable to signal properly (Kabouridis 
et al., 1997). Alternatively, it has been proposed that, in lymphocyte plasma 
membranes, Lck and Fyn kinases exhibit optimal activity in raft microdomains but 
encounter inhibitory conditions in surrounding membrane areas with a non-raft 
morphology (Ilangumaran et al., 1999).
In resting cells, rafts appear to be dynamic structures that are estimated to be 
small, but may fuse to form larger domains upon receptor ligand binding, to 
contribute to the immunological synapse (IS) (Janes et al., 1999).
1.7.2.2 The immunological synapse
Circulating T cells are rounded and non-polarised, with uniform radial 
distribution of membrane domains, receptors and microvilli on the cell surface 
(Sanchez-Madrid and del Pozo, 1999). Within minutes of contacting an APC, a T cell 
undergoes a dramatic polymerisation of actin filaments at the site of cell-cell contact. 
This specific molecular organisation is observed only at the interface between the DC 
and T cell. The interaction thus creates a specific physical site, termed the 
‘immunological synapse’ (Grakoui et al., 1999), at which specific ligands and 
receptor molecules trigger and sustain the T cell activation process. Key to this 
mechanism is the DCs ability for high expression of MHC, accessory (CD80 and 
CD86) and adhesion (ICAM-1 and ICAM-3) molecules (Banchereau and Steinman, 
1998).
The IS is currently viewed as a concentric structure, with a central 
supramolecular activation cluster (cSMAC) enriched in TCR, CD2 and CD28, that is 
surrounded by the peripheral SMAC (pSMAC), which is enriched in lymphocyte 
function-associated antigen-1 (LFA-1). Importantly, the large membrane molecules 
CD43 and CD45 are excluded from the IS (Johnson et al., 2000). Topological models 
of T cell signalling predict that those molecules with large extracellular domains 
would be excluded from sites of TCR -  MHC/peptide interactions due to the small
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distances between apposing membranes (~15 nm) (van der Merwe et al., 2000). This 
size-exclusion model is supported by the demonstration that elongated forms of CD2 
can severely impair T cell activation (Wild et al., 1999). Close contacts may be 
achieved indirectly through cytoskeletal protrusions anchored to larger adhesion 
molecules like LFA-I and ICAM-1, or more directly by smaller adhesion receptor 
pairs like CD2 and CD58 that would work immediately beside the TCR.
The formation of sSMACs may be driven by an initial TCR -  MHC/peptide 
interaction and the subsequent recruitment of additional molecules, a process that is 
driven by T cell motility and promotes redistribution of molecules within the two 
membranes. Indeed, the formation of the mature IS is preceded by TCR signalling 
(Lee et al., 2002). Effector T cells polarise their microtubule organising centres 
(MTOC) toward APCs (Kupfer and Singer, 1989). Fluorescence studies show that 
redistribution of involved membrane structures occur within a few minutes and lead 
to a stable configuration for extended periods of time (Grakoui et al., 1999).
IS formation requires an active cytoskeletal rearrangement, which is closely 
associated with T cell activation (Wulfmg and Davis, 1998). However, it can occur 
between T cells and DCs in the absence of exogenous antigen, a process associated 
with several T cell responses (Kondo et al., 2001; Revy et al., 2001). IS formation 
was found tightly associated with small calcium fluxes, increased tyrosine 
phosphorylation of TCRÇ and Lck, recruitment of Zeta-chain Associated Protein of 
70 kDa (ZAP-70) and prolonged T cell survival. Other receptor-ligand interactions 
besides the TCR -  MHC/peptide ligation can affect actin organisation. For example, 
intergrin-dependent recruitment of actin crosslinking proteins such as talin to the 
contact site creates a dense network of filaments (Sedwick et al., 1999). Actin 
organisation is also important for the assembly of proteins involved in TCR 
signalling. Actin regulatory molecules like Wiskott Aldrich Syndrome protein 
(WASP), Fyn-binding protein (Fyb)/ Src homology (SH)2 domain-containing 
Leukocyte Protein of 76 kDa (SLP-76)-associated protein (SLAP) and Vav play 
important roles in actin remodelling at the synapse (Krause et al., 2000), together with 
the Rho family of guanosine triphosphatases (GTPases), including Cdc42, Rac and 
Rho. Thus, T cell signalling and actin remodelling are intricately interwoven for 
optimal T cell activation and differentiation.
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Importantly, APCs regulate the lateral distribution of their surface MHC class 
II molecules also in micro-domains, even before contact with T cells and formation of 
the IS (Kropshofer et al., 2002). The local concentration of MHC molecules probably 
facilitates antigen presentation at low doses of antigen (Anderson et al., 2000). 
However, DCs contain only few MHC molecules in lipid rafts, the majority being 
found in tetraspan micro-domains, displaying specific peptides, co-localised with 
important ligands for the accessory molecules on T cells like B7.2, CD82 and CD9. 
This lateral association of MHC with adhesion and co-stimulatory molecules might 
facilitate synapse formation and T cell activation.
Complexes between peptide and MHC molecules are generally thought to 
have a low affinity for TCRs, with relatively fast off-rates, but they can nonetheless 
deliver sustained stimulation to the T cell (Davis et al., 1998). It is known that just a 
few MHC-peptide complexes on a DC can be sufficient to trigger T cells (Valitutti et 
al., 1995; Sykulev et al., 1996). A mechanism to increase the overall avidity of this 
interaction is the formation of TCR and accessory receptor arrays that interact with 
specific as well as non-specific MHC-peptide dimers. It was demonstrated that TCRs 
are enriched in the central region of the IS, viewed as a means to generate stable 
molecular complexes able to sustain the signal over time. In addition, T cell signalling 
is viewed as an ongoing process that is sustained by serial engagement and triggering 
of TCRs by MHC-peptide complexes (Valitutti et al., 1995).
The recent report by Lee et al. (2002), challenged the current ideas about the 
precise role of the IS in TCR signalling. They showed that the TCR resides at the 
periphery of the immature synapse upon first contact with an ARC, whereafter it , 
moves to the central position in the mature synapse. They subsequently showed that 
active Lck only co-localises with the external ring of TCR in the immature synapse, 
and that at the formation of the mature synapse, active Lck is undetectable. Also, 
active ZAP-70 was first found at the peripheral ring and only weakly at the centre of 
the mature synapse. They concluded that it appears that the initiation of signalling 
precedes the formation of the IS, and that synapse formation may not be directly 
involved in either the initiation or enhancement of TCR signalling. It does not 
exclude, however, that the IS provides an initiation point where engagement and 
activation of receptors other than the TCR takes place (van der Merwe and Davis, 
2002).
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1.7.3 Initiation of T cell signalling
It is not yet known how engaged TCRs are recruited into raft domains. It is 
possible that ligation of TCRs by MHC-peptide tetraspan micro-domains on the ARC 
surface might decrease the lateral diffusion of the engaged receptors in the membrane 
and drive their recruitment into raft micro-domains. The limited space between the T 
cell and its participating APC may lead to exclusion of large receptors, including the 
tyrosine phosphatases CD45 and CD148, but would allow smaller receptors to remain 
in the contact zone. This receptor sorting is critical to the forming of the IS and 
topologically organisation of the SMAC. In addition, the TCR-CD3 complex 
undergoes a conformational change, leading to recruitment of actin-remodelling 
molecules (Gil et al., 2002).
Interestingly, upon first contact between T cell and APC, LFA-1 molecules are 
recruited to the centre of the contact area, whereas TCRs were found at the periphery 
of the immature synapse co-localised with activated Lck. This pattern is reversed 
shortly after, with the TCR and Lck in the centre, surrounded by LFA-1 in the mature 
synapse (Lee et al., 2002). Once TCRs are recruited into the immature synapse, the 
kinase-rich environment, created by the recruitment of Lck, allows subsequent 
phosphorylation of CD3Ç and the recruitment of ZAP-70, resulting in signal 
transduction. The underlying concept is that by keeping phosphatases apart from 
substrates of TCR-induced phosphorylation, the IS would protect the propagation of 
positive signals. Indeed, CD45, the most abundant membrane tyrosine phosphatase, is 
excluded from raft domains (Rodgers and Rose, 1996; Janes et al., 2000). The 
coalescence of raft microdomains induced by the formation of the IS will exclude 
CD45 from the signalling area and protect activated kinases and signalling motifs 
from dephosphorylation (Thomas, 1999).
A discreet pool of CD45 moves back into the central region of the mature 
synapse, adjacent to the area of TCR/MHC engagement (Johnson et al., 2000). The 
positive or negative role of this CD45 movement is unknown, but it may provide a 
mechanism to sustain Lck activity near engaged TCRs. However, these CD45 
molecules are not found in the plasma membrane, but intracellularly, and thus may 
serve a quite different function. Many other phosphatases that may be involved in the 
regulation of TCR signalling are mostly expressed in T cells as cytosolic proteins and 
excluded from rafts (Gjorloff-Wingren et al., 2000). The importance of this was
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demonstrated by deliberately targeting the SH2 domain containing tyrosine 
phosphatase (SHP-1) into the raft microdomains by using the N-terminal region of 
Lck, which profoundly inhibited CD3 induced tyrosine phosphorylation and 11-2 
production (Su et al., 2001).
Exactly how Lck is activated during TCR engagement is unclear. Activation 
of Lck is negatively regulated through the carboxy-terminal (C-terminal) tyrosine 
phosphorylation site (Y505), which mediates intramolecular binding to its SH2 
domain that places the kinase in a closed conformation leaving its kinase domain 
inaccessible (Sicheri et al., 1997). The removal of the C-terminal phosphate residue 
leads to Src kinase unfolding (Veillette et al., 1988). This conformational change frees 
up the SH2 domain that allows Lck to interact with new partners, including ZAP-70 
(Di Bartolo et al., 1999). However, phosphopeptide-mapping experiments have shown 
that the majority of Lck in resting T cells is already dephosphoiylated at Y505 
(Ostergaard et al., 1989). Based on these data, it has been suggested that recruitment, 
and not activation of Lck may be the critical activation step (Shaw et al., 1995). 
Phosphorylation of inhibitory Y505 is controlled by the opposing actions of the 
protein tyrosine kinase (PTK) Csk and by the protein tyrosine phosphatase (PTP) 
CD45. CD45 is excluded from aggregated rafts, whereas the Csk docking protein Cbp 
is an acylated transmembrane protein that is concentrated in rafts (Kawabuchi e tal.,
2000). Under steady state conditions, Cbp is basally phosphorylated, allowing 
recruitment of constitutively active Csk to the rafts to keep present Lck quiescent. 
Upon triggering of the TCR however, Cbp is rapidly dephosphorylated leading to 
dissociation of Csk from lipid rafts (Torgersen et al., 2001).
The localisation of Lck in and around the IS is due to its unique N-terminal 
domain, which is acylated at its two cysteine residues (Resh, 1994), and binds to the 
cytoplasmic tails of the co-receptor molecules CD4 and CD8 (Barber et al., 1989). In 
the IS, the SH3 domain can engage with a proline-rich sequence in the cytoplasmic 
domain of CD28 (Holdorf et al., 1999), consequently stimulating its activity. 
Conversely, a second site of tyrosine phosphorylation (Y394) found in the activation 
loop of the kinase domain is autophosphorylated to activate the kinase for substrate 
phosphorylation. Interestingly, Y394 is also dephosphorylated by CD45, as well as by 
Proline-, Glutamic acid-. Serine-, and Threonine-rich [PEST]-domain Phosphatase 
(PEP) (D'Oro and Ashwell, 1999). Recruitment of Lck was shown to be delayed in 
CD4-deficient T cells compared with wild type, resulting in slow autophosphorylation
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of Y394. In CD28-deficient T cells Y394 phosphorylation could be detected at 
comparable rate, however, it was quickly lost (Holdorf et al., 2002). This suggests 
that CD4 or CD8 initially recruit Lck and stimulate its autophosphorylation at the 
synapse, whereas CD28 sustains the phosphorylation state and activity.
Upon TCR crosslinking, the CD3 multichains enter rafts, supplying the 
ITAMs as substrates for kinase binding and phosphorylation. Full activation of the 
Src kinases also results, after several minutes, in the re-phosphorylation of Cbp, 
which recruits Csk back into the synapse, thus providing a mechanism by which 
signalling can be terminated (Brdicka et al., 2000; Torgersen et al., 2001). This 
suggests that all the machinery necessary for the initiation and termination of TCR 
signalling is concentrated in the IS.
1.7.4 Proximal T cell signalling
Following receptor engagement, phosphorylation of ITAM tyrosine residues 
by PTKs of the Src family of kinases is one of the earliest events in the signalling 
cascade (Weiss, 1993). Phosphorylation of both tyrosine residues within an ITAM is 
generally thought to be essential for signalling, and is required for efficient 
recruitment of the tandem SH2 domain-containing PTK ZAP-70 to the receptor 
complex. ITAM phosphorylation by a pool of active Src kinases is continuously 
opposed by PTPs (van der Merwe et al., 2000). This repressive effect is removed 
during the formation of the immunological synapse, allowing Src kinases to dominate 
the phosphorylation status of the ITAMs (Shaw and Dustin, 1997).
After its recruitment to the ITAM motifs, ZAP-70 is phosphorylated by Lck, 
resulting in its activation (Iwashima et al., 1994). Lck interacts directly with ZAP-70 
through the binding of the Lck SH2 domain to the phosphorylated Y319 residue of 
ZAP-70 (Pelosi et al., 1999). This interaction is critical for sustained ITAM 
phosphorylation, leading to additional recruitment of ZAP-70 molecules and Lck 
substrates, such as the Tec kinase Itk (van der Merwe et al., 2000). Interestingly, not 
all the ITAMs appear to be phosphorylated on every occasion the TCR is triggered. 
Depending on the ITAM phosphorylation pattern, the TCRÇ migrates during SDS- 
PAGE as either a 21- or 23-kD peptide (Kersh et al., 1998a; van Gers et al., 2000).
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The molecules that bridge the activated TCR with its associated PTKs to the 
tyrosine kinase substrates play a critical role in TCR-mediated signalling. Propagation 
and amplification of the TCR signal is directed via adapter or linker proteins. The 
most prominent are SLP-76 and linker of activation of T cells (LAT). The latter, a 
36/38 kDa transmembrane key signalling molecule localised in raft microdomains, is 
tyrosine phosphorylated by ZAP-70 and is, like Lck, associated with the co-receptor 
molecules CD4 and CD8 (Bosselut et al., 1999). LAT mutants lacking palmitoylation 
sites are excluded from rafts and do not become phosphorylated by ZAP-70, resulting 
in inefficient TCR-induced signal transduction (Zhang et al., 1998). LAT provides a 
scaffold by which multiple signalling molecules, such as phospholipase C (PLC)yl 
can be recruited. In addition, tyrosine-phosphorylated LAT also recruits multiple 
members of the growth factor receptor-bound protein (Grb2/Gads/Grap) family of 
adaptor proteins, which are able with their multiple protein-protein interaction 
domains to assemble macromolecular signalling complexes.
PLCyl tyrosine phosphorylation is one of the major determinants for calcium 
signalling, and requires the activity of three PTKs, Lck, ZAP-70 and Itk (Kurosaki 
and Tsukada, 2000). Consensus phosphotyrosine residues are responsible for the 
recruitment of PLCyl SH2 domains to LAT and consequently to bring it in close 
contact with the inner leaflet of the surface membrane. LAT also stabilises SLP-76 
binding, which brings the Tec kinase Itk into this macromolecular complex, 
ultimately resulting in phosphorylation of PLCyl (Kurosaki and Tsukada, 2000). This 
catalytically activates PLCyl, utilising phosphatidylinositol-4,5 biphosphate 
(PI(4,5)P2), concentrated in plasma membrane rafts (Caroni, 2001), to generate 
inositol-1,4,5-triphophate (IP3) and diacylglycerol (DAG). IP3 stimulates the release 
of calcium ions from intracellular stores, mainly the ER (Berridge et al., 1998). Once 
these stores are depleted, store-operated calcium channels in the surface membrane 
allow extracellular calcium influx. This results in a sustained elevation of intracellular 
calcium levels, which act as a trigger for transcriptional activation in the nucleus. 
Calcium binds to calcineurin, a calcium calmodulin-dependent serine phosphatase 
that dephosphoiylates the nuclear factor of activated T cells (NEAT) (Baksh and 
Burakoff, 2000). This leads to the conversion of cytoplasmic NEAT to nuclear NEAT, 
capable of binding to sites in promoters.
DAG binds to a small 5 kDa zinc containing domain, called the protein kinase 
C homology-1, which has been identified in protein kinase C (PKC) and RasGRP
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amongst others. T cells express multiple functionally distinct PKC isoforms. Calcium, 
DAG and other phospholipids regulate them. Among the many isoforms, only PKC-0 
is recruited into the immunological synapse (Monks et al., 1997), where it is involved 
in the activation o f the nuclear factor kB (NF-kB) pathway and possibly also the N- 
terminal c-Jun kinase (JNK) cascade (Khoshnan et al., 2000).
1.7.5 T cell signalling downstream of PTKs
In addition to PLCyl activation, PTKs affect phosphatidylinositol (PI) 
turnover through phosphoinositol-3 kinase (PI3K). The membrane phospholipid 
phosphatidylinositol is the precursor for a family of lipid second messengers, known 
collectively as phosphoinositides, which differ solely in the phosphorylation status of 
their inositol head group. The abundance of phosphoinositides makes it possible to 
target a large number of distinct proteins to a particular membrane without saturating 
the binding sites. In addition, the structurally distinct phosphoinositides, with rapid 
sequential interconversions between phosphorylated forms, can activate different 
downstream effectors.
LAT is also involved in regulation of the GTPase Ras and mitogen-activated 
protein kinases (MAPK) cascades. A central role, linking proximal signalling events 
to cascades of the MAPKs, is played by the guanine nucleotide binding protein 
p21Ras. The level of active Ras is determined by a balance of the rate of hydrolysis of 
bound GTP and the rate of exchange of bound GDP for cytosolic GTP. Receptor 
tyrosine kinases regulate Ras activity via interactions with guanine nucleotide 
exchange factors (GEF), such as Sos and RasGRP (Polakis and McCormick, 1993; 
Ebinu et al., 1998), and GTPase-activating proteins (GAP), such as p i 20-GAP 
(Downward et al., 1992). Activation of Ras triggers a cascade of the MAPK 
extracellular signal-regulated kinase (Erk), and is suggested to cross-talk to Rho 
GTPases, which in turn activate other MAPK families such as JNK and p38 (Genot et 
al., 1996).
There are three major groups of MAPKs in mammalian cells, Erks, p38 
MAPK and JNK. Dual phosphorylation of a tyrosine and a threonine residue activates 
them. The sequence of the motif containing these two amino acids is different in each 
group of MAPKs. Each group is activated by a conserved protein cascade; Erks are 
activated by the MAP kinase kinases (MKK) MKKl and MKK2; p38 MAPKs by
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MKK3, MKK6  and possibly MKK4; while JNKs are activated by MKK4 and MKK7. 
In their turn these MKKs are activated by MAP kinase kinase kinases (MKKK), 
which are activated by different upstream signals with a prominent role for GTPases. 
Erks are the end of the cascade activated by the GTPase Ras via the MKKK Raf. In 
contrast, p38 MAPKs and JNKs are at the end of cascades initiated by Rac/Rho 
GTPases. All three kinases play an important role in the innate immune response, as 
well as in the adaptive immune response, where they are involved in the signalling 
cascades leading from TCRs to cytokine production and cellular responses to 
inflammatory cytokines (Dong et al., 2002).
Erk, downstream of Ras, is often involved in the regulation of cell growth and 
differentiation. There are two isoforms of Erk, Erkl and Erk2, also known as p44/p42 
MAPK. TCR engagement activates the Ras-Raf-MKK-Erk pathway, resulting in the 
expression of the activator protein-1 (AP-1) transcription factor Eos, as well as Myc 
(Dong et al., 2002). Fos is involved in transcriptional regulation of the AP-1 response 
elements in the 11-2 promoter (Jain et al., 1995).
The role of JNK in T cell activation and 11-2 production is somewhat more 
controversial. TCR ligation is required for the activation of JNK, but it is not clear 
what signals regulate the enhanced expression and activity of JNK proteins. Studies 
with JNKl and JNK2 knockout mice suggest that both may have an important 
functional role in the establishment and maintenance of Thl cells (Dong et al., 1998; 
Yang et al., 1998).
The p38 MAPK regulates IFNy gene expression in Thl cells but apparently 
does not affect Th2 cytokines (Dong et al., 2002). It regulates AICD in CD8 T cells 
but not in CD4 T cells, demonstrating that activation of the same signalling pathway 
can have different outcomes in the two T cell subsets (Merritt et al., 2000). Hence, 
activation of p38 MAPK results in increased production of IFNy by CD4 T hl cells 
and CD8 T cells, but also leads to a decrease in the number of effector CD8 T cells.
Activation of the 11-2 promoter by T cell signalling cascades also involves the 
NF-KB pathway (Harhaj and Sun, 1998). The exact mechanisms by which the NF-KB 
pathway is initiated by TCR ligation still needs to be clarified, but seems to involve 
the recruitment of PKC0 into the immunological synapse (Lin et al., 2000). NF-kB 
activation depends on a multisubunit cytosolic complex. It includes the catalytically
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active IkB kinases IKKa and IKKP, which form heterodimers with the non-catalytic 
subunit IKKy (Regnier et al., 1997). The activated complex initiates the 
phosphorylation and subsequent degradation of the inhibitory iKBa and IxBp 
proteins. This releases the NF-kB transcription factors, p65, c-Rel, RelA and p50, 
which were sequestered by iKBa and iKBp, and allows them to enter the nucleus to 
initiate transcription of their target genes. One of these target genes is 11-2.
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Figure 3. MAPK signalling pathways. Various stimuli lead to activation of the 
small GTPases like Ras and Rac, these initiate the various MAPK pathways, leading 
to Erk, p38 and JNK activation and resulting in activation of various transcription 
factors. The figure does not display all aspects of cross-talk between the three 
pathways, but illustrates the complexity involved at this level of signal transduction in 
T cells.
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1.7.6 Accessory receptors
It is known that only a few receptor -  MHC/peptide interactions are required 
to trigger and activate T cells (Valitutti et al., 1995). However, the affinity of tile TCR 
for antigen is very low, unlikely to be sufficient to drive formation and stabilisation of 
the tight contact between T cell and APC. To maintain such a high degree of 
sensitivity and fidelity of T cell recognition, a number of co-stimulatory and 
accessory molecules are co-ordinately engaged in the immune recognition process. 
These include among others; CD2, CD4, CDS, CD28, LFA-1, CD9, CD44, CD48 and 
CD5.
The identification of co-stimulators led to the two-signal model for T cell 
activation, proposing that the first signal is provided by the TCR/CD3 complex, while 
a second signal is generated by engagement of T cell accessory receptors (Schwartz, 
1990). Although numerous molecules have been implicated as accessory receptors, 
CD28 is the classical example. The interaction of CD28 on T cells with B7 family 
molecules on APCs is important for providing signal 2, since it up-regulates 11-2 
production and T cell proliferation (Linsley and Ledbetter, 1993; June et al., 1994). 
However, the unification of the two-signal model with the immunological synapse 
model is currently challenged. An alternate view is that co-stimulators function to 
fine-tune the TCR signal by organising the T cell -  APC contact site for optimal TCR 
engagement and subsequent signal transduction (Dustin and Shaw, 1999; Gett and 
Hodgkin, 2001).
1.7.6.1 The co-receptors CD4/CD8
The co-receptors CD4 and CD8 play an important role in TCR signalling, but 
the nature of their contribution is not clear. It is thought that CD4/CD8 increase the 
efficiency of formation of the IS, by enhancing contact between the TCR and MHC 
molecules. CD4/CD8 associates with the TCR following activation by recruitment of 
the TCR into rafts (Xavier et al., 1998). During activation, CD4 increases T cell 
sensitivity to antigen by 10- to 100-fold (Hampl et al., 1997). Part of this contribution 
stems from its ability to recruit the PTK Lck to the TCR/CD3 complex (Barber et al., 
1989). But even without its cycloplasmic Lck-binding domain, CD4 still augments T 
cell reactivity by 3- to 9-fold (Janeway Jr, 1992).
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Anti-TCR blockade prevents TCR/CD3 accumulation and abolishes 
accumulation of CD4. Thus CD4 accumulation seems dependent on TCR binding or 
signalling even though its ligand is present. This suggests that early TCR -  
MHC/peptide recognition serve to recruit CD4 to the interface and initiate signalling. 
Surprisingly, this is not a function of the cytoplasmic tail, although associated with 
the important signalling molecules Lck and LAT (Bosselut et al., 1999), since a 
deletion mutant behaved in the same way (Krummel et al., 2000).
In the mature synapse, CD4/CD8 is localised together with TCRÇ at the centre 
of the synapse, but the co-receptor then progressively migrates out of the central zone 
(Krummel et al., 2000). These findings do not support a model in which CD4/CD8 act 
to stabilise the TCR -  MHC/peptide complexes. Instead, they suggest that the 
function of these co-receptors may be to boost the early phase of activation. 
Thereafter, they are excluded from the cSMAC.
1.7.6.2 CD2 and LFA-1
Lymphocytes usually travel in a non-adhesive form through the blood and 
lymph but become adherent when they have to interact with other cells. The LFA-1 
integrin and its cellular ligands ICAM-1 and -3 play a crucial role in this process 
because they are involved in adhesion and transmigration through endothelial cells of 
the blood vessels and stabilisation of cell-cell contacts with APCs. LFA-1 has a 
relative large extracellular domain (the LFA-l/ICAM-1 interaction spans -30-40 nm), 
and by the formation of the IS is excluded from the cSMAC, but is found abundantly 
in the outer ring, stabilising the cell-cell contact site. Furthermore, LFA-1 has been 
demonstrated to increase its avidity for ICAM-1 after raft clustering, one potential 
mechanism by which TCR engagement increases LFA-1 adhesion (Krauss and 
Altevogt, 1999). LFA-1 does not deliver a co-stimulatory signal but facilitates the 
generation of the TCR signal, in particular at low antigen concentrations, by 
promoting adhesion of T cells to APCs, which can influence T cell activation and 
differentiation (Smits et al., 2002).
The membrane protein CD2, expressed on T cells and NK cells (and B cells in 
mice), is present in a different subregion of the pSMAC than LFA-1 (Grakoui et al., 
1999), and promotes a tight homogeneous interaction between the membranes of the 
T cell and APC by specific interaction with its ligands CD48 and CD58 (Selvaraj et
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al., 1987). This happens with similar physical dimensions as the TCR /MHC 
interactions (TCR/MHC, CD4/8/MHC and CD2/CD48 all span ~15nm). Its 
association with CD3 could serve to recruit the TCR to the contact surface. CD2/CD3 
co-clustering increases TCR association with rafts and CD2 engagement facilitates 
TCR clustering, cytoskeletal reorganisation and receptor patterning at the TCR 
contact site (Dustin et al., 1998; Yashiro-Ohtani et al., 2000). These processes are 
mediated by the binding of CD2-Associated Protein (CD2AP), a protein containing 
three SH3 domains that binds to polyproline motifs in the cytoplasmic tail of CD2. 
Overexpressing a dominant-negative form of CD2AP blocked both CD2-triggered 
cytoskeleton polarisation and IS formation, illustrating the importance of adhesion 
molecules. However, T cells from mice lacking CD2 do not exhibit a significant 
phenotype; other molecules, topologically similar in size to CD2, like CD28 may 
compensate for some functions of it (Killeen et al., 1992).
Most studies on CD2-CD48 interactions have focussed on T cell CD2 binding 
to APC CD48, because human CD2 expression is limited to T cells. However, in 
murine immune systems CD2 is also expressed on APCs. Moreover, because CD48 is 
a glycosylphosphatidylinositol (GPI)-anchored molecule, expressed on T cells, 
binding to CD2 expressed on APCs may similarly facilitate adhesion and TCR 
contact. Indeed, CD48 can shorten the duration of TCR engagement required for 
commitment to T cell activation, by possibly inducing the migration and clustering of 
lipid rafts to the TCR contact cap, a process that requires the Lck SH3 domain (Patel 
et al., 2001). Besides these enhancer mechanisms, CD2-CD58 interactions have been 
implicated in tolerance induction due to the lack of additional co-stimulation (Punch 
et al., 1998; Wakkach et al., 2001).
So far, studies suggest that T cell engagement of the APC is first mediated by 
LFA-1 and CD2 in distinct domains of non-antigen-specific contact areas. These co­
stimulators differ in how they associate with the plasma membrane and where they 
partition within the synapse. They facilitate T cell activation by formation of a 
signalling platform, which increases the number of receptors engaged.
1.7.6.3 CD28 and CTLA-4
CD28, the most prominently studied accessory receptor, is a disulphide-linked 
homodimeric glycoprotein, which is expressed on T cells and upregulated after T cell
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activation. CD28 interacts with B7-1 and B7-2 on APCs (Linsley and Ledbetter,
1993; June et al., 1994). It contains a 41 amino-acid residue cytoplasmic domain that 
lacks any obvious catalytic capacity. However, like the TCR, CD28 becomes 
phosphorylated on tyrosine residues by Src family kinases and Tec family kinases 
(Itk) (Raab et al., 1995). In addition, the CD28 cytoplasmic tail contains a proline-rich 
motif, which can serve to recruit SH3 domain containing molecules, like Lck 
(Holdorf et al., 1999). Despite the potential of the phosphorylated CD28 tyrosine 
motif to regulate signalling via recruitment of SH2-containing molecules like PI3-K 
and Grb2 or Gads, it is not clear whether this is essential for CD28 co-stimulation in 
vivo.
High doses of antigen in the absence of co-stimulation do not manage to 
activate naive T cells, whereas in the presence of co-stimulation naive T cells respond 
to low doses of antigen with high efficiency (Viola and Lanzavecchia, 1996; lezzi et 
al., 1998). It is known that co-stimulation via CD28, although to some extent 
dispensable as demonstrated in CD28-deficient mice (Shahinian et al., 1993), can 
dramatically enhance the response of naive T cells and prevent the induction of 
anergy. Double mutant mice lacking CD28 and CD2 are more impaired in T cell 
activation than are the corresponding single mutant mice (Green et al., 2000). This 
suggests a degree of redundancy among adhesion/co-stimulation molecules. The 
unique phenotype associated with CD28 deficiency is the inability to respond to a 
wide range of peptide antigens, in contrast to lacking CD2, CD48 or LFA-1, which 
alters the quantitative aspects of the T cell response to a given peptide-MHC complex.
The different attributes of the different accessory receptors correlate with the 
localisation of these molecules in the mature IS; CD28 is localised in the sSMAC, 
whereas LFA-1 is engaged in a different subregion of the pSMAC (Grakoui et al., 
1999). Therefore, CD28 is perfectly positioned to directly manipulate TCR signals. 
TCR triggering is weak in the mature synapse, but sustained TCR signals are required 
for full T cell activation (Lee et al., 2002). As demonstrated recently, CD28 
influences immediate and sustained TCR signalling by enhancing activation of Lck 
(Holdorf et al., 2002). CD4 or CD8 initially recruit Lck and stimulate its 
autophosphorylation, but CD28 sustains the phosphorylation state and activity. Thus, 
CD28 affects the earliest process associated with TCR signalling and formation of the 
IS, enhances engagement processes in the cSMAC and consequently sustains TCR 
signalling.
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Co-stimulatory molecules also provide negative signals required to attenuate 
the immune response and to maintain peripheral T cell tolerance to protect against 
autoimmunity. The interaction of B7 molecules with the cytolytic T lymphocyte 
associated antigen 4 (CTLA-4) provides inhibitory signals required for down- 
regulation of the T cell response. CTLA-4 protein is not detectable in naive T cells, 
but it is upregulated upon T cell activation, where it is targeted to the endosomal 
compartment (Lindsten et al., 1993).
CTLA-4 is translocated by polarised exocytosis to the centre of the mature 
synapse, thereby directly able to inhibit TCR signalling in addition to blocking CD28 
signals (Egen and Allison, 2002). It also binds to B7, but with much higher avidity 
than CD28 (van der Merwe et al., 1997). Upon binding, it delivers an opposing signal 
to the T cell compared with CD28, it reduces the production of 11-2 and restricts T cell 
expansion by reducing the production of cyclins and cyclin dependent kinases (Cdk) 
(Brunner et al., 1999). Interestingly, localisation of CTLA-4 to the synapse is 
favoured under conditions of strong TCR ligation, suggesting that it controls the 
amplitude of TCR signalling (Egen and Allison, 2002). Thus, the activation of a T cell 
is initiated by the TCR, sustained by CD28 located in the cSMAC and modulated by 
targeted exocytosis of CTLA-4 into the cSMAC.
1.8 Signalling in development, differentiation and anergy
The induction of a cellular response following engagement of signal 
transduction receptors is based on the co-ordinated activities of diverse intracellular 
signalling pathways. The spectrum of biological activity elicited by TCR-mediated T 
cell activation seems to correlate with the binding affinity of the TCR for its peptide- 
MHC ligand (Rabinowitz et al., 1996; Wulfîng et al., 1997; Germain and Stefanova, 
1999). However, the signals that drive T cells into activation or regulation are as yet 
poorly defined. The amount of ligand required to activate T cells varies according to 
the state of the T cells (naive or memory) and the number of adhesion and co­
stimulatory molecules on the APC (Inaba and Steinman, 1984). T cells respond only 
when the number of triggered TCRs reaches an appropriate threshold, and this 
threshold can be adjusted by co-stimulatory molecules (Viola and Lanzavecchia, 
1996). This suggests that TCR and co-stimulatory pathways synergise along signal 
transduction cascades (Tuosto and Acuto, 1998; Salojin et al., 1999; Sedwick et al., 
1999; Tsuchida et al., 1999; Holdorf et al., 2002). APCs lacking adhesion and co-
62
Introduction
stimulatory molecules may induce TCR triggering below a certain threshold, leading 
to T cell anergy (Ferber et al., 1994), while the inflamatory milieu may determine the 
combination and level of accessory molecules expressed on DCs, leading to 
differentiation of activated CD4 T cells into Thl, Th2 and Treg.
Contributing to a model of T cell activation with hierarchical thresholds for 
different functional responses were studies analysing T cell responses demonstrating a 
significant heterogeneity within a clonal population during an immune response 
(Assenmacher et al., 1994; Bucy et al., 1994; Openshaw et al., 1995; Valitutti et al., 
1995; Itoh and Germain, 1997). More recently, a correlation was found between the 
level of IFNy secretion and Lck expression, suggesting a relationship between 
signalling strength and cell differentiation into effector cells with characteristic 
cytokine profiles (Slifka and Whitton, 2001).
The affinity of the TCR for the peptide-MHC complex determines the level of 
ITAM phosphorylation and thus seems an important determinant in the outcome of an 
immune response (Sloan-Lancaster et al., 1994; Madrenas et al., 1995; Love and 
Shores, 2000a). The TCRÇ chain contains three ITAMs, including a total of six 
tyrosines that are phosphorylated in an ordered manner after TCR ligation (Kersh et 
al., 1998a). Recognition of a less potent ligand leads to partial phosphorylation of a 
subset of tyrosine residues, while a potent ligand, induces complete phosphorylation 
of the ITAMs. By viewing the phosphorylation process as a series of reversible 
sequential steps, it was proposed that weak ligands having a rapid dissociation, would 
only manage a limited amount of TCRÇ phosphorylation, subsequently reducing the 
recruitment of ZAP-70, thus allowing the T cell to discriminate among antigens 
(Kersh et al., 1998b).
As a result of quantitative reduction in TCR signalling, possible qualitatively 
different signals determine the outcome of T cell activation. It is however still unclear 
whether these qualitative signals include novel signalling molecules or complexes. It 
is possible that monophosphorylated ITAMs recruit other molecules than ZAP-70, 
like negative regulators of TCR signalling (Love and Shores, 2000a). By using 
agonist and altered peptide ligands (APL) to stimulate T cells, several differences in 
signal transduction pathways have been reported. Stimulation of naive CD4 T cells 
with an agonist leads to sustained and high stoichiometry of phosphorylation of the 
TCRÇ chain (p23), ZAP-70 recruitment and phosphorylation, phosphorylation of
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LAT, sustained increase of intracellular calcium, activation of Erk and JNK and 
translocation of NEAT to the nucleus. In contrast, ligation with APLs can result in 
substoichiometric phosphorylation of TCRÇ (p21), failure to recruit and activate ZAP- 
70, weak and transient calcium mobilisation and low levels of Erk and JNK activation 
(Sloan-Lancaster et al., 1994; Sloan-Lancaster et al., 1996a; Sloan-Lancaster and 
Allen, 1996b; Boutin et al., 1997; Leitenberg and Bottomly, 1999). Changes in TCR- 
mediated signalling or its downstream signalling cascades might drive the 
differentiation of the naive T cell into different response modes, varying from 
Thl/Th2 modes to T^g cells and T cell unresponsiveness.
1.8.1 Signalling during T cell development
After structural studies in mature T cells showed the differential 
phosphorylation capacity of the TCRÇ, it was speculated that weak and strong signals 
in the thymus also result in partial phosphorylation of ITAMs. They clearly amplify 
the TCR signal during thymic development, but data to date do not suggest that 
ITAMs qualitatively mediate positive or negative selection (Shores et al., 1997; van 
Oers et al., 1998; Ardouin et al., 1999; Love et al., 2000b). Interestingly, it was shown 
that the signalling properties of the TCR change during thymocyte maturation, 
differentially affecting responses to related peptide-MHC molecule complexes and 
contributing to this discrimination (Lucas et al., 1999).
More recent data suggest a duration model, where at veiy proximal points in 
the signalling pathway, positive selection signals are like negative selection signals, 
only shorter. High affinity interactions trigger a strong but transient signal whereas 
low affinity ligands trigger a weak but sustained one. This is also consistent with 
subsequent biochemical data on the role and duration of other key players in TCR 
signalling like PKC (Ohoka et al., 1997), Ras (Shao et al., 1997) and MAPKs (Sharp 
et al., 1997; Bommhardt et al., 1999; Mariathasan et al., 2001; Wilkinson and Kaye, 
2001). When the signalling potential of the TCR was modified by substituting 
transgenic TCRÇ chains containing either three, one, or no ITAMs for endogenous 
TCRÇ, it was shown that negative selection could be converted to positive selection in 
the presence of TRCÇ containing none or one ITAM (Love et al., 2000b). However, 
this process is more complex, since not only TCRÇ but also the other CD3 chains, al 
containing one ITAM are actively involved in selection processes (Dave et al., 1997;
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Delgado et al., 2000; Haks et al., 2002). The role of particular CD3 components in 
these events remains unclear. However, the multiplicity of CD3 components and their 
evolutionary conservation suggest that they may serve distinct functions.
Erk activation has been identified as a potential point where the signals of 
positive and negative selection qualitatively diverge (Alberola-Ila et al., 1996; Sharp 
et al., 1997; Sugawara et al., 1998). High affinity ligands stimulate a strong and 
transient activation of Erk, while low affinity ligands stimulate a much weaker 
activation but this is sustained over a longer time period (Werlen et al., 2000; 
Mariathasan et al., 2001). Importantly, similar results were obtained using mice 
deficient in one of the CD3 chains. CD38 is critical for TCR signalling in positive 
selection, and in CD36-deficient mice Erk activation was severely impaired, while 
JNK and p38 activation were unaffected (Delgado et al., 2000). The underlying 
mechanism by which TCR signalling is linked to Erk activation in thymocytes points 
towards RasGRP (Dower et al., 2000; Priatel et al., 2002). TCR engagement leads to 
the activation of PLCy, resulting in accumulation of DAG at the plasma membrane, 
subsequently recruiting RasGRP, which activates Ras. Interestingly, mice that have 
decreased levels of Grb2, capable of activating Ras by recruiting Sos, show impaired 
activation of JNK and p38, but normal activation of Erk (Gong et al., 2001). The 
sustained signal may be the result of the absence of TCR downregulation when low 
affinity ligands trigger the TCR. These data are especially important in light of data 
from other signalling systems where transient and sustained Erk activation led to 
different cell fates (Marshall, 1995; York et al., 1998).
Models based on signalling strength or duration have also been implicated in 
lineage commitment to CD4 or CD8 . An important role here was suggested for the 
PTK Lck. A constitutively active form of Lck led cells expressing a MHC class I- 
restricted receptor to adopt the CD4 fate, while a catalytically inactive form of Lck 
forced cells expressing a MHC class Il-restricted receptor to adopt the CD8 fate 
(Hemandez-Hoyos et al., 2000). Duration of the stimulus was shown to be important 
in in vitro studies, where high affinity ligands were presented by DCs. Short 
incubation times resulted in CD8+ thymocytes while long exposure to the ligand led 
to CD4+ thymocytes (Yasutomo et al., 2000). Again the Ras/Raf/Erk pathway has 
been implicated in this lineage decision (Bommhardt et al., 1999; Sharp and Hedrick,
1999).
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Models applying for thymocyte selection in the thymus may apply to some 
extent in the periphery. Weak signals, or interactions with a short half-life, may lead 
to T cell survival (van Oers et al., 1994), intermediate signals to unresponsiveness, 
and only strong enough signals to fully activate T cells. Very strong signals would 
lead to clonal deletion, another way of peripheral tolerance (Webb et al., 1990).
1.8.2 Signalling in peripheral T cell differentiation
Differences in the organisation of TCR signalling pathways may also 
determine the differentiation of naive T cells into effector subsets with unique 
cytokine and immunoregulatoiy profiles. A change in TCR signalling potency can 
determine the type of cytokine that will be induced (Constant et al., 1995; Hosken et 
al., 1995; Boutin et al., 1997; Leitenberg and Bottomly, 1999). In the absence of a 
dominant cytokine, low potency TCR signals preferentially generate 11-4 production 
and Th2 differentiation. In contrast, priming naive CD4 cells with optimal doses of 
high affinity peptide favour 11-2 and IFNy production resulting in Thl differentiation.
Both subsets of Th cells require a spectrum of transcription factors to activate 
cytokine promoters. Thl development is critically dependent upon transducer and 
activator of transcription (STAT) 4, class II transcription factor (CIITA), and T-bet, 
while Th2 development requires STAT6 , GATA3, JunB, c-Maf and NFAT45 
(Asnagli and Murphy, 2001). Most transcription factors are regulated by MAPKs, 
suggesting that differential activation of MAPKs affect the differentiation of CD4 T 
cells. Indeed, JNK2 has been reported to be an important factor for the polarisation of 
CD4 T cells towards a Thl phenotype (Yang et al., 1998), while JNKl is capable of 
blocking the development of a Th2 response (Dong et al., 1998). After differentiation, 
Th2 cells fail to induce JNK activation, while Thl cells easily activate it. JNKl acts 
by decreasing the nuclear NFATc abundance, required for the activation of the 11-4 
promoter. JNK2, probably in synergy with other factors, positively regulates IFNy 
production, and induces the expression of the p2 subunit of the 11-12 receptor 
(Murphy et al., 2000).
Thus, the ratio between transcription factors present in the nucleus determines 
the T cell differentiation fate. High levels of NFATc over NFATp and NFAT4 favour 
11-4 expression and subsequent Th2 differentiation, whereas a reversal of this ratio 
interferes with 11-4 production and thus favours Thl development. It is unclear
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whether these differences in ratio of NFAT isoforms, as well as JNK activation, 
reflect TCR signalling potency. However, there are numerous links suggesting such a 
possibility. A sustained calcium flux promotes the nuclear relocation of NFAT 
proteins, as well as JNKl activation, leading to NFATp and NFAT4 accumulation in 
the nucleus (Leitenberg and Bottomly, 1999). A potent agonist, promoting strong 
TCR signalling, sustained calcium release and high stoichiometry of ITAM 
phosphorylation could thus promote Thl differentiation. In contrast, low potency 
ligands induce a short but sufficient burst of calcium flux to allow Erk activation and 
NFAT translocation to the nucleus (Sloan-Lancaster et al., 1996a; Leitenberg and 
Bottomly, 1999). In the absence of JNK activation, which possesses a higher 
threshold for activation than Erk (Gong et al., 2001), NFATc will dominate in the 
nucleus, favouring IL-4 production and Th2 differentiation.
In addition to the role of the TCR, a number of accessory molecules exert an 
effect on the polarity of T cell differentiation. These include contributions by CD4, 
CD45 and CD28 (Schweitzer and Sharpe, 1998), Their influence may reflect the 
stimulation of unique additional signalling pathways, but likely some synergies with 
the TCR cascades, thereby influencing thresholds for activation of downstream 
molecules.
1.8.3 T cell non-responsiveness/ anergy/ Treg
Stimulating naive T cells in the absence of the CD28 signal can induce a state 
of unresponsiveness, in vitro often referred to as anergy. It is defined by the inability 
of individual T cells or T cell clones to produce 11-2 and to proliferate when 
restimulated with their appropriate antigen presented by APCs (Schwartz, 1992). This 
two-signal concept is also applicable in vivo, and can induce tolerance to organ grafts 
(Salomon and Bluestone, 2001). However, correlation between in vitro anergy and in 
vivo tolerance is not clear as yet, the more so since in vivo tolerance spans a variety of 
mechanisms from clonal deletion and ignorance to the induction of immunoregulatory 
T cell subsets.
Anergic T cells exhibit poor phosphorylation of TCRÇ and CD3e chains, are 
incapable of activating ZAP-70, Ras, JNK and Erk, and have impaired relocation of 
Grb2-Sos complexes to the membrane (Kang et al., 1992; Gajewski et al., 1994; 
Boussiotis et al., 1996; Fields et al., 1996; Mondino et al., 1996; Salojin et al., 1997).
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As a result, transcription factors fail to bind to the 11-2 promoter thus disabling anergic 
cells from secreting this cytokine. However, they maintain their capacity to induce 
PLCyl phosphorylation and calcium flux, along with elevated levels of IP3, cyclic 
adenosine monophosphate (cAMP), and an increased Fyn kinase and Rapl A activity 
(Quill et al., 1992; Gajewski et al., 1995; Boussiotis et al., 1997). These findings 
suggest that anergy induction is dependent on the down-regulation of some pathways, 
while maintenance depends on others that are upregulated. Increased levels of cAMP 
lead to the induction of the cyclin-dependent kinase inhibitor 27 kD cyclin-dependent 
kinase inhibitor (p27^^^). p27^^^ blocks cell cycle progression and 11-2 production by 
associating with the c-Jun co-activator JAB 1, thereby disrupting AP-1 binding sites in 
the 11-2 promoter (Boussiotis et al., 2000). In addition, cAMP activates the Exchange 
Protein directly Activated by cAMP (EPAC), a GEF that catalyses GTP exchange on 
Rapl.
Tolerance can also be induced in some peripheral T cell populations in the 
presence of CD28 (Wells et al., 2001). This kind of tolerance is dependent on the role 
of CTLA-4 but, interestingly, both forms of anergy show elevated levels of p27^^^\ 
When expressed on the cell surface, CTLA-4 is able to modulate several aspects of 
TCR signalling, including JNK and Erk phosphorylation, and the transcriptional 
activity of NF-kB, NFAT and AP-1 (Calvo et al., 1997; Alegre et al., 2001). The 
mechanisms behind CTLA-4 signalling are still poorly understood, but may include 
the recruitment of PTP to the TCR, inhibition of B7 binding to CD28 by competition, 
and disruption of signalling arrangements in the immunological synapse (Alegre et 
al., 2001).
Interestingly, the phenotypically distinct subset of CD4+/CD25+ T cells, 
which are suggested to play a role in maintenance of in vivo tolerance, are reported to 
exhibit constitutive CTLA-4 expression (Salomon et al., 2000). CTLA-4 also induces 
secretion of TGF-p, providing a possible explanation for some of the 
immunoregulatory capacities of these T cells (Chen et al., 1998). By removing the 
signal from engaged CTLA-4, suppressive activity could in some in vitro experiments 
be abrogated (Read et al., 2000; Takahashi et al., 2000).
The subpopulation of CD4+CD25+ T cells have been reported to be important 
in controlling autoreactive T cells in vivo; in vitro they have been shown to be 
hyporesponsive and suppressive (Papiemik, 2001). However, populations of T^g are
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described in a variety of experimental contexts; they have been identified using 
different cell surface markers and thus seem to be a heterogeneous population. Many 
questions regarding these cells remain as yet unresolved; these include their origin, 
their specificity and their mode of action. However, recent data indicate the existence 
of distinct pathways resulting in the generation of T^g. Monospecific naive T cells can 
differentiate autonomously into antigen-specific, predominantly CD25-, Treg cells in 
peripheral tissues. In addition, antigen expression in the thymus can lead to antigen- 
specific, predominantly CD25+, Treg cells (Apostolou et al., 2002).
Insights into the mechanism of induction of Treg cells are still very poor. 
However, 11-10 seems to play an important role, cells stimulated in its presence 
differentiate into a new subset of CD4 T cells, and these cells secrete high levels of II- 
10 themselves. In addition, 11-10 pre-treated DCs are able to induce anergy 
(Steinbrink et al., 1997). These effects can only be observed in immature DCs; mature 
DCs are resistant to 11-10. The functional mechanism of 11-10 is associated with a 
reduction of antigen-presenting capacity, and stimulating T cells with anti-CD3 in the 
presence of 11-10 did not generate regulatory T cells (Wakkach et al., 2001). It down- 
regulates the expression of MHC molecules and essential accessory molecules like B7 
and the adhesion molecule LFA-1, but not CD58 (Willems et al., 1994; Steinbrink et 
al., 1997; Wakkach et al., 2001). Since these are all important elements of the IS, this 
indicates that non-responsiveness is induced by interfering with proximal TCR 
signalling pathways. This is in parallel to in vitro protocols, where the absence of 
sufficient co-stimulatory signals results in anergy.
TGFp has also been reported to enhance tolerance. Stimulation of naive CD4 
T cells in its presence resulted in CD4+CD25+ T cells with potent suppresser activity 
on the development of CD8 T cells (Yamagiwa et al., 2001). The possibility was 
raised that CD4+CD25+ T cells produce TGFP, whereupon they bind it to their cell 
surface, and deliver it directly to responder cells by a cell-cell contact-dependent 
delivery system (Nakamura et al., 2001). However, the mechanism behind TGFP- 
induced tolerance is unknown, and many studies failed to find a role for it (Chen et 
al., 1994; Takahashi et al., 2000; Thornton and Shevach, 2000; Jonuleit et al., 2001; 
Read and Powrie, 2001). The only indication of a possible role came from Yamaguchi 
et al., (1997) who showed that TGFP inhibited the maturation and differentiation of 
DCs, again suggesting that alteration of co-stimulatory molecules determines the 
differentiation of effector cells.
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Interference with TCR signal transduction cascades in immortalised cell lines 
or genetically modified animal systems have provided valuable insights into complex 
system properties required to trigger a response. However, these techniques have 
limitations; molecules of interest can be expressed outside the targeted cell types, loss 
of crucial proteins can result in lethality or selection for cells that employed 
compensatory mechanisms, and immortalised cell lines have altered signalling 
properties and have lost their homing potential.
1.9 DNA- or protein-based modifications of cell functions
Many genes and their products have several roles in different tissues and at 
different stages of development. Phenotypes caused by genetic manipulations are 
often difficult to interpret since they might be due to differential expression in place 
or time. Conditional and cell-specific regulatory elements have been found to control 
transgene expression. Transcription of the gene of interest can now be kept under 
specific intracellular conditions when a specific promoter is activated. These 
regulatory signals are required to maintain specific activity. Furthermore, they should 
be reversible and specific for the target gene, and should not interfere with other 
cellular components or with cell metabolism (Lewandoski, 2001). During recent 
years, binary transgenic systems have been developed in which gene expression is 
controlled by the interaction of two compounds, such as Cre/loxP and the TetR-based 
transactivators. All these systems, however, rely on the laborious process of 
generating transgenic animals.
Cultured cells can be manipulated by the use of pharmacological agents and 
transfection of expression vectors via microinjection, electroporation, retroviral gene 
transfer, or association with cationic lipids and liposomes. While these approaches 
have been somewhat successful, problems such as the specificity of pharmacological 
inhibitors, low transfer efficiency, complex manipulation and cellular toxicity, 
precluded routine use of these methods, especially with fragile primary cells such as 
ex vivo T cells that are refractive to ordinary transfection methods. Additionally, 
reliance on the use of DNA results in very limited control over the exact amounts of 
protein expressed and present in the cytosol. Because timing of many events is a 
critical determinant of the outcome of biological processes, it would be useful to have
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temporal control over the amount or activity of specific proteins, currently not 
feasible with genetic mutants.
1.9.1 Protein-transduction
A wide variety of methods have been proposed for the delivery of proteins 
into living cells. However, most of these methods were inefficient, caused high 
amounts of cell death, or resulted in protein trapping in intracellular vesicles without 
delivery into the cytoplasm. The explanation is that cells poorly take up most 
“information-rich” molecules, such as peptides and proteins, since they do not 
efficiently cross the lipid bilayer of the plasma membrane or of the endocytic vesicles 
(Lebleu, 1996). This is a major limitation for their ex vivo or in vivo use in 
fundamental studies or in clinical applications.
Until recently it had not been considered that some proteins might be 
internalised and directly targeted to the cell cytoplasm and nucleus without involving 
the classical endocytosis pathway. However, some transcription factors, involved in 
morphological processes during development, known as homeoproteins, can pass 
freely from cell to cell. They are secreted in an unconventional way and re- 
intemalised by neighbouring cells where they can be found intact in the cytoplasm 
and nucleus (Joliot et al., 1991; Chatelin et al., 1996; Joliot et al., 1998). Green and 
Frankel first reported protein transduction, the internalisation of proteins into the cell 
from the external environment. They independently demonstrated that the Human 
Immunodeficiency Virus (HIV)-l transactivator of transcription (Tat) protein could 
enter cells when added to the surrounding culture medium (Frankel and Pabo, 1988; 
Green and Loewenstein, 1988).
Since this initial observation, other proteins possessing this ability have been 
identified. These include the herpes simplex virus-1 DNA-binding protein VP22 
(Elliott and O'Hare, 1997) and several homeobox-containing proteins of which 
Antennapedia (Antp) is the best known, and used to develop several penetrating 
peptides, the Penetratin family (Derossi et al., 1996; Han et al., 2000). The three 
protein-transduction domain (PTD) -  containing proteins mentioned have the highest 
level of protein-transduction efficiency demonstrated so far and are internalised by all 
tested cell types and by approximately 100% of the cells present in culture (Derossi et 
al., 1996; Vives et al., 1997).
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The apparent efficiency with which these PTD-containing proteins were 
shown to enter cells raised the possibility of utilising them as delivery vehicles for 
macromolecules. A method that allows the delivery of bioactive molecules into cells 
using membrane-permeable proteins has a great potential to modify cellular processes 
on a protein level. Indeed, PTD-containing peptides conjugated to proteins, DNA and 
RNA were shown to deliver their cargo intracellularly (Mann and Frankel, 1991; 
Fawell et al., 1994; Astriab-Fisher et al., 2000). The responsible transduction domain 
was identified as a short stretch of 11 to 16 amino acids, in Tat and Antp respectively 
(Schwarze et al., 2000). The Tat PTD, composed of six arginine and two lysine 
residues within a stretch of 11 amino acids, seems to be the most powerfull. It was 
shown to be capable of delivering biologically active fusion proteins, including the 
120-kD P-galactosidase protein, into all mouse tissues after intra-peritoneal injection 
(Schwarze et al., 1999).
Taken together, the short sequence necessary for translocation, the power to 
translocate large full-length proteins that keep their biological activity after 
translocation, and the ubiquitous internalisation in any mammalian cell type, make 
PTDs a powerful tool for intracellular protein delivery. They have already 
successfully been used conjugated to several peptides, proteins, DNA and magnetic 
particles (Fawell et al., 1994; Bonifaci et al., 1995; Nagahara et al., 1998; Schwarze et 
al., 1999; Vocero-Akbani et al., 1999; Chellaiah et al., 2000; Lewin et al., 2000; 
Vocero-Akbani et al., 2001). The most impressive aspect of PTD-mediated delivery is 
its size independence. PTDs have been shown to deliver proteins in excess of 100 kD 
into cells in culture and animal systems. Interestingly, 40 nm super-paramagnetic iron 
nanoparticles conjugated to Tat PTD peptides were internalised into hematopoietic 
and neural progenitor cells and into peripheral T cells, without affecting cell viability, 
differentiation, proliferation or homing potential (Lewin et al., 2000; Dodd et al., 
2001).
1.9.2 Mechanism of cellular internalisation
Despite the large number of potential applications of these PTD containing 
proteins, the mechanism by which translocation proceeds remains essentially 
unknown. Initial studies with homeoproteins, like Antp, suggested that interference 
with their helix structure was able to prevent cell entry, and thus that the helix 
structure has a key role in internalisation (Le Roux et al., 1993). However, chemical
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synthesis of short sequences of this helix, one composed of the inverso D-isomer, one 
in which the order of the amino acids was reversed, and one in which the helix 
structure was broken by introducing proline residues, showed that all four peptides 
were internalised (Derossi et al., 1996). Similar results where obtained using the PTD 
domain of Tat, with the retro-inversion form of Tat having the highest translocation 
efficiency (Wender et al., 2000). This indicates that translocation of PTD domains 
across the plasma membrane does not require a helicoid conformation, and more 
importantly does not require a chiral receptor.
In agreement with the observation of apparent absence of a receptor, cellular 
internalisation of PTD-containing proteins occurs at 4°C, a temperature that abolishes 
active transport mechanisms involving endocytosis, as well as at 37°C.
This indicated that the transduction mechanism, besides being receptor-independent, 
is also energy-independent (Joliot et al., 1991; Derossi et al., 1996). Protein 
transduction seems therefore to be independent of the classical endocytosis pathways 
and is not specific for any cell type (Mann and Frankel, 1991; Derossi et al., 1996; 
Elliott and O'Hare, 1997; Vives et al., 1997). The latter is consistent with the notion 
that Tat is able to enter into a wide variety of human, rodent, and simian cell lines.
Sequence comparisons between Tat, Antp and VP22 PTDs show the presence 
of the basic positively charged amino acids arginine and lysine (Schwarze et al.,
2000), corresponding to the sequence responsible for cellular uptake (Vives et al., 
1997; Schwarze et al., 2000). This points out that charge may be an important factor 
for protein internalisation, whereby positively charged amino acids interact with 
negatively charged phospholipids. Indeed, by preparing a series of analogues of Tat- 
PTD alanine substitutions, it was shown that cationic residues play a critical role in 
cellular uptake (Wender et al., 2000).
The positively charged arginine residues in PTD domains are essential for 
translocation as deletion or substitution by alanine of a single arginine reduces 
internalisation (Vives et al., 1997; Wender et al., 2000). Their charge alone, however, 
is insufficient. Homopolymers of citrulline, an arginine isostere in which the nitrogen 
of the guanidine group is replaced with oxygen, showed no transduction activity 
(Mitchell et al., 2000). Indeed, a 9-mer of arginine residues is more efficient than Tat 
itself in cellular uptake, suggesting that the guanidinium groups play a greater role in 
facilitating internalisation than their charge alone. The number of arginine residues
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within the Tat peptide appears to be the main determinant for maintaining a high 
translocation activity (Futaki et al., 2000; Wender et al., 2000). Moreover, the length 
of the poly-arginine peptide seems critical, as a maximal rate of internalisation was 
observed for a peptide 9 arginine residues in length. The D-isoform and the retro- 
inverso form of the poly-arginine peptide were found to internalise even more 
efficiently; the reason might be found in the higher stability of the D-isoform in 
serum-containing medium, as the rate of uptake was the same in serum-free medium 
(Wender et al., 2000).
A possible important clue about the mechanism of PTD-containing protein 
internalisation came from mixing these proteins with lipids extracted from rat brain. 
This provoked the formation of reverse micelles, not observed with chemically 
defined lipids or with non-intemalised proteins (Berlose et al., 1996). Interestingly, 
the translocation of full-length Tat fusion proteins was shown to result in inactivation 
or dénaturation of the conjugated protein, thus resulting in a linear protein without a 
specific structure (Bonifaci et al., 1995). Further studies revealed that the flexibility of 
the PTD backbone allows their adaptation to the concave surface of a micelle, and 
might be the explanation for the necessity of unfolding of conjugated proteins in order 
to get internalised. This was also illustrated by transduction of correctly folded Tat - 
green fluorescent protein (GFP) fusion protein into cells, which resulted in a high 
intracellular level of Tat-GFP, but with significantly altered kinetics and loss of GFP 
emission (Caron et al., 2001).
Tyagi et al. (2000) recently demonstrated that cell membrane heparan sulphate 
proteoglycans (HSPG), distributed ubiquitously on all mammalian cell types, might 
act as a receptor for extracellular Tat. Previously it had been shown that the addition 
of soluble heparin could modulate several of the biological properties of Tat (Rusnati 
et al., 1998). In addition it was now shown that specific lysases for HSPGs block Tat 
internalisation, and that cell lines with genetic defects in the metabolic pathways 
involved in the production of HSPGs fail to internalise Tat. A common motif for 
HSPG binding consists of a region rich in basic amino acids flanked by hydrophobic 
residues, like the PTD domain (Esko, 1991). Although other basic amino acid 
sequences are capable of binding HSPGs, these fail to be transduced over the 
membrane (Lappi et al., 1996), indicating that ionic interactions alone are not 
sufficient for internalisation. Only arginine-rich basic peptides seem to share this 
internalisation pathway (Futaki et al., 2000; Suzuki et al., 2002).
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The current model of PTD internalisation proposes that protein is stabilised at 
the cell surface by electrostatic interactions between the positively charged arginine 
and lysine residues, and the negatively charged phospholipids and cell HSPGs. This 
loading may be sufficient to allow protein accumulation at the water-membrane 
interface thus destabilising the membrane organisation, allowing the formation of 
inverted micelles. It is also speculated that fusion of the Tat PTD peptide to the N- 
terminal region of proteins favours its steric accessibility to cellular structures 
involved in the translocation process. The micelles trap the protein in hydrophobic 
cavities, which might explain the importance of the hydrophobic residues arginine 
and lysine other than for their positive charge, and deliver it into the cytoplasm.
1.10 Aims of this study
The aim of this project is to study whether manipulation of the signalling 
pathways downstream of the TCR/CD28 receptor can result in distinct functional 
differentiation of monoclonal CD4+ T cell populations with known antigenic 
specificity. To this end I set out to develop a protein transfer mechanism capable of 
delivering proteins or peptides into naive ex vivo T cells that can compete with or 
inhibit endogenous proteins within the signalling pathways downstream of the TCR.
The initial focus was on the generation of a peptide delivery system and its 
ability for transferring full-length proteins and protein domains into naive ex vivo T 
cells. For this purpose fusion proteins with the Tat PTD domain were generated. 
Given the important position in the proximal signalling cascades downstream of the 
TCR, the aim was to focus on the PTKs Lck and ZAP-70 and to use domains of these 
fused to Tat-PTD that can interfere with their endogenous function. Using these, the 
aim was to analyse the consequences of modifying TCR-mediated signals on 
activation and differentiation of naive CD4 T cells.
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Materials and Methods
2.1 Animals
The mice strains used were A18 TCR transgenic (Ragl  ^ C5  ^) (Zal et al., 1994), A l TCR 
transgenic (Ragl  ^ C5  ^) (Zelehika et al., 1998), AND Ragl ' (Kaye et al., 1989), F5 
Ragl ’ (Mamalaki et al., 1993), BM3 Rag'^' (Sponaas et al., 1994), OT-1 Ragl"^'
(Hogquist et al., 1994), and TCRa (Mombaerts et al., 1993). Polyclonal controls used
b  a
were BIO (H-2 ) and A/J (H-2 ). All mice were kept in conventional, but pathogen-free, 
animal facilities at the National Institute for Medical Research (London, UK).
2.2 Cell lines, cultures and culture media
2.2.1 Cell lines and culture media
E6.1 Jurkat T cells were cultured in RPMl-1640 medium (Gibco BRL) supplemented
with 5% heat inactivated Fetal Calf Serum (FCS) (Gibco BRL), 2x10  ^M L-glutamine,
100 U/ml penicillin, 100 pg/ml streptomycin and 5x10  ^M p-mercaptoethanol (all 
Sigma).
CTLL-2 is an 11-2 dependent T cell line, ATCC cat. No. TIB 214.
The culture medium used for ex vivo cultures and cell lines was Iscove’s Modified 
Dulbecco’s Medium (IMDM) (Gibco BRL) supplemented with 5% heat inactivated FCS
- 3
(Gibco BRL), 2x10 M L-glutamine, 100 U/ml penicillin, 100 pg/ml streptomycin and
5x10  ^M P-mercaptoethanol (all Sigma). Medium for washing cells was Air-Buffered 
IMDM containing 25 mM HEPES and L-glutamine and supplemented with 0.21% NaCl, 
100 U/ml penicillin, 100 pg/ml streptomycin and 12.5 mM NaOH (AB medium).
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2.2.2 Determination of cell viability and numbers
Trypan blue (Sigma) at a final concentration of 0.08% in phosphate buffered saline (PBS) 
(10.1 g NaCl, 0.362 g KCl, 0.362 g K H 2PO 4,1.449 g Na2HP04 in 1 1 H 20) was used to 
determine the viability of cells. Cells were counted in a 1:1 mixture of Trypan blue using 
a Neubauer counting chamber (BDH Ltd., UK) under the light microscope. Dead cells, 
stained blue, were excluded from counting.
2.2.3 Cholerae toxin B-subunit (CtxB) binding and toxicity tests
Tests were performed with different concentrations of commercial CtxB (Calbiochem- 
Novabiochem Corp.) and FTTC-conjugated CtxB (Sigma). For toxicity assessments, CtxB 
was added to ex vivo splenic T cell cultures for up to three days. Anti CtxB mAb 
(Calbiochem-Novabiochem Corp.) was used to crosslink CtxB on the cell surface.
2.2.4 Bone Marrow Cultures
Bone marrow-derived dendritic cells were generated as described previously (Stockinger 
and Hausmann, 1994) with some modifications. Briefly, 5 IO6 bone marrow cells were 
cultured in 9 cm petri dishes (NUNC, Denmark) in 10 ml culture medium containing 
10% supernatant of Ag8653 myeloma cells transfected with murine GM-CSF cDNA 
(about 25 U/ml). On day 4 of culture, non-adherent granulocytes were removed and GM- 
CSF medium was replaced. Loosely adherent cells were transferred to a fresh dish on day 
6 of culture. From day 6  to day 8 these transferred loosely adherent cells were used as a 
source of DCs. DCs were incubated at 1 x 10^/ml for 2-4  h at 37 °C with indicated 
concentrations of specific antigen and washed to generate antigen-pulsed APC.
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2.2.5 E x  vivo cell cultures
Spleen and lymph nodes (Axillary, Branchial, Mesenteric, and Inguinal) were harvested 
from relevant mice strains and gently pressed through a mash using AB medium for 
resuspension of cells. Cells were washed once, and erythrocytes were removed by 
resuspending in 5 ml/mouse ACK lysis buffer (0.15 NH4CI, 1 mM KHCO3, 0.1 mM 
EDTA, pH 7.2-T.4) for 5 min at RT. Cells were washed, clumps were removed by 
passing cells through a 70 pm cell strainer (Falcon, Becton Dickinson Labware) and 
viable cells were counted.
2.2.6 Plate-bouud auti-CD3 stimulatiou
Anti-CD3 antibodies (145-2C11) and 10 pg/ml anti-CD28 (37.51) antibodies were coated 
onto 24-well tissue-culture plates in PBS by over night (o/n) incubation at 4°C. Prior to 
use, cells were washed with AB medium, and kept at RT. Cells were put on the plates at 
2 lOVml in 2 ml culture medium, followed by a short spin at 500 rpm for 1 minute. Cells 
were incubated for 4 hours at 37°C, resuspended, and replated on a non-coated 24-well 
plate for the rest of the experiment.
2.2.7 MACS selectiou
Cells were labelled with biotinylated antibody (Thy 1.2 (CD90.2) (53-2.1), 1:500 
(PharMingen)) at lO’/ml total cells. Cells were washed by addition of lOx the volume of 
labelling buffer (PBS supplemented with 2 mM EDTA and 2% BSA). Thereafter, cells 
were resuspended in 90 pi labelling buffer per 10  ^total cells, and 10 pi of MACS 
streptavidin microbeads (MACS, Miltenyi Biotec, GmbH) per 10  ^total cells was added. 
Alternatively, single cell suspensions were directly labelled using mouse CD4 (L3T4) 
MACS microbeads (MACS, Miltenyi Biotec, GmbH). After 15 minutes at 6°C, cells were 
washed and resuspended in 500 pi of labelling buffer per 10  ^total cells. Cells were 
loaded into the AutoMACS (MACS, Miltenyi Biotec, GmbH) using the POSSEL
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program for positive selection. After selection, recovered cells were washed, counted, 
and resuspended in 500 pl/10^ cells 5% FCS IMDM culture medium.
2.3 Flow cytometry
2.3.1 Cell surface m arker staining
Analytical flow cytometry was conducted using a Fluorescence Activated Cell Sorter 
(FACS) Calibur (Becton Dickinson), and the data were processed using CellQuest 
software (Becton Dickinson). Cells (not exceedinglO^/50 pi) were preincubated with 
unlabeled mAb to Fey III/II Receptor to minimize unspecific staining. Four-colour 
staining was performed with fluorescein isothiocyanate- (FITC), phycoerythrin- (PE), 
allophycocyanin (APC), and biotin- (Bio) conjugated mAbs followed by streptavidin PE 
Cy7 using forward and side scatter characteristics to exclude dead cells. All stainings 
were performed on ice and cells were washed with washing buffer (PBS, 2% FCS, 0.1% 
azide) in between staining. The Abs used for phenotypic analysis are summarised in 
Table 1.
Specificity Conjugate Clone name Company
Fey III/II R none 2.4G2 Home made
CD3 FITC 145-2C11 Home made
CD4 FITC GK1.5 Pharmingen (San Diego, CA)
PE H129.19 Pharmingen (San Diego, CA)
APC RM4-5 Pharmingen (San Diego, CA)
CD5 FITC 53-7.3 Pharmingen (San Diego, CA)
CD8a FITC 53-6.7 Pharmingen (San Diego, CA)
PE CT-CDSa CalTag Laboratories (Burligame, CA)
APC 53-6.7 Pharmingen (San Diego, CA)
CD25 FITC 7D4 Pharmingen (San Diego, CA)
PE PC61 Pharmingen (San Diego, CA)
Bio 7D4 Pharmingen (San Diego, CA)
CD62L Bio MEL-14 Pharmingen (San Diego, CA)
CD69 FITC H1.2F3 Pharmingen (San Diego, CA)
PE H1.2F3 Pharmingen (San Diego, CA)
Bio H1.2F3 Pharmingen (San Diego, CA)
CD44 FITC IM7 Home made
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PE IM7 Pharmingen (San Diego, CA)
Bio IM7 Pharmingen (San Diego, CA)
CD45RB Bio 16A Pharmingen (San Diego, CA)
CD95 (Fas) Bio Jo2 Pharmingen (San Diego, CA)
Streptavidin PECv7 CalTag Laboratories (Burligame, CA)
TCRB FITC H57-597 Pharmingen (San Diego, CA)
PE H57-597 Pharmingen (San Diego, CA)
APC H57-597 Pharmingen (San Diego, CA)
2.3.2 Apoptosis assay
For detection of early apoptosis, single cell suspensions were incubated with 20 pg/ml 7- 
Amino-actinomycin D (7-AAD; Sigma) for 20 min at 4°C as previously described 
(Lecoeur et al., 1997).
2.3.3 Intracellular staining
Cytokine production is induced by stimulating the cells with 500 ng/ml PdBu, 500 ng/ml 
lonomycin and 10 pg/ml BrefeldinA for 4 hours at 37°C. Cells were collected, and the 
extracellular staining protocol followed to stain for surface markers. Thereafter, cells 
were resuspended in 100 pi 3% paraformaldehyde in PBS and incubated for 20 minutes 
on ice. Cells were washed, and resuspended in 0.1% NP40 PBS for 3 minutes, whereafter 
cells were washed and incubated with unlabeled mAb to Fey III/II Receptor, followed by 
specific cytokine Abs or isotype controls for 20 minutes each. Before acquisition, cells 
were given a final wash in PBS for 15 minutes to wash out non-bound Abs. The Abs used 
for cytokine profile analysis are summarised in Table 2.
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Tabel 2. Specificity of anti-mouse Abs used for intra cellular staining.
Specificity Conjugate Company
11-2 FITC Pharmingen (San Diego, CA)
PE Pharmingen (San Diego, CA)
11-4 PE Pharmingen (San Diego, CA)
11-5 PE Pharmingen (San Diego, CA)
11-10 APC Pharmingen (San Diego, CA)
IFNy FITC Pharmingen (San Diego, CA)
PE Pharmingen (San Diego, CA)
Isotype IgGl FITC Pharmingen (San Diego, CA)
Isotype IgGl PE Pharmingen (San Diego, CA)
2.3.4 Calcium flux
3x10^ CD4+ T cells were resuspended in 500 pi IMDI with 1% FCS and a final 
concentration of Indo-1 AM (Sigma) of 2 pM. Cells were incubated for 30-40 minutes to 
load Indo-1 in the dark at 37°C. Thereafter, cells were washed and collected, resuspended 
in 500 pi 1% FCS IMDM and stained with appropriate antibodies for phenotypic staining 
and a suitable concentration of anti-CD3 (145-2C11) for 15 minutes in the dark at RT. 
Hereafter, cells are washed, collected and resuspended in 300 pi 1% FCS IMDM. Cells 
are kept shielded from light at RT before acquisition. Samples were allowed to achieve a 
baseline on the LSR Benchtop Flow Cytometer (Becton Dickinson) with time as a 
parameter on the x-axis and the FL5 (400/40nm)/FL4 (510/20nm) ratio on the y-axis for 
1 minute. Hereafter, a calcium flux was induced using 20 pg/ml final concentration of 
goat anti-Armenian Hamster (Jackson Immuno Research laboratories Inc.) crosslinking 
antibody, whereafter data were collected for a further 5 minutes. Data analysis was 
performed using CellQuest (Becton Dickinson), FCS assistant (shareware) and Excel 
(Microsoft) software.
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2.3.5 Tat internalisation
FITC-conjugated fusion proteins were added to the culture medium at desired 
concentrations for a limited period of time. Cells were collected, and washed twice with 
ice-cold PBS. Some fractions were treated with 5 pg/ml Trypsin for 15 minutes on ice. 
Subsequently, cells were washed into ice-cold PBS 0.1% Azide at pH 7.4 or pH 6 .8 . Cells 
were acquired on a FACS Calibur, whereby sheet fluid was replaced with PBS 0.1% 
Azide with appropriate pH.
2.4 Assays for T cell activation
2.4.1 Proliferation and 11-2 production
Splenocytes were cultured for the indicated time in round-bottom 96-well plates (2x105 
/well) in the presence of the indicated amounts of specific antigen, or 24-well plates 
(1x105 /well) with the indicated amounts of plate-bound anti-CD3 (145-2C11) and 5 
pg/ml anti-CD28 (37.51). Transfer of 50 pi aliquots of supernatant to fresh flat-bottom 
96-well plates together with 5000/well Il-2-dependent CTLL cells assessed 11-2 
production.
Incorporation of [^H] thymidine by CTLL was measured 24 hours after transfer of 
supernatant. Alternatively, the AlamarBlue™ (Biosource) assay was used to measure 
quantitatively the proliferation of cells based on detection of metabolic activity. The 
system incorporates an oxidation-reduction indicator that both fluoresces and changes 
colour in response to chemical reduction of growth medium resulting from cell growth. 
Data were collected by monitoring fluorescence at 590nm using a Luminescence 
Spectrometer LS50B (Perkin Elmer) analyzing data with FL WinLab software (Perkin 
Elmer).
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2.4.2 Cytokine ELISA
IFNy- and 11-10 production was measured in a sandwich Enzyme Linked Immunosorbent 
Assay (ELISA) using a pair of antibodies. 50 pi supernatants were transferred to 96-well 
flat bottom plates (Dynatech) coated o/n with 10 pg/ml AN 18 (rat) anti-mouse IFNy or 
5 pg/ml JES52CA5 (Rat) anti-mouse 11-10, and blocked with PBS supplemented with 5% 
FCS and 5% horse serum and incubated for two hours at RT. Following washes with 
PBS/0.05% Tween 20 (Sigma) biotinylated R4-6A2 (raty l) anti-mouse IFNy or anti-Il- 
10 (pharmingen) (1:2000) was applied for 1 hour RT. Wells were extensively washed and 
bound IFNy was detected using Streptavidin-Horseradish Peroxidase (HRPO) (1:2000) 
(Southern Biotechnology) for 1 hour RT, whereafter detection of the bound conjugate Ab 
was performed using 2,2'-Azino-bis-(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) 
(Sigma) substrate, activated by the addition of 1 pl/ml 30% H2O2. Absorbances were read 
at 414 nm on a Multiskan EX (Labsystems) analyzing data with Genesis software 
(Labsy stems).
2.5 Engineering of Tat expression vectors
2.5.1 Digestions and ligations
All restriction enzyme (Roche) digestions were performed in the appropriate buffers at 
37°C for at least 2 hrs, unless otherwise mentioned. Restriction enzymes were removed 
prior to further manipulation with use of the Bio 101 Geneclean Spin kit (Anachem Ltd) 
or Qiagen DNA purification column (Qiagen Ltd), according to the suppliers manual. 
Before ligation with T4 DNA ligase (Roche), DNA fragments were excised from agarose 
gels and purified with use of the Geneclean Spin kit. After linearising vectors, the 
terminal phosphates were removed using Shrimp Alkaline Phosphatase (Roche) by 
incubating 30 minutes at 37°C. Ligations were performed as described by Sambrook et al. 
(1989).
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Oligonucleotides were annealed following resuspension of both complementary primers 
at the same molar concentration in annealing buffer (10 mM Tris, pH 7 .5,50 mM NaCl, 1 
mM EDTA). The suspension was thereafter brought to 95°C in a heatblock for 2 minutes, 
whereafter the block was allowed to cool to room temperature on the workbench (45-60 
minutes). The resulting mix was stored short term at 4°C until use, or long term at -70°C.
2.5.2 Polymerase Chain Reactions
PCRs were performed with use of 2 units Taq polymerase (Perkin Elmer) for checking of 
oligonucleotides and colony screening, 1 unit PJu Turbo DNA polymerase (Stratagene 
Ltd) for general cloning purposes, or 2 Units Pfu DNA polymerase (Perkin Elmer) for 
sequencing, in the appropriate buffer supplemented with 40 mM dNTPs (Roche), 4 pi of 
each desired primer at optical density (OD) 1, and approximately 20 ng of template DNA 
or in case of screening colonies, a few bacteria. Generally the following PCR program 
was followed; 50 seconds 95°C dénaturation, 50 seconds 60°C annealing, and depending 
on the size of the desired product an elongation time at 72°C, repeated for 30 cycles.
2.5.3 Competent cells and transformations
D H5a (dcm ) E. coli bacteria for general cloning purposes were made competent using 
the TSB method, from 200 ml fresh bacteria grown in Luria Bertani (LB) broth at 3TC  to 
ODôoo 0.4-0.6. Thereafter, cells were cooled on ice for 10 minutes, collected and 
resuspended in 20 ml ice-cold TSB (LB supplemented with 10% PEG 3350 (BDH 
chemicals Ltd), 5% DMSO (Sigma), 20 mM MgCl:, pH 6.5, filter-sterilised), distributed 
into 500 pi aliquots, and stored at -70°C after snap freezing in liquid nitrogen.
Competent D H5a were incubated 20-30 minutes on ice mixed together with DNA, 
followed by a heat shock of 42°C for 40 seconds; hereafter they were allowed to express 
the Ampicilin resistance gene for 1 hour at 37°C whereafter they were plated on nutrient 
agar plates containing 100 pg/ml Ampicilin (Sigma) or 50 pg/ml Carbicillin (Novagen). 
Alternatively, the Top 10 one-shot kit (Invitrogen) was used for low efficiency cloning, 
according to the suppliers’ manual.
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Expression of proteins was achieved using BL21 (Novagen) as host, transformed 
according to the suppliers’ manual.
2.5.4 Sequencing
All generated vectors were sequenced using the ABI Prism 373 Genetic Analyzer (Perkin 
Elmer) according to the manufacturer’s directions. Approximately 500 ng of plasmid 
DNA were used for sequence analysis.
2.5.5 Generation of Tat protein expression vectors
pET-TAT was constructed by inserting two double-stranded oligomeric nucleotides (PI 
and P2) encoding the 11-amino acid TAT PTD (YGRKKRRQRRR) into the pET-15b 
vector (Novagen) under the control of a strong bacteriophage T7 promoter. Subsequent 
vectors were constructed by inserting a PCR fragment encompassing the desired cDNA 
flanked by engineered restriction sites and a HA-tag in frame into pET-TAT. In addition 
a complete pTAT-HA vector was generated for future use, inserting the 9-amino acid HA 
epitope tag (YPYDVPDYA), P3 and P4 into pET-TAT.
pET-TAT Lck-wt was generated using oligonucleotides P5 and P6 , spanning the entire 
cDNA of Lck, amino acid 1 to 509. pET-Tat Lck NSH2 was generated using 
oligonucleotides P5 and P7, spanning wild type Lck from the first amino acid to the 
valine at position 240. pET-Tat Lck SH2 was generated using primers P8 and P7, 
spanning the Lck wt sequence from amino acid 102 to 240.
Alternatively, two double-stranded oligomeric nucleotides encoding the 11-amino acid 
Tat-PTD and the C-terminal His-tag, P l l ,  P12, P13 and P14, were inserted into the pET- 
15b vector. Thereafter, a PCR fragment encompassing the desired region and at the 5 ’ 
site the HA-tag flanked by engineered restriction sites was inserted, thereby replacing its 
original N-terminal His-tag. This enabled the expression of desired proteins with a free 
N-terminus.
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Table 3. Oligonucloutides used in this study.
PI Tat F GGAATTCCATATGTATGGCAGGAAGAAGCGGAGACAGCGACG
AAGAGGGGATCCATA
P2 TatR TATGGATCCCCTCTTCGTCGCTGTCTCCGCTTCTTCCTGCCAT
ACATATGGAATTCC
P3 HA F CGCGGATCCTGGTTACCCATACGAGGTCCCAGACTACGCTGGA
TGAGAA7TCTGATCACGC
P4 H A R GCGTGATCAGAATTCTCATCCAGCGTAGTCTGGGAGGTCGTATG
GGTAACCAGGATCCGCG
P5 Lck 1-24 F ATTTGATCATATGGGCTGTGTCTGCAGCTCAAAC
P6 Lck 1527-1506 R 
+ HA
ATTTGATCAAGCGTAGTCTGGGACGTCGTATGGGTAAGGGTGG
GGCTGGTACTGGCCC
P7 Lck 720-698 R 
+ HA
ATTTGATCAAGCGTAGTCTGGGACGTCGTATGGGTAAACTTCC
CATTCGTCCTCCCACC
P8 Lck 306-327 F ATTTGATCACCTGACGACTGGCCAAGAAGGC
P9 ZAP70 1-21 F CGCGGATCCTATGCCAGACCCCGCGGCGCAC
PIO ZAP70 792-769 R 
+ HA
CGCGGATCCAGCGTAGTCTGGGACGTCGTATGGGTACCTGAGG
CGTTGCTGGCACTG
P ll Tat F GGAATTCCATATGGGATATGGCAGGAAGAAGCGGAGACAGCG
ACGAAGAGGAGGTCTCGAGCAAG
P12 TatR CTTGCTCGAGACCTCCTCTTCGTCGCTGTCTCCGCTTCTTCCTG
CCATATCCCATATGGAATTCC
P13 Tb His F CTTGCTCGAGGGCCTGGTGCCGCGCGGCAGCAGCGGACATCATC
ATCATCATCACAGCAGCGGCTAGGATCCCGA
P14 Tb His R TCGGGATCCTAGCCGCTGCTGTGATGATGATGATGATGTCCGCT
GCTGCCGCGCGGCACCAGGCCCTCGAGCAAG
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2.6 Biochemistry
2.6.1 Peptide synthesis
Tat-PTD (CYGRKKRRQRRRGGYPYDVPDYA) and Tat-PTD-Z70I 
(MAYGRKKRRQRRRGGKLBLFLLLLAKKK) were prepared with an automated 
peptide synthesizer (ABI431A) by using solid-phase fluorenylmethoxycarbonyl (Fmoc) 
chemistry with HBTU as the peptide-coupling reagent. Cleavage from the resin was 
achieved by using 90% trifluoroacetic acid (TFA) /  5% thioanisole /  2.5% H2O /  2.5% 
ethane-dithiol for 1.5 hrs. The reaction mixture was paper-filtered whereafter the peptide 
was precipitated and washed with methyl-tertiary-butyl-ether. The ether was removed by 
rotary evaporation, and the resulting solid was solved in H2O, freeze-dried o/n, and 
purified by RP-HPLC (H2O/CH3CN in 0.1% TFA). The products were recovered by 
lyophilisation and characterised by electrospray mass spectrometry.
2.6.2 Tat fusion protein expression and localisation
A single colony from an agar plate was used to inoculate 10 ml LB medium containing 
appropriate antibiotic and grown o/n. 10 pi of culture was added to 10 ml fresh LB 
medium. Expression was induced by the addition of isopropyl p-D-thiogalactopyranoside 
(IPTG; Sigma) (0.5 -  1.0 mM final concentration) when the optical density (ODeoo) 
reached approximately 0.5. Samples of 1.5 ml were taken after 2 ,5 , 8 hours and o/n (15- 
18 hours) incubation. The pellet was taken up in 200 pi lysis buffer (50 mM Tris pH 7.5, 
300 mM NaCl, 1 mM EDTA) and cells were disrupted by sonication using an Ultrasonic 
sonicator at 60% duty cycle for 2-3 times 20 sec. Lysates were cleared from cell debris, 
and supernatants were analyzed as the cytosolic fraction; the pellet suspension was used 
as the insoluble fraction and resuspended in an equal volume of 8M Urea buffer (8M 
Urea, 50 mM Tris pH 7.5; 300 mM NaCl, 1 mM EDTA).
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2.6.3 Tat fusion protein expression and purification
3 1 Terrific Broth (TB) containing 50pg/ml Carbenicillin (Novagen) was inoculated with 
a suspension of high expressing BL21 (Novagen) cells picked up from three overnight- 
incubated thinly colonised agar plates containing 50 pg/ml Carbenicillin. Tat fusion 
proteins were purified by sonication of 1 g of wet weight bacterial pellet per 10 ml 5.8 M 
Guanidine HCl lysis buffer (5.8 M Guanidine HCl (Fluka Biochemica), 50 mM Tris pH 
8.0 (BDH laboratory supplies), 200 mM NaCl (BDH laboratory supplies), 2 mM MgClz 
(BDH laboratory supplies), 0.1% Triton X-100 (Sigma), 5 mM P-mercaptoethanol 
(Sigma), 5 mM Imidazole (Fluka Biochemica), 200 mM PMSF (Sigma)). The resulting 
suspension was cleared by centifugation at 10,000 g for 20 minutes. The supernatant was 
applied on a Nickel-NitriloTriacetic Acid (Ni-NTA) column (Qiagen), and allowed to 
flow through by gravity. The column was washed once with 2 column volumes of lysis 
buffer, thereafter with 2 column volumes of washing buffer 1 (5M Guanidine HCl, 50 
mM Tris pH 8.0,500 mM NaCl, 2 mM MgCh, 0.1% Triton X-100, 5 mM P- 
mercaptoethanol, 15 mM Imidazole) and 2 column volumes of washing buffer 2 (5M 
Guanidine HCl, 50 mM Tris pH 7.5,500 mM NaCl, 2 mM MgCli, 0.1% Triton X-100, 
30 mM Imidazole). Protein bound to the Ni-NTA column was eluted using with 2x1 
column volume of Elution buffer (4M Guanidine HCl, 50 mM Tris pH 7.5,500 mM 
NaCl, 2 mM MgClz, 0.1% Triton X -100,500 mM Imidazole, 100 mM PMSF). All 
fractions collected were routinely checked for their protein content by Sodium Dodisyl 
Sulphate- Protein acrylamide Gel Electrophoresus (SDS-PAGE).
2.6.4 Tat fusion protein slow desalting
Collected protein eluate from the Ni-NTA column was brought to a concentration of 2 
mg/ml by the addition of elution buffer. Oxidation of the protein was allowed by 
incubating the eluate for three days at room temperature under slow stirring in an open 
bottle. The solution was concentrated using a stirred-cell concentrator (Amicon) with a 
10 kD cut-off PES membrane (Millipore) to a volume of 25-40 ml. Thereafter it was 
slowly dripped over 18 hours into 11 vigorously stirring Solubilisation buffer 1 (2 M
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Urea (Sigma), 1 M NaCl, 50 mM Glycine (BDH laboratory supplies, UK), 20 mM 
HEPES pH 7.5 (Sigma), 5 mM EDTA (Sigma), 20 % Glycerol (BDH laboratory 
supplies), 100 mM PMSF, 2 mg/ml PepstatinA (Sigma) and 2 mg/ml Leupeptin (Sigma)) 
at 4°C. The resulting solution was incubated slowly stirring for three days at 4°C. More 
protein inhibitors were added (100 mM PMSF, 2 mg/ml PepstatinA and 2 mg/ml 
Leupeptin), the solution was filtered over a 45 pm PES membrane bottle-top filter 
(Nalgene) and concentrated to 50-60 ml using a stirred-cell concentrator with a 10 kD 
cut-off PES membrane. This was slowly dripped over 18 hours into 11 vigorously stirring 
Solubilisation buffer 2 (1 M NaCl, 50 mM Glycine, 20 mM HEPES pH 7.5, 5 mM 
EDTA, 20 % Glycerol, 100 mM PMSF, 2 mg/ml PepstatinA and 2 mg/ml Leupeptin) at 
4°C and subsequently incubated for three days under slow stirring. More protein 
inhibitors were added (100 mM PMSF, 2 mg/ml PepstatinA and 2 mg/ml Leupeptin), the 
solution was filtered over a 45 pm PES membrane bottle-top filter and concentrated to 40 
ml using a stirred-cell concentrator with a 10 kD cut-off PES membrane. The resulting 
solution was dialysed over two days against PBS at 4°C using Slide-A-lyser cassettes 
(Pierce), whereafter the protein content was determined using the Lowry method, and 
subsequently the protein solution was brought to the desired concentration using a stirred- 
cell concentrator with a 10 kD cut-off PES membrane. Protein content was checked by 
SDS-PAGE and Coomassie blue staining after filter sterilisation using 0.2 pm syringe 
filters (Sartorius AG, Germany). Obtained solutions were thereafter stored at 4°C.
2.6.5 Tat fusion protein rapid desalting
Tat fusion proteins were purified by sonication of 1 g of wet weight bacteria pellet per 10 
ml 8 M Urea lysis buffer (8 M Urea, 50 mM Hepes pH 8.0 ,100 mM NaCl, 10% Glycerol, 
5 mM Imidazole). The resulting suspension was cleared by centrifugation at 10.000 g for 
20 minutes. The supernatant was applied on a Ni-NTA column (Qiagen), and allowed to 
flow through by gravity. The column was washed once with 2 column volumes of lysis 
buffer, thereafter with 2 column volumes of washing buffer (8M Urea, 50 mM Hepes pH 
8.0,100 mM NaCl, 10% Glycerol, 25 mM Imidazole). Protein bound to the Ni-NTA 
column was eluted using with 2x 1 column volume of Elution buffer (8M Urea, 50 mM
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Hepes pH 8.0,100 mM NaCl, 10% Glycerol, 500 mM Imidazole). 15 ml of the eluted 
fraction was mixed with 5 ml of Source 30Q or Source 30S (Amersham Biosciences) in a 
total volume of 15 ml Dilution buffer (20 mM Hepes, 10% Glycerol, pH and NaCl 
concentration is protein dependent, see Figure 15C), and incubated for 30-60 min on a 
rotator. The Source material was collected by centrifugation, washed with Buffer A (20 
mM Hepes, 10% Glycerol, pH and NaCl concentration is protein dependent, see Figure 
15C), and protein was eluted with 10-15 ml of Buffer B (20 mM Hepes, 10% Glycerol, 1 
tablet of protease inhibitor (Roche), pH and NaCl concentration is tailor made for each 
fusion protein, see Figure 15C). The eluted fraction was subsequently slowly diluted in 
PBS + 10% Glycerol, dialysed against PBS + 10% Glycerol and filter sterilised. All 
fractions collected were routinely checked for their protein content by SDS-PAGE.
2.6.6 Western Blot Analysis
For checking the expression of desired fusion proteins, a fresh colony was taken from an 
o/n grown plate and cultured in 10 ml LB medium to OD6oo=0.5; expression was induced 
by 0.5 mM IPTG for 3-6 hours at 30°C. Thereafter the equivalent of 1 ml OD6oo=l was 
lysed in 100 pi lysis buffer (8 M Urea, 50 mM Hepes pH 8 .0 ,1 0 0  mM NaCl) and 10-20 
pi sample were analysed by SDS-PAGE and transferred to nitrocellulose (Immubilon-P, 
Millipore) or stained with Coomassie-blue.
Blots were blocked with 5% Albumin in PBS-Tween, and stained with Abs in 0.5% 
Albumin in PBS-Tween. The anti-bodies used for Western blots were: 12CA5 (1:2000) 
anti HA mAb (Roche), anti Hise mAb (1:1000) (Santa Cruz), ant-P-Tyr (4G10) 
(1:12,500), ProteinA-HRPO (Amersham Life Sciences) (1:5000).
Blots were developed using Enhanced Chemo Luminescence (ECL) (PerkinElmer Life 
Sciences) and exposed for the desired time to X-ray film (Kodak).
Blots were stripped o f bound Abs by washing with an 100 mM Glycine pH3.0 solution 
for 30 min, where after blots were tested for residue Ab by ECL.
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2.6.7 Biochemical Tat binding assay
To measure binding and endocytosis of Tat, 5x10^ cells were incubated in 2 ml RPMI 
with indicated Tat concentrations for varying lengths of time. Cells were washed three 
times with ice-cold PBS and trypsinised for 15 min on ice where indicated. After
treatment, the cells were washed in cold PBS and harvested in lysis buffer at 10^ cells/ 40 
pi (50 mM Hepes, pH 7.5,150 mM NaCl, 1.5 mM MgCl2 , 1 mM EGTA, 10% glycerol,
1% Triton X-100, 20 mM NaF, andlO mM sodium pyrophosphate).
2.6.8 FITC conjugation
Fusion proteins were dialysed into 0.25 M carbonate buffer at alkaline pH of 9.3. FITC 
isomer (Molecular Probes), dissolved at 10 mg/ml in DMSO was added to give 100 pg 
FITC/mg protein, followed by an o/n incubation, rotating at 4°C. Subsequently, 
conjugated protein was dialysed against multiple changes of PBS. Conjugated protein 
was aliquoted and stored at 4°C in 0.01% Azide.
2.6.9 Protein A antibody coupling
200 ml packed protein A beads (Pharmacia Biotech) in a 1.5 ml Eppendorf tube were 
washed in PBS-A to wash out the ethanol. Subsequently, beads were equilibrated to 0.2 
M Boric Acid pH 9.0. Antibodies and protein A beads were mixed (5-10 pg Antibody per 
10 pi packed beads) in an Eppendorf tube for 1 hour at RT, extra Boric Acid was added 
to make the volume 1 ml. Beads were washed 4 times with 10 volumes 3M NaCl, 50 mM 
Boric Acid pH 9.0 by centrifugation and aspiration. Beads were resuspended in 1.5 ml of 
3 M NaCl, 50 mM Boric Acid pH 9.0 for IgGl or 0.2 M Boric Acid pH 9.0 for IgG2 plus 
20 mM Dimethylpimelimidate (Sigma). Beads and antibodies were mixed on a rotator for 
a further 30 min, thereafter the reaction was stopped by washing the beads once in 0.2 M 
ethanolamine pH 8.0 at RT for 2 h while gently mixing. Beads were washed once with 
PBS-A, followed by a 100 mM Glycine pH 3.0 wash to remove all non-covalently bound
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antibodies. This was followed by two washing steps in PBS-A and a final wash into PBS 
0.01% Azide.
2.6.10 Immune precipitations
10  ^Jurkat T cells were used for each fraction. Cells were grown for the desired time in 
medium containing the desired concentration of Tat-PTD fusion protein. Thereafter cells 
were collected and resuspended in 1 ml medium. 180 pi 100 mM sodium ortho- 
pervanadate (Sigma) were activated 15 minutes prior to use with 20 pi 1 M H2O2, giving 
a 100-times stock solution. 10 pi were added to the 1 ml Jurkat cells for 15 min at 37“C. 
Subsequently, cells were collected and lysed in 1 ml 1% Triton lysis buffer (50 mM 
Hepes, pH 7.5,150 mM NaCl, 1.5 mM MgCl2 , 1 mM EGTA, 10% glycerol, 1% Triton 
X -100,20 mM NaF, 10 mM sodium pyrophosphate, 1 mM sodium ortho-pervanadate 
and per 50 ml a tablet of protease inhibitors (Roche)). Cells were lysed during 1 h 
rotating at 4°C. DNA and cell debris were spun out by 15 min centrifugation 14,000 rpm 
at 4°C. Supernatant was transferred and pre-cleared with protein A beads for 30 min at 
4°C, thereafter beads were removed, and protein A beads coupled to antibody (anti-HA, 
12CA5 (Roche); or 33.1 anti-ZAP-70 mAb (kindly provided by J. Tite, Glaxo Smith 
Kline) were added for an o/n incubation rotating at 4°C. Subsequently, supernatants were 
removed, and protein A beads were washed 5 times with 1 % Triton X-100 lysis buffer. 
After the last wash, 100 pi of loading buffer were added, and samples were stored at - 
20°C until boiling for 3 min at 95°C and loading of 50 pi on a SDS-PAGE maxi gel.
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3 Results
The major limitation for introducing proteins and peptides into live cells is 
their poor uptake by cells due to the low efficiency with which they cross the lipid 
bilayer of the plasma membrane or of endocytic vesicles. The delivery of these 
compounds therefore depends on physical disruption of the membranes in order to 
allow entry to the cytosol, as achieved during microinjection and electroporation. 
Alternatively, delivery might be accomplished using a vehicle that facilitates the 
crossing of lipid membranes without causing major disruption, such as cationic lipids 
and liposomes. At the start of this study, the potential of one such vehicle, the B 
subunit of E.coli enterotoxin (Etx) was considered.
In order to introduce potential signal attenuators into naive ex vivo T cells, the 
most appropriate and effective delivery vehicle had to be found. Any effect of the 
delivery vehicle itself can potentially disturb the balance of the signalling pathways in 
resting T cells, and may influence the eventual differentiation and the effector 
functions once the naive T cells are activated in its presence. Therefore, initial studies 
started with testing EtxB and its influence on naive T cells.
3.1 The use of EtxB as a delivery vehicle
A number of proteins from plant and bacteria are highly toxic to mammalian 
cells because of their ability to enter the cytosol and attack essential constituents. The 
majority of these toxins are referred to as AB-toxins. The A moiety generally has 
enzymatic activity and modifies a cellular target upon entry into the cytosol. The B 
moiety, consisting of one or more subunits, serves as a vehicle to bind the toxin to the 
cell-surface via a specific receptor and thereafter translocates the A moiety to the 
cytosol, in most cases by receptor-mediated endocytosis.
The B subunit of E.coli enterotoxin (Etx) and cholera toxin (Ctx) are 
internalised via the cell surface ganglioside that is ubiquitously expressed on all 
cells (Lencer et al., 1992). Both toxins are structurally and functionally almost
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identical. Indeed, the two toxins share 80% amino acid identity. As members of the 
AB toxins, and more precisely the AB5 toxins, the A-subunit is responsible for the 
toxic effect while the B-subunit is regarded as a non-toxic carrier needed for delivery 
of the A-subunit into target cells. In case of Etx and Ctx, the B-subunit carrier is a 
doughnut-shaped pentameric ring formed by five B-subunits. In the holotoxin, the A- 
subunit is located on one side of the plane of the B pentamer opposite the side that 
binds the receptor (Figure 4). Previous studies have established that the B-subunit 
pentamer can be used to deliver peptides attached by either chemical or genetic 
conjugation into the cytosol and nucleus of eukaiyotic cells (Loregian et al., 1999). As 
such this protein has the unique capacity to deliver substances into resting primary 
cells that are otherwise very resistant to transfection.
Figure 4. Ribbon crystal structure of 
Escherichia coli enterotoxin I. The top part 
of the toxin consists of the bioactive A 
subunit, shown in the shades of blue. The A 
subunit is raised above a platform made up by 
five B subunits, and is generally considered 
as the non-toxic carrier. It delivers the A 
subunit to the cells by binding G^.i and 
allowing its subsequent internalisation and 
delivery into the cell cytoplasm (Sixma et al.,
1993).
3.1.1 Binding of CtxB to naive T cells
The first criterion for the delivery vehicle is its capacity to bind to naive 
murine T cells. The B subunits of EtxB and CtxB are internalised via the cell surface 
ganglioside Gm -1 that is reported to be ubiquitously expressed on all cell types 
(Lencer et al., 1992). To confirm this, FITC-conjugated CtxB, 80% homologous to 
EtxB, was used to determine the capacity of the B-subunit pentamer to bind to e.\ vivo 
murine T cells (Figure 5).
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Figure 5.
A single cell suspension of A/J strain splenocytes was incubated for 20 minutes with 1 
pg/ml FITC-conjugated or non-conjugated CtxB, and stained with PE-conjugated 
anti-CD4 or anti-CD8 followed by FACS analysis. Splenocytes incubated with 
antiCD4 and (A) non-conjugated CtxB, or (B) FITC-conjugated CtxB. Splenocytes 
incubated with anti-CD8 and (C) non-conjugated CtxB, or (D) FITC-conjugated 
CtxB.
Alternatively, a single cell suspension of A/J strain splenocytes was incubated for 20 
minutes with indicated amounts of FITC-conjugated CtxB, and stained with PE- 
conjugated anti-CD4 (#■) or anti-CD8 (C) (E).
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Binding of CtxB to CD4+ and CD8+ polyclonal T ceils.
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Figure 5 shows the ability of virtually all cells, and 100% of both subsets of 
murine T cells, CD4+ as well as CD8+, to bind CtxB molecules on the surface. In 
addition, comparing Figure 5B and 5D, CD8+ T cells seemed capable of binding 
more CtxB than CD4+ T cells. This difference in binding capacity was studied in 
more detail, and Figure 5E shows that murine CD8+ T cells have the capacity of 
binding twice as much CtxB than murine CD4+ T cells. The capacity to bind naive T 
cells of both subsets meets the first criterion to use EtxB as a potential delivery 
vehicle for TCR signalling attenuators
3.1.2 Effect of EtxB on naive T cells
A subsequent criterion is that CtxB/EtxB should not have an effect on cell 
physiology by itself, so that the effect of the delivered molecules alone or in 
conjunction with a T cell receptor-mediated signal can be assessed. The enterotoxin B 
subunit has been shown to signal calcium release and 11-2 production in Jurkat T cells, 
but this was dependent on crosslinking surface-bound EtxB with anti-B-subunit 
antibodies and has not been reported in the absence of crosslinking (Gouy et al.,
1994). The effect of enterotoxin B subunit on naive polyclonal and transgenic T cells 
had not been studied in detail yet and this was the focus of the next experiments.
Different concentrations of CtxB varying from 25 ng/ml to 25 pg/ml were 
added to ex vivo splenic T cells in culture for up to three days. The influence of CtxB 
was studied at the level of proliferation, by tritiated thymidine incorporation, 
apoptosis (7AAD), cytokine production (IL-2 and IFNy) and the expression of the 
surface markers CD4, CD8 , CD69, CD62L, CD25, CD44, CD45RB, CD95 and the 
TCR, by FACS analysis.
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Figure 6 .
Splenic single cell cultures of the polyclonal BIO strain were incubated with indicated 
amounts of CtxB for up to 3 days, and stained with PE-conjugated anti-CD4 (A, C, E) 
or anti-CD8 . (B, D, F). Shown are the expression levels of CD69 (A, B), CD25 (C,
D), and CD44 (E, F) as determined by FACS analysis on live T cells. For 
comparison, cells were stimulated with 10 pg/ml anti-CD3 (mAb 145-2C11) as 
positive control. The figure shows mean percentages + SD of positive cells from two 
individual experiments.
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Influence of CtxB on surface marker expression of 
polyclonal murine CD4+ and CD8+ T cells.
CD4+ CD8+
A
so
«30
02 5
01 5
Activation marker CD69
□
□
E
Day 1 
Day 2 
Day 3
c
25 ng/ml 250 ng/ml 2.5 ug/ml 25 ug/ml 
ICT-B]
Activation marker CD25
B
50sS30
025
015  
1 0
10 ug/ml 
2011
D
Activation marker CD69
25 ng/ml 250 ng/ml 2.5 ug/ml 25 ug/ml 
ICT-Bl
Activation marker CD25
10 ug/ml 
2011
100 -|
«"°^ 8 0
« 7 0 -
« 60
Q  50
O  30 -
5;:&
0 25 ng/ml 250 ng/ml 2.5 ug/ml 25 ug/ml 10 ug/ml
[CT-B] [CT-B]
Activation marker CD44 Activation marker CD44
1 0 0  -IIÊ 100 -I% 805  60 
0  50
O  30
25 ng/ml 250 ng/ml 2.5 ug/ml 25 ug/ml 10 ug/ml0 0 25 ng/ml 250 ng/ml 2.5 ug/ml 25 ug/ml 10 ug/ml
[CT-B] [CT-Bl
99
________________________________________________________________ Results
Figure 6  shows results obtained using the polyclonal mouse strain BIO, and 
shows three important activation markers, the early marker for T cell activation 
CD69, the intermediate marker CD25 and the late activation marker CD44. Similar 
results were obtained using the polyclonal mouse strain A/J, the MHC class II- 
restiicted. Rag-negative TCR-transgenic strains A18 (Zal et al., 1994), A l (Zelenika 
et al., 1998), and AND (Kaye et al., 1989), and the MHC class 1-restricted, Rag- 
negative TCR-transgenic mice strains F5 (Mamalaki et al., 1993), BM3 (Sponaas et 
al., 1994) and OT-1 (Hogquist et al., 1994). No significant differences in cell surface 
marker expression could be observed, as shown in Figure 6 , for CD25 and CD44. In 
addition no significant differences were found for the tested markers CD4, CD8 , 
CD45RBandtheTCR.
In contrast, CD69 levels do seem to increase slightly in a dose-dependent way 
over time in the CD8+ T cell subset (Figure 6B). However, the results obtained on the 
time points after day 1 are greatly biased in this subset due to the low cell numbers 
left for analysis. In addition to changes in CD69, the expression level of the L- 
selectin, CD62L, declined in a dose-dependent manner over time during culture with 
CtxB (Figure 7A-D). This was observed in both T cell subtypes, but more 
prominently in the CD8+ subset. The differences observed between both T cell 
subsets probably reflect the difference in binding capacity of CtxB (Figure 5). When 
comparing polyclonal T cell populations with monoclonal TCR-transgenic T cells, it 
was further noticed that the effects of CtxB were more evident on the latter (Figure 7).
The most significant influence of CtxB on ex vivo T cells in this study was its 
effect on their survival (Figure 7E-G). The CD8+ subset of T cells and, to a somewhat 
lesser extent the CD4+ subset, show high susceptibility to apoptosis in the presence of 
CtxB. Culture with 2.5 jig/ml CtxB results in almost 100% cell death within 2 days 
for the TCR-transgenic mouse strains F5 (Figure 7H) and OT-1, and within 3 days for 
the CD8+ subset in the polyclonal mouse strains BIO (Figure 7F) and A/J.
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Figure 7.
Splenic single cell cultures of the polyclonal BIO strain (A, B, E, F) the MHC class 
Il-restricted Rag-negative TCR-transgenic strain A18 (C), or the MHC class I- 
restricted, Rag-negative TCR-transgenic strain F5 (D, G) were incubated with 
indicated amounts of CtxB for up to 3 days, and stained with PE-conjugated anti-CD4 
(A, C, E) or anti-CD8 . (B, D, F, G). Shown are the expression levels of CD62L (A,
B, C, D) and uptake of 7AAD (E, F, G) as determined by FACS analysis. For 
comparison, cells were stimulated with 10 pg/ml anti-CD3 (mAb 145-2C11) as 
positive control. The figure shows mean percentages ± SD of positive cells from two 
individual experiments. Panels D and G have data missing due to high levels o f cell 
death.
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Influence of CtxB on CD62L expression and apoptosis
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In this study, addition of a crosslinking antibody against surface-bound CtxB 
on ex vivo T cells, resulted in an enhancement of the observed effects on cell death, 
shedding of CD62L and upregulation of CD69; however, the high amount of T cell 
death prevented accurate analysis of these results.
The initial aim of this study was to generate a peptide delivery system. This 
delivery system needs to fulfil two important criteria; it should be capable of binding 
to naive ex-vivo T cells and subsequently facilitate the entry of fused proteins in 
sufficient quantity, and the vehicle itself should be inert to allow analysis of the 
transferred signalling attenuators. This study shows that EtxB/CtxB is capable of 
binding ex vivo T cells; however, the results show that it is not an inert delivery 
vehicle, and therefore not suitable for the intended aims of this study.
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3.2 Determining the influence of HIV-1 Tat-PTD on ex vivo T cells
Several other proteins capable of intracellular delivery have been described 
and offer an alternative to receptor-mediated endocytosis. The most powerful seems 
to be the HIV-1 Tat transactivator protein, which is efficiently taken up by cells. The 
domain responsible for this translocation has been ascribed to an 11 amino acid region 
and has already successfully been used to transfect cells with wild-type full-length 
peptides that stayed biologically active after translocation across the membrane.
The biological effects of the 11 amino acid Tat-PTD peptide, 
YGRKKRRQRRR, on activation markers, cytokine profile, survival and proliferation 
of transgenic and polyclonal T cells was, as in the case of EtxB, the focus of initial 
experiments. Several reports showed the inhibitory effect of the full-length Tat protein 
on T lymphocyte proliferation and gene transcription (Ensoli et al., 1993; Helland et 
al., 1991; Holloway et al., 2000; Viscidi et al., 1989), describing its possible role in 
enhancing viral infection and replication. However, these effects require several 
domains of the full-length protein, and the PTD itself has not been reported to have 
any of these effects on its own.
To test this on murine T lymphocytes, a peptide was synthetically generated 
containing the Tat-PTD, a glycine bridge and an HA-tag, CYGRKKRRQRRR- 
GGYPYDVPDYA. Primary T cells from monoclonal TCR-transgenic mouse strains; 
from both the CD4+ (A 18, AND and A l) and the CD8+ (F5, BM3 and OT-1) subsets 
as well as polyclonal T cells (A/J, BIO), were cultured in the presence of this peptide 
for up to three days with concentrations varying from 0.5 pM to 10 pM.
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Figure 8.
Splenic single cell cultures of the Rag-negative TCR-transgenic strains AND (A, C, 
E) and F5 (B, D, F) were incubated with indicated amounts of Tat-PTD peptide for up 
to 3 days, and stained with PE-conjugated anti-CD4 (A, C, E) or anti-CD8. (B, D, F). 
Shown are the expression levels of CD69 (A, B), CD25 (C, D), and CD44 (E, F) as 
determined by FACS analysis on live T cells. For comparison, AND and F5 T cells 
were stimulated with their respective antigen, 1 pM MCC or 10 nM NP68, as positive 
controls. The figure shows mean percentages ± SD o f positive cells from three 
individual experiments.
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Influence of Tat-PTD on surface marker expression of TCR- 
transgenic murine CD4+ and CD8+ T cells.
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Figure 8 shows a summary of several experiments in which the influence of 
the Tat-PTD peptide was assessed on monoclonal primary T cell populations. AND 
and F5 strains are shown as representatives of the CD4+ and CD8+ subpopulations 
respectively. Depicted in Figure 8 are the early marker for T cell activation CD69, the 
intermediate marker CD25 and the late marker CD44. These and other surface 
markers tested, including CD4, CD8, TCR, CD45RB, CD62L and CD95, did not 
show any alteration in their expression pattern compared with the medium control.
The results show that the Tat-PTD peptide has no effect on cell surface marker 
expression in ex vivo naive T cells when compared with medium controls. In addition, 
levels of apoptosis were studied in greater detail. Ex vivo naive T cells were cultured 
in the presence of the Tat-PTD peptide, in concentrations up to 10 pM and followed 
over a period of 3 days. These tests were conducted on the polyclonal strain B 10, and 
the TCR-transgenic strains AND and F5. Figure 9 shows that no difference could be 
observed between medium controls and Tat-PTD-treated cells with regard to 
apoptosis levels.
The aim of this study is to use the Tat-PTD peptide as a delivery vehicle for 
TCR signalling attenuators, to ascertain if manipulation of the signalling pathways 
downstream of the TCR/CD28 receptor can result in distinct functional differentiation 
of T cell populations after a stimulus. In order to assess the effect of the delivered 
molecules on their own, the Tat-PTD peptide should not interfere with a TCR- 
mediated signal. The next experiments therefore focussed on priming naive T cells in 
the presence of the Tat-PTD peptide in order to study this.
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Influence of Tat-PTD on apoptosis levels in 
murine CD4+ and CD8+ T cells
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Figure 9. Splenic single cell cultures of the Rag-negative TCR-transgenic strains 
AND (A) and F5 (B) and the polyclonal strain BIO (C, D) were incubated with 
indicated concentrations Tat-PTD peptide for up to 3 days, and stained with PE- 
conjugated anti-CD4 (A, C) or anti-CD8. (B, D). Shown is the uptake of 7AAD, as 
determined by FACS analysis. The figure shows mean percentages ± SD o f positive 
cells from three individual experiments.
108
Results
Figure 10.
Splenic single cell cultures of the Ragneg TCR-transgenic strains AND (A, C, E) and 
F5 (B, D, F) were incubated with 10 pM Tat-PTD peptide for up to 3 days, and 
stained with PE-conjugated anti-CD4 (A, C, E) or anti-CD8. (B, D, F). Shown are the 
expression levels of CD69 (A, B), CD25 (C, D), and CD44 (E, F) as determined by 
FACS analysis on live T cells. AND and F5 T cells were stimulated on day 0 with 
indicated concentrations of their respective antigenic peptide, MCC or NP68. The 
figure shows mean percentages ± SD of positive cells from three individual 
experiments.
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Influence of the presence of Tat-PTD on surface marker 
expression of TCR-transgenic murine CD4+ and CD8+ T 
cells during priming.
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Results
Figure 10 represents a summary o f several experiments in which the influence 
o f the Tat-PTD peptide on T cell activation was assessed on monoclonal primary T 
cell populations. The AND and the F5 strains are shown as representatives o f the 
CD4+ and CD8+ subpopulations respectively. Similar to Figure 8, depicted are the 
early marker for T cell activation CD69, the intermediate marker CD25 and the late 
marker CD44. These and the other surface markers tested, including CD4, CD8, TCR, 
CD45RB, CD62L and CD95, did not show any alteration in their normal expression 
pattern when cells were stimulated with their specific antigenic peptide in the 
presence o f up to 10 pM Tat-PTD, compared with medium controls. This applies to 
the proportion o f cells changing their expression level, the total level o f surface 
molecules and the pattern o f expression over time.
In addition to activation markers, the influence of the Tat-PTD peptide on 
proliferation, and the production of the cytokines 11-2 and IFNy was also assessed. 
Figure 11 shows a summary of these results. No effect of the Tat-PTD peptide could 
be observed on the level of 11-2 and IFNy production and on proliferation, when 
compared with medium controls in these cultures over a period of 3 days. Not only 
did the overall level of 11-2 production not change, but in the presence of Tat-PTD the 
kinetic profile over time was also identical.
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Figure 11.
Splenic single cell cultures of the Rag-negative TCR-transgenic strains AND (A, C,
E) and F5 (B, D, F) were incubated with 10 pM Tat-PTD peptide for up to 3 days. 
Shown are the incorporation of [^H] thymidine at day 3 after stimulation with the 
respective specific antigenic peptide, MCC or NP68 (A, B), 11-2 secretion in the 
medium as measured in a CTLL-assay at day 1 and 2 after stimulation with the 
respective specific antigenic peptide (C, D), and IFNy secretion in the medium as 
measured by ELISA at day 3 after stimulation with the respective specific antigenic 
peptide (E, F). The figure shows mean percentages ± SD o f positive cells from two 
individual experiments.
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A
Influence of Tat-PTD on proliferation, and cytokine 
production of TCR-transgenic murine T cells
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3.3 Production of Tat-PTD fusion proteins
The previous results indicated that the Tat-PTD peptide itself does not affect naive 
T cells, and therefore may serve as a suitable carrier for the intended aims of this 
study. In order to transfer signalling attenuators into naive T cells, fusion proteins 
with the Tat-PTD peptide were generated.
3.3.1 Targets in the TCR signalling cascade
Activation of the PTK Lck following TCR engagement is responsible for 
phosphorylation of ITAM tyrosine residues, one of the earliest events in the TCR 
signalling cascade (Weiss, 1993). The two critical tyrosines in each ITAM are 
independently phosphorylated, resulting in the generation of differently 
phosphorylated TCRÇ isoforms, p21 and p23, predominantly found in resting 
peripheral spleen and lymph node T cells and in activated T cells, respectively. The 
21-kD isoform is generated by the phosphorylation of the four tyrosines located in 
ITAMs 2 and 3, whereas p23 is fully phosphorylated on all three ITAMs (Figure 12) 
(van Oers et al., 2000). Analysis of phosphorylated TCRÇ isoforms using site-specific 
antibodies have shown that p21 predominantly contains singly phosphorylated 
ITAMs, while p23 predominantly contains dually phosphorylated ITAMs (Kersh et 
al., 1998a). This sequential phosphorylation of the six tyrosine residues of the TCRÇ 
was found to be highly ordered, and completion of phosphorylation steps is dependent 
on the nature of the ligand; full phosphorylation was found to depend on the strength 
of TCR triggering. This indicates that each phosphorylation step may establish a 
threshold for T cell activation.
Stimulation of T cell clones with altered peptide ligands (APLs), 
predominantly results in the p21 TCRÇ isoform, that either antagonises or anergises 
the T cell response. Thus, there is a correlation between the induction of particular 
isoforms of TCRÇ and the functional responsiveness of T cells (Kersh et al., 1999; 
Sloan-Lancaster and Allen, 1996b).
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The TCRÇ chain isoforms
pl6
^ 3  Y
Y/P-Y 
P-Y
p21 p23
nnI ZAP-70 recruitment ZAP-70 phosphorylation 
T cell activation 
Cytokine production
I I No ZAP-70 recruitment No ZAP-70 phosphorylation Anergy/ Non-responsiveness
Figure 12. The TCRÇ chain has multiple isoforms, based on its phosphorylation 
state. The non-phosphorylated form, p i6, is the predominant form found in cell lines, 
hybridomas and in ex vivo cell cultures after 24 hours. The p21 semi-phosphorylated 
isoform is found in spleen and lymph node T lymphocytes, and is capable of binding 
ZAP-70. Upon TCR triggering, all ITAMs are phosphorylated, resulting in the p23 
isoform that recruits ZAP-70 and allows subsequent activation of the T cells. T cells 
activated with specific APLs can express a different isoform of p21, which does not 
allow ZAP-70 binding, and results in T cell anergy or non-responsiveness.
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Only dually-phosphorylated ITAMs recruit the crucial PTK molecule ZAP-70 
via its tandem SH2 domain (Iwashima et al., 1994). Hence, p21 can be found 
associated with a pool of ZAP-70 molecules; these, however, are not phosphorylated. 
Since there are three ITAMs in each TCRÇ, this allows up to three ZAP-70 molecules 
to bind each chain. Indeed, recombinant ZAP-70 binds the phophorylated TCRÇ in a 
3:1 molar ratio (Weissenhom et al., 1996), providing a mechanism for signal 
amplification. Although all doubly-phosphorylated ITAMs will compete with each 
other, there is a hierarchy in affinity of ITAM1>ITAM2>ITAM3 (Isakov et al., 1995).
Binding of ZAP-70 to the ITAMs results in the phosphorylation of multiple 
residues of ZAP-70, regulating its activity (Watts et al., 1994; Di Bartolo et al., 1999). 
Crucial for its kinase activity is phosphotyrosine residue 319, with which it recruits 
the SH2 domain of Lck (Di Bartolo et al., 1999; Pelosi et al., 1999), allowing 
phosphorylation of Y493 by Lck and subsequent autophosphorylation of Y292 and 
Y 492(C hanetal., 1995).
The central question that this study tries to address is whether manipulation of 
signalling pathways can drive T cells into different response modes. Both Lck and 
ZAP-70 are likely candidates to set such thresholds for T cell activation and both have 
been reported to play a role in induction or maintenance of T cell anergy. The relative 
importance of these kinases for lymphocyte activation has been evaluated by gene 
disruption in the mouse. However, the possibility of compensatory function of other 
proteins complicates the interpretation of these studies. In addition, the use of 
immortalised cell lines does not reflect the signalling mechanism in naive T cells. 
Therefore, these molecules, involved in the most proximal TCR signalling events, 
became the target of this study in which specific peptide-based inhibitors of individual 
proteins were generated, to help clarify the role that these enzymes play in signalling 
pathways and differentiation of T cells.
The Tat-PTD should allow the entry of these specific inhibitors into naive ex 
vivo T cells, which are otherwise difficult to transfect. The specific inhibitors were 
designed to be capable of competing with important protein-protein interaction sites 
of the endogenous Lck and ZAP-70 molecules. The function of ZAP-70 in TCR
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signalling depends on its recruitment to the plasma membrane by dually- 
phosphorylated TCRÇ chains, its subsequent phosphorylation and interaction with 
Lck. The interaction between ZAP-70 and the TCRÇ depends entirely on its tandem 
SH2 domains. Therefore, when these are introduced in sufficiently high 
concentrations, one might expect them to compete with endogenous ZAP-70, thereby 
reducing the amount recruited to the plasma membrane and decreasing downstream 
signals. Therefore, a genetic fusion was generated between the Tat-PTD and the 
truncated form of ZAP-70, consisting only of its two SH2 domains (Tat- 
Zap70(SH2)2) (Figure 13).
The PTK Lck is responsible for the phosphorylation of the TCRÇ chains and a 
tyrosine residue on ZAP-70. It binds with its unique N-terminal part to the co­
receptors CD4 and CDS, allowing it to come into close contact with the TCR 
signalling machinery. In addition, Lck has two other motifs for protein-protein 
interactions, a SH2-domain and a SH3 domain. The SH2 domain enables its 
recruitment to phosphotyrosine residues like Y392 in ZAP-70, which permits 
subsequent phosphorylation of Y493 determining ZAP-70 kinase activity (Chan et al., 
1995), and the SH3 domain allows interaction with CD28 to sustain Lck activity 
(Holdorf et al., 1999). In order to interfere with possible recruitment and function of 
Lck, as in the case of ZAP-70, a kinase-truncated molecule was genetically fused to 
the Tat-PTD. With the intention of allowing acylation, myristoylation and recruitment 
of Lck to the plasma membrane, to compete with endogenous Lck, a fusion protein 
was generated that left the N-terminus of Lck free of interfering tags as well as the Tat 
PTD (Lck^^"^-Tat), and a second one that would not allow this recruitment because of 
the His-tag and Tat-PTD at the N-terminus (Tat-Lck^^"^) (Kabouridis et al., 1997) 
(Figure 13). In addition, a smaller version was generated, expressing its specific SH2 
domain only (Tat-Lck^"^). Finally, wild type Lck was fused to the Tat-PTD at the N- 
or C-terminus, allowing to test Lck functionality in the Jurkat mutant cell line JCaM l, 
containing a defect in the expression o f functional lck (Straus and Weiss, 1992).
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Overview of the generated Tat-PTD fusion proteins
T a t-L c k '^ ^  
Lck'^ -^Tat
T at-L ckN S H 2  
LckNSH2_xat
T a t-L c k S H 2
ZAP-70' ‘^ 
Tat-Zap70(SH2>2
m Tat PTD m SH3 domain
HA-tag SH2 domain
m His-tag 0  Kinase domain
Figure 13. Contructs 1 and 2 represent wild-type Lck (Lck"') cloned in between a 
His-tag for purification purposes and the Tat-PTD at the N-terminus, and a HA-tag for 
immuno-detection purposes at the C-terminus (Tat-Lck"'), or with a free N-terminal 
end and all modifications at the C-terminus (Lck"'‘-Tat), respectively. Constructs 3 
and 4 represent truncated forms of Lck, lacking its kinase domain, but maintaining its 
unique N-terminus and SH3 and SH2 domain, in between tags (Tat-Lck^^""), or with 
a free N-terminus (Lck^^'*“-Tat), respectively. Construct 5 represents the SH2 domain 
of Lck only (Tat-Lck^'*“), cloned in between His and HA tags. Construct 6 is wild- 
type ZAP-70 (ZAP-70'^'), and construct 7 represents the kinase-truncated form of 
ZAP-70 (Tat-Zap70(SH2)i), leaving only its characteristic tandem SH2 domain, 
cloned in between both tags.
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The functionality of the fusion partners depends greatly on their refolding 
capacity after translocation across the cell membrane, since cellular uptake by Tat- 
PTD is preceded by an unfolding step. The refolding properties are different for every 
protein, and therefore, full-length Lck was also included as a fusion partner. This 
would allow testing the functionality of Lck in this system by reconstitution of the 
functional Lck-negative mutant Jurkat T cells, JCaMl (Goldsmith and Weiss, 1987).
3.3.2 Expression of Tat-PTD fusion proteins
cDNA fragments of ZAP-70 and Lck were cloned into the pET-Tat-HA 
vector. Figure 14A, derived from the pET15b vector, and sequenced to check for 
irregularities. After transduction into Bl-21 bacteria, expression of the desired fusion 
products was tested in small-scale cultures. Two single colonies were grown up, 
expression was induced with IPTG for four hours and total cell lysates were tested for 
the presence of full-length fusion proteins by separation by SDS-PAGE and Western 
blotting. Since two tags were engineered into the proteins, a His-tag at the N- 
terminus, and an HA-tag at the C-terminus (Figure 13), immuno-blotting for these 
tags would reveal if the desired protein is expressed at full-length. Figure 14 shows 
the expression of the following Tat-PTD fusion proteins; Tat-Lck"'*, Tat-Lck^^"^, Tat- 
Lck^"^ and Tat-Zap70(SH2)2. Panel B shows staining for the His-tag, located at the 
N-terminus, and panel C shows the same blot stained for the HA-tag, located at the C- 
terminus. Since panel B and C show identical patterns of staining, at the expected 
molecular weights of the intact full-length fusion proteins, it was concluded that the 
engineered vectors expressed the complete fusion proteins.
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Figure 14.
Fragments of cDNA were cloned into the pET-Tat-HA vector (A), containing a His- 
tag, the Tat-PTD and a HA-tag.
Expression of the genetically engineered Tat-PTD fusion proteins was tested by SDS- 
PAGE and Western blotting. Total cell lysates were separated on a 12% SDS-PAGE 
gel, blotted onto nitrocellulose, and stained with anti-His mAbs (B); subsequently the 
blot was stripped and reprobed with anti-HA mAbs (12CA5) (C). Shown are lysates 
of two individual colonies of; (1) Tat-Lck"^\ (2) Tat-Lck^^"^, (3) Tat-Lck^"^, (4) Tat- 
Zap70(SH2)2, (5) empty vector and (6) control protein containing both tags.
The expression levels over time, and the solubility of the expressed fusion proteins 
was tested by separating the soluble and insoluble fractions of cell pellets taken at 
time intervals of 5 and 8 hours after IPTG induction (D). Depicted here are the soluble 
fraction (lanes 1,4), the insoluble fraction (lanes 2 ,5) and the total cell lysate (lanes 
3 ,6 ) of Tat-ZAP-70(SH2)2 fusion protein expressed by B l-21,5 hours (lanes 1 ,2 ,3 ) 
and 8 hours (lanes 4 ,5 ,6 )  post-IPTG induction.
Purification of expressed fusion proteins was done with the help of the engineered 
His-tag and Ni-NTA columns (E). Shown here is a Coomassie Blue staining o f the 
total cell lysate before applying it to the Ni-NTA column (L), the flow through (F), 
the first (W l), second (W2) and third (W3) washing steps and finally the eluted 
fraction (E) of a Tat-Zap70(SH2)2, (indicated by the arrow), purification, separated on 
a 12% SDS-PAGE gel.
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Expression and isolation of Tat-PTD fusion proteins
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To obtain maximum amounts of protein, the expression kinetics of each fusion 
protein was tested. Inoculated cultures were grown to OD6oo=0.5, whereafter 
expression of the fusion proteins was induced with 0.6 mM IPTG. Samples were 
taken at 2 ,5  and 8 hours post-induction and checked for total amount of fusion 
protein by SDS-PAGE. This expression system performed optimally when cultures 
were grown at 30°C with 0.6 mM IPTG for 4 to 6 hours.
Important for the purification purposes was to know if the target proteins were 
expressed in a soluble form, or in inclusion bodies. Therefore, bacteria expressing 
each Tat-PTD fusion protein were collected 5 or 8 hours post-IPTG induction, and 
divided into a soluble and insoluble fraction. Figure 14D depicts the study for Tat- 
ZAP-70(SH2)2, and shows that the shorter time interval of 5 hours results in higher 
expression of this fusion protein per weight of bacterial pellet. More importantly, it 
shows that the majority of this protein is expressed in inclusion bodies, which was the 
case for all fusion proteins tested in this study.
3.3.3 Purification of Tat-PTD fusion proteins
The expression of the fusion proteins in the insoluble fraction required 
purification of these proteins under denaturing instead of native conditions. Most 
proteins in inclusion bodies are solubilised with detergents or dénaturants such as 8 M 
Urea or 6 M Guanidine HCl. Urea solutions must be used promptly and not stored for 
long periods of time because of the formation of the Urea isomer ammonium cyanate; 
the cyanate ions can covalently modify primary amines on the target protein (Stark et 
al., 1960). Both dénaturants were initially used for these studies, but the more stable 
dénaturant Guanidine HCl was chosen in the final protocol.
The chosen method of purification, immobilised-metal affinity 
chromatography using the engineered 6x His-tag, does not depend on tertiary 
structure, which is lost once proteins are denatured. The advantage is that the 6x His- 
tag will be fully exposed so that binding to the chelating ligand will improve, and the 
efficiency of the purification will be maximised by reducing the potential for non­
specific binding. Utilising the Tat-PTD system for intracellular delivery, efficient 
translocation is dependent on an unfolding step to enable the membrane translocation.
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and this is followed by a refolding step whereby several proteins are reported to 
regain their biological function (Bonifaci et al., 1995).
A general purification protocol for all Tat-PTD fusion proteins was established 
using small-scale cultures and optimal conditions were determined empirically. 
Bacterial pellets were dissolved in a 5.8 M guanidine HCl lysis buffer supplemented 
with 5 mM imidazole, and with help of additional sonication. The cell debris was 
spun out, and the resulting fraction was applied to a Nickel-Nitrilotriacetic acid (Ni- 
NTA) column and allowed to flow by gravity. The column was washed with different 
concentrations of imidazole to decrease non-specific binding, and finally the bound 
proteins were eluted in a high concentration imidazole buffer. Figure 14E shows a 
purification of Tat- Zap70(SH2)2, and shows that the majority of the target protein has 
bound to the Ni-NTA column, comparing the lysates before (L) and after (F) 
application to the Ni-NTA column. Washing resulted in the clearing of non- 
specifically bound proteins, where the last wash sometimes elutes a minor amount of 
the target protein (W3), and subsequently the highly purified fusion proteins were 
successfully eluted (E).
3.3.4 Slow desalting of denatured Tat-PTD fusion proteins
The ultimate use of the Tat fusion proteins requires them to be added to the 
medium in which ex vivo T cells are cultured. This means that the high concentrations 
of dénaturants used during purification need to be removed from the final protein 
solution. When proteins are purified under denaturing conditions, some renaturation 
may be necessary to allow the proteins to be soluble in physiological buffers, for 
which the conditions must be determined empirically for each target protein. Table 4 
shows an overview of different strategies, and recommendations from the literature 
that have been tried alone and in combination throughout this study. During a long 
period of trial and error, conditions were determined to establish a protocol allowing 
solubilisation of Tat fusion proteins in a physiological buffer in sufficient quantity to 
allow multiple experiments from one round of purification.
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Table 4: Overview of different strategies tried during this 
study to allow solubilisation of Tat fusion proteins.
Reagents Effect
Dilution Reducing dénaturants
Dialysis Slide-a-lyser Removing dénaturants
Desalting PD-10 columns/Mono Q/S Removing dénaturants
Protein concentration 10-50 ng/ml
Cosolvents Glycerol 5-20% Stabilising hydrophobic 
interactions
Glucose 10% Decrease unfolding rate
Sucrose 10% Decrease unfolding rate
Ethanol 5-20% Stabilising hydrophobic 
interactions
Anions : phosphate and 
sulphate
Decrease unfolding rate
Cations : HEPES Decrease unfolding rate
Oxidising/ Thiol reagents Glutathione/oxidised 
Glutathione 
Oxidation by air 
Cu^+
Allowing/ inhibiting 
formation of cysteine 
bridges
Salts lOOmMKCl 
150-500 mMNaCl 
2 mM MgCb
Prevent ionic interactions
pH Neutral / pi Enhance solubility
Protease inhibitors 0.5 mM PMSF 
0.05-2 mg/ml aprotinin 
2 jig/ml pepstatin 
2-5 pg/ml leupetin
Suppress proteolysis
Immobilised refolding Dénaturant gradient in 
high salt and 20% glycerol
Prevent intermolecular 
interactions
Amino acids L-arginine; Glycine Enhance solubility
Other additives MgClz; CaClz Essential ions
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A general method of Tat fusion protein production was published in 2000 
(Schwarze et al., 2000); this protocol formed the basis for the protein production in 
this study, but failed to generate high yields of Tat-PTD fusion proteins. In short, 
recombinant proteins are isolated from the bacterial pellet by sonication in 6 M 
Guanidine HCl and purified over a Ni-NTA affinity column. After purification, the 
dénaturant will have to be removed. This can be done rapidly using a PD-10 desalting 
column. Mono Q/S columns, or dialysis against a physiological buffer like PBS.
Initial attempts to remove the dénaturant in this way all failed due to extensive 
aggregation of the target protein. The addition of various cosolvents like salts and 
glycerol did not lead to any improvement.
The solubility of the Tat fusion proteins will depend on their complexity and 
the structure that is energetically the most favourable. The fusion proteins used in this 
study all have a SH2 domain in common. Additional domains are: the unique N- 
terminus of Lck that is not known to favour a particular structure, the SH3 domain 
which forms an additional complexity, and the complex kinase domain in the Lck^\ 
making Lck'^‘ likely the most complex and thus most difficult protein to solubilise. 
None of the proteins in the initial stages, however, allowed rapid removal of the 
dénaturant. Slow dilution and step-wise dialysis against decreasing concentrations of 
the dénaturant offered an alternative for dénaturant removal. Dilution was found to be 
the most desirable, since this led to higher amounts of soluble protein. The protein is 
diluted many fold (>10) directly but slowly into refolding buffer to achieve low 
concentration conditions that promote a folding state whereby the protein is soluble 
and disfavours aggregation. The critical point of removing the dénaturant was around 
the 2M concentration, and a 2M Urea solution served as the first dilution buffer. 
Thereafter, a Tris- or HEPES-based buffer served as the second dilution buffer. After 
dilution steps, the volumes were kept at reasonable levels using a stirred-cell 
concentrator. The final step in the solubilisation protocol was a dialysis step, whereby 
the protein was dialysed against 10% glycerol in PBS, allowing removal of residual 
chemicals and a cell-compatible end product.
The presence of a high number of aromatic and aliphatic residues is thought to 
decrease the solubility of proteins and contribute to aggregation (Burgess, 1996). 
These hydrophobic interactions can be minimised by including mild detergents and
125
Results
glycerol in the solubilisation buffers. The use of glycerol in this study did enhance 
protein yield considerably at concentrations between 10 and 20%.
Another frequently used approach is to dilute the protein in order to decrease 
intermolecular aggregation, already applied in this study for dénaturant removal. The 
net charge of the target protein can also be used as a guide for the determination of 
buffer conditions that may enhance solubility. The high amount of positively charged 
residues, arginines and lysines, in the Tat-PTD peptide, suggested that pH adjustments 
might result in greater solubility and recovery of soluble protein. Adjustments of pH 
in this study did not result in significant improvements, however.
The presence of cysteine residues and disulfide bonds in a fusion protein helps 
to indicate what refolding reagents to use. All fusion proteins in this study contain 
between 4 and 10 cysteine residues, but these are not used to create disulfide bonds in 
vivo. Thiol redox reagents, such as oxidised/reduced glutathione, can be added to 
catalyse disulfide bond formation and to inhibit the formation of non-productive 
disulfide intermediates. As reported previously, although Lck does not form disulfide 
bonds, the redox state affects its solubility (Yasukawa et al., 1995). Alternatively, the 
target protein can be fully oxidised by the use of CUSO4 or NaSeOs and exposure to 
air under slow stirring. The latter has proved to be the most powerful method tested 
during this study.
After many trials and adjustments it proved difficult to obtain high enough 
quantities of the Tat-PTD-Lck'^* fusion protein. Since the only aim of making this 
protein was testing its refolding and functional capacity after transduction, as a model 
for the other Lck domains-containing fusion proteins, it was decided to abandon the 
production of this particular fusion protein. The other proteins in Figure 13, could all 
be produced by stepwise dilution of the dénaturant; first in a high salt HEPES buffer 
supplemented with 2M Urea, 20 % glycerol and 50 mM Glycine, secondly in a high 
salt HEPES buffer supplemented with 20% glycerol and 50 mM Glycine, thereafter a 
final dialysis step followed against 10% glycerol in PBS.
126
________________________________________________________________ Results
3.3.5 Rapid desalting of denatured Tat-PTD fusion proteins
Although removal of dénaturants by slow dilution resulted in about 10 mg of 
fusion protein per isolation, it seemed possible that alternative strategies might give 
higher yields of protein. Rapid removal from 8M Urea by PD-10 desalting-columns 
and with ion exchange chromatography was successfully reported for several proteins 
before. This method has been reported to give the highest yield and quality of Tat- 
PTD fusion proteins (Vocero-Akbani et al., 2001).
The general method of Tat fusion protein production, published by Schwarze 
et al (2000), proposes the use of ionic exchange chromatography and FPLC 
equipment. However, initial small-scale experiments using Mono Q or S resin 
resulted in precipitation of eluted protein or irreversible binding to the resin, and the 
technique was therefore abandoned. At a later stage, attempts were made using single 
step elutions, thereby avoiding the use of automated FPLC or HPLC equipment. The 
purification of proteins by ionic exchange chromatography is largely dependent on 
their isoelectric point (pi), however, due to the use of high molar Urea solutions and 
the addition of a highly positively charged Tat-PTD amino-sequence, some fusion 
proteins used in this study were found to bind to Mono Q or S resin independently of 
their theoretical pi (Figure 15C).
Because 6 M Guanidine HCl is a more stringent dénaturant than 8 M Urea, 
this is in some cases favoured above Urea, because it allows better exposure of the 
His-tag purification leader. However, due to the ionic nature of Guanidine HCl it can 
not be used in conjunction with ion exchange chromatography, and when used for 
purification, needs to be replaced with 8 M Urea prior to ion exchange 
chromatography. Figure 15B shows that dénaturation and isolation under 8 M Urea 
conditions works equally well for the proteins used during this study, and since the 
dénaturant is removed very quickly using this method, 8 M Urea was chosen as 
dénaturant. Once the fusion proteins are eluted from the Ni-NTA column, they were 
diluted in a dilution buffer, which has to be tailored to each individual fusion protein, 
with specific sodium chloride concentration and pH (Figure 15C) resulting in a 4 M 
Urea solution. Since Tat-proteins bind to Mono Q or S more or less strongly
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depending on their pi, optimal conditions for each protein need to be determined 
empirically.
As a general method, newly purified proteins were added to 5 ml Source Q in 
batch form, equilibrated with 20 mM Hepes, pH 8.0, or Source S, equilibrated with 20 
mM Hepes, pH 6.5. If no or weak protein binding is observed with one resin, 
regardless of predicted pi, the use of other Source resin is indicated. If strong binding 
is observed, but poor yield in the eluate, several modifications can reduce the 
effective avidity of the protein to the resin. The goal is to decrease the avidity of the 
protein for the resin in Urea to the point of obtaining a reversible binding. The sample 
and resin can be equilibrated with increasing amounts of NaCl, until recovery yield is 
high. Alternatively or in combination, the pH of the buffer can be decreased (Source 
Q) or increased (Source S) in steps until improvements in yield in the eluate.
After collection of the eluate, generally containing 1-2 M NaCl, some proteins 
may be desalted to physiological salt concentrations using a PD-10 desalting column. 
Proteins used in this study, however, still showed a tendency to precipitate, and were 
therefore diluted in PBS 10% glycerol in three steps, thereby increasing the volume, 
and thus reducing the protein concentration allowing the protein to stay soluble. 
Precipitated protein was filtered-out using a 45pm syringe filter prior to overnight 
dialysis against PBS 10% glycerol. On average, 50-80 mg of protein was obtained 
from a 3 1 starting culture. Figure 15 A shows a schematic purification protocol.
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Rapid desalting of denatured Tat-PTD fusion proteins
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Figure 15. (A) Rapid purification protocol. (B) Purification of Tat-Lck'^^**" over Ni- 
NTA resin and Source S resin. Crude lysate (BN) from 3 L culture was applied to the 
Ni-NTA resin, allowed to flow through (AN) by gravity, washed twice (W l, W2), 
eluted (NE), applied to Source S, washed, eluted (SE), diluted and dialysed against 
PBS (PBS). 10 pi of each fraction were resolved by SDS-PAGE and stained with 
Coomassie blue. (C) Overview of rapid desalting conditions used for the Tat-PTD 
fusion proteins generated during this study.
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3.4 The use of a small Zap70 inhibitor peptide
Since numerous technical problems were encountered with the purification of 
large fusion proteins, interest was aroused by two recent reports showing the use of 
chemically synthesised protein transduction domains fused to a short peptide 
sequence (Nishikawa et al., 2000; Bonny et al., 2001). Nishikawa et al. (2000) 
screened a tyrosine-oriented peptide library, substituting the tyrosine residue by a 
phenylalanine residue. They identified a specific and competitive peptide inhibitor of 
ZAP-70 (ICso^lO pM in kinase assay). By delivering this peptide at high 
concentrations to the interior of Jurkat T cells, making use of the penetratin system, 
they showed diminished phosphorylation levels of proteins known to be ZAP-70 
substrates, as well as inhibition in transcriptional activation of the 11-2 gene upon CD3 
crosslinking.
This approach circumvents the problems encountered with protein solubility, 
and the described peptide-sequence (KLILFLLLL) can be synthesised covalently 
attached to the Tat-PTD. It offers an alternative approach of the original aims of this 
study. Instead of utilising large protein domains, short peptide-sequences designed to 
bind to and to interfere with protein-protein binding domains can be transferred into 
naiveT cells in order to compete with endogenous proteins with the aim of modifying 
T cell differentiation.
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Concentrations varying from 0.1 pM to 50 pM of the peptide, named Tat- 
PTD-Z70I, were tested on monoclonal and polyclonal T cell populations, in the 
presence or absence of antigen-specific stimulation or CD3 crosslinking. T cell 
populations from different TCR-transgenic and polyclonal mice (A l; BM3; OT-1, A- 
strain and BIO) were tested for activation markers and cytokine production as 
described before, but none of them showed diminished activation in the presence of 
Tat-PTD-Z70I. Figure 16 shows the results of one of the tested transgenic strains, 
AND, and the absence of any influence of the reported Zap-70 inhibitor peptide at the 
tested concentrations on the activation markers CD69, CD25 and CD44 as well as the 
cytokines 11-2 and IFNy. As shown in panel A, the peptide appears to be toxic for ex 
vivo T cells at concentrations above 5 pM. Concentrations reported to inhibit Jurkat T 
cells, ranging from 10-100 pM, could therefore not be tested and the Tat-PTD-Z70I 
peptide was found not suitable for the intended aims of this study.
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Figure 16.
Splenic single cell cultures of the Rag-negative TCR-transgenic strain AND were 
incubated with indicated concentrations of Tat-PTD-Z70I peptide for up to 3 days, 
and stained with PE-conjugated anti-CD4. Shown is the uptake of 7AAD, as 
determined by FACS analysis (A).
Splenic single cell cultures of the Rag-negative TCR-transgenic strain AND were 
incubated with 5 pM Tat-PTD-Z70I peptide for up to 3 days, stimulated on day 0 with 
indicated concentrations of the specific antigenic peptide MCC, and stained with PE- 
conjugated anti-CD4. Shown are the expression levels of CD69 (B), CD25 (C), and 
CD44 (D) as determined by FACS analysis. 11-2 secretion in the medium as measured 
in a CTLL-assay at day 1 and 2 after stimulation with the specific antigenic peptide 
(E), and IFNy secretion in the medium as measured by ELISA at day 3 after 
stimulation with the specific antigenic peptide (F). The figure shows mean 
percentages ± SD o f positive cells from two individual experiments.
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Influence of the small peptide, KLILFLLLL, a reported 
ZAP-70 inhibitor, on activation of AND T cells
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3.5 Transduction of Tat-PTD fusion proteins
Following production of Tat-PTD fusion proteins in soluble form and in a 
physiological buffer the first question to be addressed was if Tat-PTD is indeed 
capable of intracellular delivery of the fused proteins. The first protein that to be 
produced in larger quantities, Tat-Zap70(SH2)2, was used to test if Tat-PTD could 
deliver large proteins into T cells.
3.5.1 Cell entry of slowly desalted Tat-PTD fusion proteins
The first experiments were set up with Jurkat T cells. Cells were incubated 
with slowly desalted Tat-PTD fusion protein for various times, thereafter cells were 
washed, lysed and loaded on a SDS-PAGE gel. In order to discriminate between 
membrane-bound fusion protein and cytoplasmic protein, treated cell fractions were 
split in two, and one of the fractions was left untreated, while the other was treated 
with trypsin, removing extracellular proteins.
Figure 17A shows that after 10 minutes fusion proteins were pulled down with 
the cells, indicating binding. However, upon trypsin treatment, this fraction 
disappeared, indicating that it had not entered the cells. Upon prolonged exposure to 
the fusion protein, for 1 and 4 hours, it was still detectable after trypsin treatment, 
showing that it had entered the cells, since intracellular proteins are protected from 
trypsin by the plasma membrane. This indicates that a fraction of the fusion protein 
had entered the cells.
The most important point for this study was to test if Tat-PTD fusion proteins 
are able to cross the membrane of naive ex vivo T cells. In order to test this, fusion 
proteins were labelled with the fluorochrome FITC, which has the characteristic of 
being quenched at acidic pH levels. Since cells keep their interior milieu at 
physiological levels with the help of ion channels, intacellular FITC will be able to 
emit, while extracellular FITC is quenched by low pH. This principle is shown in 
Figure 17B, where T cells are stained with FITC-conjugated anti-TCR antibodies.
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Acquisition at neutral pH leads to a high FITC signal, while an acidic pH of 6.8 
quenches the extracellular bound antibodies.
Co-cultures of naive ex vivo T cells with FITC-conjugated Tat-Zap70(SH2)2 
could now be assessed for the uptake of fusion protein. Figure 17C shows that after 90 
minutes of co-culture, and washing, acquired cells at pH 7.4 gave a strong positive 
signal. Upon acquisition at an acidic pH, part of this signal was lost, but it was still 
above background levels. In comparison, co-cultured cells were treated with trypsin, 
and subsequently acquired at pH 7.4, showing identical signal intensity. This suggests 
that Tat-PTD is indeed capable of delivering large proteins into naive T cells. In 
addition. Figure 17C shows that the majority of T cells are transduced with the fusion 
protein.
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Figure 17.
(A) 5x10^ Jurkat T cells were incubated for indicated minutes with slowly desalted 
200 nM Tat-Zap70(SH2)2 at 37°C. They were then collected, washed twice, split into 
two fractions of which one fraction was treated with 10 pg/ml trypsin for 15 min on 
ice. Cells were subsequently washed with cold PBS, lysed, and loaded onto a 12% 
SDS gel. After transfer, blots were stained with anti-His-tag or anti-HA (12CA5) 
antibodies. Shown here is the result of anti-HA staining; anti-His staining gave 
identical results.
(B) MACS-purified BIO T cells were stained with FITC-conjugated anti-TCR 
antibody, and were subsequently acquired by FACS at pH 7.4 or pH 6.8.
(C) MACS-purified B 10 T  cells were incubated for 90 minutes with or without 2 pM 
FITC-conjugated Tat-Zap70(SH2)2, thereafter cells were left untreated or treated with 
5 pg/ml trypsin for 15 min on ice, followed by acquisition on a FACScalibur at pH
7.4 or pH 6.8.
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3.5.2 Kinetics of cell entry of slowly desalted Tat-Zap70(SH2)2 fusion protein
This study is based on the hypothesis that transduced proteins can interfere 
with TCR signalling events during T cell priming. This implies that the fusion protein 
should be present at high enough concentrations just before and during the stimulus. 
Timing is probably an essential parameter in these experiments, and therefore it is 
important to know the kinetics of transduction of naive T cells. It is important to know 
how long it takes before the fusion proteins are taken up, and when they are at their 
highest concentration inside the cell.
In order to test this, different concentrations of slowly desalted Tat- 
Zap70(SH2)2-FITC were added to the medium, and primary Magnetic Activated Cell 
Sorter (MACS)-selected CD4'*’ T cells were cultured in this medium for different 
periods of time. Figure 18 shows that after an incubation period of 10 minutes, cells 
are loaded on the outside, in a concentration-dependent way, with the Tat fusion 
proteins (Figure ISA), but no fluorescence can yet be detected inside the cells (Figure 
18B). After one hour (Figure 18C), FITC-conjugated protein has entered the cell, and 
it can be observed that a higher extracellular fusion protein concentration correlates 
with a higher intracellular concentration of protein. The maximum intracellular levels 
are reached within 3 hours of coculture (Figure 18D), as compared with the 24 hours 
incubation period (Figure 18E). Identical results were obtained using FITC-labelled 
Tat-Lck'^™^ and Lck^®"^-Tat.
At the tested concentrations, protein uptake does not seem to be dependent on 
a limited amount of binding sites, and intracellular levels reflect the extracellular 
levels. The uptake o f the protein does take some time, however; an incubation period 
of three hours results in maximum levels of intracellular protein concentrations under 
these culture conditions.
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Figure 18.
MACS-purified CD4^ BIO T cells were co-cultured with indicated concentrations of 
FITC-conjugated slowly desalted Tat-Zap70(SH2)2, thereafter cells were acquired by 
FACS at indicated times of 10 minutes (A, B), 1 h {€), 3 h (D), and 24 h (E) at pH of
7.4 (A) or pH 6.8 (B, C, D, E).
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3.5.3 Functionality of slowly desalted Tat-Zap70(SH2)2
Although it could be verified that Tat-PTD fusion proteins were efficiently 
internalised, this does not provide any information about their status. Since it is 
known that in order to be transported across the cell membrane the Tat-fused protein 
is first unfolded (Bonifaci et al., 1995), it is important to test if the fused protein is 
properly refolded and performs its intended function. Tat-Zap70(SH2)2 is designed to 
compete with endogenous ZAP-70 by binding to the same phosphorylated tyrosine 
residues in ITAMs with its tandem SH2 domains. In order to do this, both SH2 
domains should be properly refolded (Isakov et al., 1995). Properly refolded Tat- 
Zap70(SH2)2 should then be capable of pulling down TCRÇ chain from activated T 
cells. As shown in Figure 13, all constructs were engineered to contain an HA-tag, 
thus allowing specific immune-precipitation of Tat-Zap70(SH2)2. Association of CDS 
chains with Tat-Zap70(SH2)2 versus endogenous Zap70 can then be compared.
The immune-precipitations of ZAP-70 and Tat-Zap70(SH2)2 in Figure 19, 
show identical bands at the expected sizes of p21 and p23, the two TCRÇ isoforms, 
and p27, CD3e. These are first detected 3 hours after coculture. Although a fraction of 
the fusion protein would already have been internalised by 1 hour after coculture 
(Figure 18), this appears to be not yet capable of binding phosphorylated ITAMs. 
Since the immune-precipitated protein was not equivalent for the different time 
points, evident from panel B, it is not possible to draw quantitative conclusions for the 
different time points. However, Tat-Zap70(SH2)2 is clearly capable of binding 
phosphorylated ITAM motifs, indicating the presence of a refolded and functionally 
active fraction of this protein in the cells.
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Figure 19.
(A) Jurkat T cells (10^) were grown in the continuous presence (or absence) of 4 pM 
slowly desalted Tat-Zap70(SH2)2. Cells were collected at indicated time points (in h) 
after the initial start of the culture, and phosphorylation was induced by 1 mM sodium 
ortho-vanadate (Na3V0 4 ) where indicated (+). Subsequently, cells were lysed and 
Tat-Zap70(SH2)2 and ZAP-70 and associated proteins were analysed by immune- 
precipitations (IPs) with anti-HA antibody (12CA5) or with anti-ZAP-70 antibody 
(33.1). Tyrosine-phosphorylated proteins were detected (IB) by using an anti- 
phosphotyrosine antibody, 4G10 (-P-Tyr), and are indicated by the arrows, and 
pulled-down Tat-Zap70(SH2)2 was detected by using anti-His antibody (B). The 
migration of molecular mass markers is indicated on the left. Data are representative 
of three experiments.
(C) Jurkat T cells (10*) were grown in the presence of 3 pM slowly desalted Tat- 
Zap70(SH2)2; at time point 4 hours, cells were washed and cultured in fresh medium 
without Tat-Zap70(SH2)2. Cells were collected at indicated time points (in h) after the 
initial start of the culture, and phosphorylation was induced by 1 mM sodium ortho­
vanadate where indicated (+). Subsequently, cells were lysed, and Tat-Zap70(SH2)2 
and ZAP-70 and associated proteins were analysed by IPs with anti-HA antibody 
(12CA5) or with anti-ZAP-70 antibody (33.1). Tyrosine-phosphorylated proteins were 
detected using an anti-phosphotyrosine antibody, 4G10 (-P-Tyr), and are indicated by 
the arrows, and pulled-down Tat-Zap70(SH2)2 was detected by using anti-HA 
antibody (D). Data are from a single experiment only.
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In the continuous presence of Tat-Zap70(SH2)2 in the culture medium, 
coprecipitation of TCRÇ can be observed up to 16 hours after addition of the fusion 
protein. In contrast, when the cells are washed after the initial loading period of 4 
hours, the fusion protein is only capable of pulling down TCRÇ for up to one hour 
after the wash step (Figure 19C). This suggests that the fusion protein easily leaves 
the cell again, or is rapidly turned over in the cytosol. This implies that future 
experiments require the constant presence of Tat fusion protein in the medium before 
and during manipulation.
3.5.4 Cell entry of rapidly desalted Tat-PTD fusion proteins
It has been reported for some Tat-PTD fusion proteins, that the kinetics of 
translocation across the cell membrane between fully and partially denatured proteins 
can be different (Nagahara et al., 1998; Caron et al., 2001). Since slowly desalting 
may induce the Tat-PTD fusion proteins to adopt a partially folded structure, this 
might have slowed down the translocation across the plasma membrane. In order to 
test this, newly generated rapidly desalted Tat-Lck^*"^ and Lck^*”^-Tat were FITC- 
labelled and added to MACS-separated CD4^ T cells. This allowed comparison of 
dose- and time-dependent uptake between slowly and rapidly desalted Tat-PTD fusion 
proteins. Figure 20 shows that after exposure of T cells to rapidly desalted FITC- 
labelled Tat-PTD fusion proteins, the proteins translocate across the membrane more 
rapidly compared with slowly desalted fusion proteins (Figure 18). The amount of 
protein transferred across the cytoplasmic membrane is still concentration dependent, 
as shown in Figure 20A and C, for Tat-Lck^*"^ and Lck^*^^-Tat respectively.
Optimal intracellular concentrations were reached after only 30 minutes of co-culture 
with both the N-terminally and the C-terminally placed Tat-PTD, shown in Figure 
2GB and D.
144
Results
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Figure 20. MACS-purified CD4^ BIO T eells were eo-eultured with FITC-eonjugated 
rapidly desalted Lek^^“‘-Tat (A, C) or Tat-Lek^^"" (B, D), thereafter eells were 
washed and aequired by FACS at pH 6.8. (A) Cells were eo-eultured with 0 nM (—), 
100 nM ( - ) ,  250 nM ( - )  and 1 pM (-)Lck^^"--Tat, or (B) with 250 nM ( - ) ,  500 nM 
(—) and 1 mM (—) Tat-Lek"^^"' for 1 h. (C, D) Cells were incubated with indicated
amount of time (min) with 1 pM Lek'^^""-Tat (C) or Tat-Lek'^^"" (D) respectivelyNSII2
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3.6 Effect of Tat-PTD fusion proteins on T cell differentiation
The first part of this project was completed with the generation and testing of 
the Tat-PTD delivery system. Tat-PTD was shown to be an inert delivery vehicle, 
capable of tranducing large proteins into naive T cells. In addition, Figures 18 and 19 
have provided an estimate for the time restrictions in which Tat-Zap70(SH2)2 protein 
is internalised and functionally active. It takes over an hour to be internalised, but 
biological activity can only be observed after 3 hours of coculture. When cells are 
washed after the initial loading step, the effect of Tat-Zap70(SH2)2 is lost within two 
hours; however, if it is continuously present in the medium, biological activity can be 
observed up to at least 16 hours after the start of the culture in constantly dividing 
Jurkat T cells.
In order to evaluate the effects of the generated Tat-PTD fusion partners on 
signal transduction and cell response modes, we chose to start with a look at a very 
early event after TCR triggering; the calcium flux.
3.6.1 Calcium fluxes
The calcium-dependent pathway is turned on after TCR ligation and is 
essential for cytokine gene expression. Furthermore, it plays an important role in 
activation of differentially expressed transcription factors (Dolmetsch et al., 1997). 
Amongst others, calcium signalling results in nuclear translocation of the transcription 
factor NFAT after it has been dephosphorylated by calcineurin, a calcium-dependent 
phosphatase. The transcription factor NFAT is known to play a role in both the 
expression of the 11-4 and IFNy genes (Kubo et al., 1994; Campbell et al., 1996).
Calcium is a ubiquitous intracellular signal responsible for controlling 
numerous cellular processes. At one level its action is simple; cells at rest have a low 
concentration of intracellular free calcium, but upon activation it rises rapidly. 
Calcium signals are, however, capable of regulating many processes due to their 
versatility in terms of speed, amplitude and spatio-temporal patterning. More
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variations are achieved through the interactions of calcium with other signalling 
pathways.
Calcium signals are directly downstream of ZAP-70, which upon recruitment 
to the TCR and phosphorylation by Lck, phosphorylates LAT. LAT provides the 
scaffold through which multiple signalling molecules, such as FLCyl, can be 
recruited. Upon tyrosine phosphorylation FLCyl becomes a major determinant for 
calcium signalling, requiring the activity of all three FTKs, Lck, ZAP-70 and Itk 
(Kurosaki and Tsukada, 2000). Since Tat-PTD fusion proteins were made with the 
purpose of interfering with the endogenous FTKs; Lck and ZAP-70, initial tests were 
focused on its influence on calcium fluxes in naive T cells.
Figure 21A shows the dose-response curve of CD3-stimulated CD4^ BIO 
lymphocytes. It reveals that anti-CD3 stimulus with doses above 1 pg/ml results in a 
maximum response in 11-2 production. In order to reveal a possible difference in 
calcium signalling in the presence of Tat-PTD fusion proteins, sub-optimal 
concentrations of the anti-CD3 stimulus were used to maximise the chance of 
observing an effect induced by the fusion proteins. Three concentrations were chosen: 
an optimum stimulus of 5 pg/ml, as a positive control, and the two sub-optimum 
concentrations of 1 pg/ml and 0.3 pg/ml.
Stimuli with 5 pg/ml anti-CD3 resulted in an amplitude of calcium flux equal 
in all T cell cultures regardless of the presence of Tat-Zap70(SH2)2 fusion protein 
(Figure 21B). However, in the presence of increasing concentrations of Tat- 
Zap70(SH2)2, a slight concentration-dependent shift in timing could reproducibly be 
observed. Lowering the stimulus to 1 fig/ml anti-CD3 (Figure 21C), showed a 
profound effect of the fusion protein. At the 2 pM concentration of Tat-Zap70(SH2)2 
there was a small delay in reaching the maximum flux, and the maximum amplitude 
reached was lower. This effect was even more dramatic upon lowering the TCR 
stimulus to 0.3 pg/ml (Figure 2 ID). At Tat-Zap70(SH2)2 concentrations of 3 pM and 
higher the calcium flux was completely lost when a sub-optimal stimulus was 
delivered (Figure 21C, D).
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Figure 21.
(A) CD4^ MACS-selected BIO T cells were incubated for 4 hours on plates coated 
with indicated amounts of anti-CD3 antibody (2C11), and 10 pg/ml anti-CD28 
(37.51). Recovered cells were cultured overnight, and 11-2 concentrations in the 
medium were determined by a CTLL assay. Results are representative of two 
independent tests.
(B, C, D) CD4’*’ MACS-selected BIO T cells were incubated for 4 hours with 
indicated amounts of slowly desalted Tat-Zap70(SH2)2, and stained with PE- 
conjugated anti-CD4, labelled with non-conjugated anti-CD3 (2C11) in 
concentrations of 5 pg/ml (B), 1 pg/ml (C) and 0.3 pg/ml (D), and loaded with indo- 
1. Baselines for intracellular calcium levels were established for 1 minute after which 
a calcium flux was induced with anti-Armenian Hamster crosslinking antibody, 
indicated by an arrow, and subsequently recorded for a further 5 minutes. Results are 
representative of three independent tests.
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Influence of slowly desalted Tat-Zap70(SH2)2 
on calcium signalling
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After the observations of an altered calcium flux in the presence of the Tat- 
PTD fusion protein Tat-Zap70(SH2)2, the kinase-truncated version of Lck was tested 
in the same way. As depicted in Figure 13, two constructs were generated; Tat- 
LckNSH2^  containing Tat-PTD and the His-tag at the N-terminus, thereby inhibiting the 
recruitment of this protein to the plasma membrane, and Lck^^^^-Tat, containing all 
tags and the Tat-PTD at the C-terminus, allowing the free unique N-terminus to direct 
this protein to the plasma membrane. Tat-Lck^^"^ could therefore serve as a diabled 
protein control for Lck^^"^-Tat.
As shown in Figure 22, Tat-Lck^^"^ had no effect on calcium flux when 
cocultured with MACS-selected CD4^ BIO T cells at concentrations of 1 and 2 pM. 
No effect was noticed when cells were stained with decreasing concentrations of anti- 
CD3, from 5 pg/ml (Figure 22A), 1 pg/ml (Figure 22B) and 0.3 pg/ml (Figure 22C). 
Lck^^"^-Tat, however, produced a dramatic decrease in calcium flux at a 
concentration of 1 pM, and even more prominent at 2 pM. This effect seems 
independent of the concentration of anti-CD3 used, identical profiles could be 
observed using 5 pg/ml (Figure 22A), 1 pg/ml (Figure 22B) and 0.3 pg/ml (Figure 
22C) anti-CD3. Anti-CD3 is incapable of triggering a full calcium flux in the presence 
of Lck^^^^-Tat but as shown in Figure 22D, the lipophilic calcium ionophore 
ionomycin, capable of circumventing the proximal signalling molecules by directly 
transporting calcium out of the ER, can overcome this inhibition.
3.6.2 T cell differentiation
Since Lck^^^^-Tat showed a profound effect on intracellular free calcium 
levels after anti-CD3 stimulation, and Tat-Lck^^"^ could serve as a disabled control 
fusion protein, these fusion proteins were tested for their ability to influence T cell 
differentiation. MACS-selected CD4^ BIO T cells were incubated with 1 or 2 pM 
fusion protein for 4 hours, whereafter cells were stimulated with plate-bound anti- 
CD3 (0.5 pg/ml) and anti-CD28 (10 pg/ml) for 4 hours. Subsequently, collection of 
the cells and culturing them on new plates separated the cells from the stimulus. 
Proliferation was tested by the Alamar-blue-method. Figure 23A shows that
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Figure 22.
(A, B, C, D) CD4^ MACS-selected BIO T cells were incubated for 4 hours with 
indicated amounts of slowly desalted Tat-Lck^^^^ or Lck^^^^-Tat (— , — ),
and stained with PE-conjugated anti-CD4, labelled with non-conjugated anti-CD3 
(2C11) in concentrations of 5 pg/ml (A), 1 pg/ml (B) and 0.3 pg/ml (C), and loaded 
with indo-1. Baselines for intracellular calcium levels were established for 1 minute 
after which a calcium flux was induced with a crosslinking antibody, indicated by an 
arrow, which was subsequently recorded for a further 5 minutes. (D) As a control for 
their calcium signalling capacity, cells pretreated with 2 pM Lck^^"^-Tat were 
exposed to 50 nM ionomycin.
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Influence of slowly desalted Lck^ "^^  Tat fusion proteins 
on calcium signalling
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proliferation was impaired and at background level in cells pre-treated with 2 pM 
Lcj^ NSH2_Tat^  but not different from medium controls in the presence o f the control 
protein Tat-Lck^^^.
Levels of the surface markers CD69, CD44, CD25, CD4 and TCR were 
assessed on three days after the primary stimulus. In cells that had been exposed to 2 
pM Lck^^"^-Tat a delayed response was apparent. The early activation marker CD69 
increased more slowly compared with the other conditions, and did not reach 
maximum levels. Upregulation of the late activation marker CD44 was also delayed 
(data not shown). The left panel of Figure 23C shows that no differences were 
observed in CD25 expression after the primary stimulus. However, a difference in the 
proportion of 11-2 producing cells was noticed (Figure 23B top row) by intracellular 
FACS-analysis at day 6 after primary stimulus. Cultures that had received their CD3 
stimulus in the presence of 2 pM Lck^^^^-Tat developed about 60% fewer 11-2 
producing cells. Little IFNy (Figure 23B top row) and no 11-4 (data not shown) and II- 
10 (Figure 23D left panel) producing cells were observed after the primary 
stimulation.
Cells were collected at day 7 after primary stimulus, and rechallenged with 
plate-bound anti-CD3 (1.0 pg/ml) and anti-CD28 (10 pg/ml) for 8 hours in the 
absence of any fusion protein. Thereafter, cytokine profiles and cell surface marker 
expression were tested 5 days after the secondary stimulus. Figure 23B (bottom row) 
shows that the majority of cells that were originally stimulated in the presence of 2 
pM Lck^^”^-Tat failed to produce 11-2 and IFNy upon restimulation, while the 
majority of cells in all other conditions produced 11-2 and in addition 50 to 70% 
produced IFNy. Figure 23C and E (right panels) show that those cells that were 
primed in the presence of 2 pM Lck^^^^-Tat showed increased levels of CD25, and a 
considerable fraction (23%) produced 11-10 upon rechallenging in the absence of any 
Tat-PTD fusion proteins. The production of 11-10 was confirmed by an 11-10 ELISA 
using the supernatants at day 5 after rechallenging of cultured cells (Figure 23E).
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Figure 23.
CD4^ MACS-selected BIO T cells were incubated for 4 hours prior to the primary 
stimulus only with indicated amounts of slowly desalted Tat-Lck^^^^, or Lck^^^^-Tat 
where indicated, wherafter cells were stimulated (primary stimulation) with plate- 
bound 0.5 pg/ml anti-CD3 (2C11) and 10 pg/ml anti-CD28 (37.51). At day 7 after 
primary stimulation, cells were collected and restimulated (secondary stimulus) with 
plate-bound 1.0 pg/ml anti-CD3 (2C11) and 10 pg/ml anti-CD28 (37.51). (A) After 
the primary stimulation, proliferative responses were measured by the Alamar-blue 
method, o/n after Day 1 and Day 2. The panel shows mean values ±SD. (B) Cells 
were restimulated with 500 ng/ml Ionomycin, 500 ng/ml PdBu and 10 pg/ml 
BrefeldinA for 4 hours, and their cytokine profile was determined by intracellular 
FACS analysis at day 6 after primary stimulus (upper panels) and day 5 after 
secondary stimulus (lower panels). Plotted is 11-2 against IFNy, whereby the 
percentage of cells is given in each quadrant. (C) Cells were stained for extracellular 
markers; shown here is their CD25 profile 6 days after the primary and 5 days after 
the secondary stimulus. (D) Cell profiles for 11-10 at day 6 after primary stimulation, 
and day 5 after secondary stimulation. (E) At day 5 after secondary stimulus, 
supernatants were tested for their 11-10 concentration by ELISA.
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‘For those who believe no explanation is 
necessary. For those who do not none will 
suffice. ” (Duiminger)
_____________________________________________   Discussion
4. Discussion
Signalling events have been well studied in T cell hybridomas and T cell lines, 
however, events in immortalised cells may not reflect the in vivo situation (Astoul et 
al., 2001), and their use greatly limits functional assessment of T cell modes of action. 
It is as yet poorly understood how changes in TCR-mediated signalling and its 
downstream signalling cascades drive the differentiation of the naive T cell into 
different response modes. The aim of this project, therefore, was to target ex vivo T 
cell populations with signalling attenuators and subsequently study the effect on T cell 
differentiation in vitro.
The use of ex vivo T cells, however, greatly limited the manipulation strategy. 
Naive T cells are known to have a very short half-life in vitro due to high levels of 
programmed cell death (Perandones et al., 1993), which limits the use of a genetic 
delivery strategy. The ability to express proteins that can alter cellular phenotypes has 
been largely limited to recombinant genetic approaches in the past. The circumvention 
of genetic approaches by the delivery of full-length proteins directly into cells is 
problematic due to the restrictions imposed by the cell membrane. Proteins can, 
nevertheless, cross this barrier either after transient membrane permeabilisation, or by 
endocytosis involving surface interactions, receptors and vesicular compartments. 
Primary T cells, however, restrict the use of membrane permeabilisation methods due 
to their fragility.
Certain naturally occurring macromolecules enter cells through an active 
transport mechanism, termed receptor-based endocytosis. One such group of proteins, 
known as AB-toxins, are highly toxic to mammalian cells because of their ability to 
enter the cytosol and attack essential constituents. The delivery of compounds 
imported through receptor-based endocytosis is selective, but limited to cells 
expressing a particular receptor. Furthermore, the receptor determines the rate o f 
compound uptake, and often targets delivery to an organelle.
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An alternative to receptor-based endocytosis is a poorly understood 
mechanism, independent of receptors, transporters and endocytosis, termed adsorptive 
endocytosis or non-chiral receptor mechanism. Although this technology was 
originally described in 1988, little was reported in the subsequent 10 years. In the last 
few years, significant steps have been taken to advance this technology into a broadly 
applicable method that allows rapid introduction of proteins into primary cells.
The potential of two delivery vehicles was investigated during this study; the 
B subunit of E xoli enterotoxin (EtxB) that enters cells via receptor-based endocytosis 
and the protein transduction domain of the HIV-1 Tat protein (Tat-PTD) that gains 
entry via adsorptive endocytosis.
Can EtxB serve as an inert delivery vehicle to target ex vivo T cells?
The mucosal adjuvanticity of cholera- and enterotoxin and the potential of 
their B subunits to serve as an oral vaccine carrier have prompted interest in coupling 
of immunogenic peptides to these proteins (Dertzbaugh and Elson, 1993; O'Dowd et 
al., 1999). In addition, it was shown that the B subunit is capable of successful 
delivery of short peptides into eukaryotic cells (Loregian et al., 1996). This initiated 
our attempt to explore the possibility of using the B subunit of E. coli heat-labile 
enterotoxin as a recombinant carrier for receptor-mediated delivery of larger protein 
domains into ex vivo T cells.
After confirming binding of the EtxB homologue CtxB to naive T cells, 
experiments focussed on the effect of CtxB on T cell physiology. From the start, a 
most striking effect was found on T cell numbers upon addition of CtxB to in vitro T 
cell cultures. A closer look at T cell survival rates and apoptosis revealed a dramatic 
increase in levels of apoptosis when T cells were cultured in the presence of CtxB. 
This induction of high levels of apoptosis after a short exposure to CtxB excluded the 
use of CtxB as an inert delivery vehicle, making it unsuitable for the intended aims of 
this study. The induction of apoptosis may, however, offer an explanation for the
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reported inhibitory effect of CtxB/EtxB on T cell activation (Francis et al., 1990; 
Woogen et al., 1993), and the depletion of CD8+ T cells in in vitro cultures (Nashar et 
al., 1997).
Ctx and Etx are recognised as two of the most potent mucosal adjuvants 
identified, able to greatly enhance antibody responses to co-administered antigens. 
However, their toxicity precluded usage in human vaccines. Although earlier studies 
suggested that adjuvant activities were completely dependent on the ability of the 
catalytic A subunit to raise intracellular cAMP levels, it is now well established that 
this is not the case. Gmi binding was found essential and responsible for both 
immunogenicity and adjuvant activity in the absence of the A subunit (Guidry et al., 
1997; de Haan et al., 1998). The adjuvant potency of CtxB/EtxB, measured by the 
humoral response to co-administered antigens, can be solely attributed to CtxB/EtxB 
binding to APCs. It has been shown that CtxB activates DCs and B cells via 
crosslinking of Gmi, thereby increasing the expression of costimulatory molecules and 
the production of antigens (Li and Fox, 1996; Nashar et al., 1997). This raised the 
possibility of using the B subunit pentamer as a strong adjuvant, but data reported 
here and by others suggest that also the B subunit alone still possesses strong 
lymphotoxic properties. This might greatly limit the use of CtxB/EtxB as an 
immunoadjuvant for inclusion in human vaccines.
What causes the dramatic effect o f CtxB on T cell apoptosis?
Cholera toxin was known to have immuno-modulating effects, but this was 
initially solely attributed to the A subunit’s enzymatic activity (Imboden et al., 1986; 
Gray et al., 1988) and to depend on cell type and experimental system used. Rat, but 
not mouse, thymocytes were shown to be stimulated upon binding of CtxB, possibly 
via crosslinking of Gmi by the multivalent B subunit (Spiegel et al., 1985). In a later 
study, the effect of CtxB was shown to include acute changes in the concentration of 
cytoplasmic free calcium. Since this effect was absent in calcium-ffee medium, this
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suggested that CtxB does not induce a release of calcium from intracellular stores, 
consistent with the observation that inositol trisphosphate was not produced upon 
CtxB binding, and that PKC and DAG levels were unaffected. Earlier criticism of A 
subunit contamination, resulting in the observed effects, was ruled out by the absence 
of increased cAMP levels. Similar results were obtained using human B cells (Dugas 
etal., 1991).
In the human Jurkat T cell line, however, an increase in intracellular free 
calcium concentrations could only be observed upon crosslinking surface-bound CtxB 
with anti-CtxB antibodies (Gouy et al., 1994). This calcium response was shown to 
involve both extra- and intracellular calcium, and to partially deplete the CD3- 
dependent and inositol trisphosphate-sensitive intracellular calcium pool and to result 
in 11-2 production. Tyrosine phosphorylation of PLCy-1 could only be observed in 
Jurkat cells that express high levels of G m i -
The reason for the dramatic effect on apoptosis levels in ex vivo murine T cells 
reported in this study might be related to the mechanism by which CtxB gains entry to 
the cytosol. The pentamer recognises, binds to and subsequently clusters the 
pentasaccharide chain of ganglioside Gmi, present in high amounts on the T cell 
membrane. The physiological function of Gmi is not well understood, but it has been 
implicated in various signal transduction pathways depending on cell type and 
experimental system used. CtxB has previously been shown to contribute to activation 
of TCR-mediated signalling via raft aggregation (Janes et al., 1999; Janes et al.,
2000), suggesting that the pro-apoptotic effect seen here may be due to inappropriate 
TCR signalling in primary T cells. These various signals, amongst others, include 
calcium release and phosphorylation events (Dixon et al., 1987; Duchemin et al., 
2002; Fang et al., 2002). Recent data have shown that crosslinking of G m i  directly 
activates a pre-existing calcium channel (Fang et al., 2002). The observed increase of 
the early T cell activation marker CD69, most prominently seen after additional 
crosslinking of G m i  with anti CtxB antibodies in this study, may well reflect this 
increase of cytoplasmic free calcium (D'Ambrosio et al., 1994).
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Upon receptor binding of the toxin, entry to the cytosol is allowed. This 
involves endocytosis o f the holotoxin-receptor complex, stimulated by the binding of 
the B subunit pentamer to Gmi (Tsai et al., 2001). Gmi is found in the raft 
microdomains on T cells, and CtxB is routinely used to make these visible. Recent 
insights into Cholera toxin entry have demonstrated that binding to Gmi anchors the 
toxin to rafts, whereby cholesterol and sphingolipids play an important role in 
trafficking the toxin into the Golgi system (Wolf et al., 2002).
Membrane sphingolipids constitute a unique signalling pathway that links 
surface receptors to the nucleus, with ceramide and other sphingomyelin products 
serving as second messengers. Models for glycosphingolipid-induced apoptosis 
generally favour an endocytotic vesicle pathway with ceramide release from vesicle 
compartments (Gulbins et al., 1995; Hannun and Obeid, 1995). Breakdown products, 
like ceramide and sphingosine act as anti-proliferative agents and regulators of 
apoptosis. Thus, the apoptosis induced by CtxB may be the result of the entry 
mechanism of CtxB, triggered by binding to G m i , and the direct result of products 
generated by the lipid metabolism involved (Janes et al., 1999). In addition, second 
messengers derived from ceramide and sphingomyelin, in conjunction with a rise in 
intracellular calcium levels, may stimulate the PKC/Ras pathway and subsequent 
expression of CD69.
CD8^ T cells were more susceptible to apoptosis following treatment with 
CtxB than CD4^ T cells. This might reflect the capacity of CD8^ T cells to bind twice 
the amount of CtxB, compared with CD4+ T cells, as was observed here and 
previously reported (Elson et al., 1995). The reason why CD8+ T cells contain almost 
twice as much G m i , and are more sensitive to apoptosis, is poorly understood. It might 
reflect a possible difference in their raft composition. It is known that activated T cells 
always show higher levels of Gmi expression than resting T cells, due to de novo 
synthesis induced by T cell activation (Tuosto et al., 2001). The synthesis of raft 
components allows effector cells to be more responsive than naive T cells. CD4^ and 
CD8^ T cells are also known to possess different proliferative responses (Foulds et
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al., 2002). CD8^ T cells become committed to differentiating fully into effector cells 
rapidly upon stimulation and respond with substantial proliferation (van Stipdonk et 
al., 2001), while CD4^ T cells differentiate into distinct sets of polarised cells and 
show a reduced proliferative capacity compared with CD8^ T cells. The differences in 
proliferative patterns and clonal expansion of CD4^ and CD8^ T cells may result from 
the composition of their respective rafts, indicated by different expression of Gmi-
Can Tat-PTD serve as an inert delivery vehicle to target ex vivo T cells?
Since EtxB could not be used as a delivery vehicle, attention was turned to 
protein transfer domains. Of the three best-characterised PTDs, Tat-PTD was found 
most suitable for this project. The protein transfer technique was extensively studied 
with help of Antp; its domain responsible for protein transduction was identified, and 
amino acid substitution resulted in a number of PTD peptides together termed the 
penetratin system (Derossi et al., 1998). However, these peptides have only shown the 
capacity to deliver short peptide sequences up to 100 amino acids long (Derossi et al., 
1998), while this study aimed at the delivery of large protein domains and full-length 
proteins. Tat-PTD was shown to be capable of transducing large proteins, including p- 
galactosidase, caspase-3, Rho-A, and superoxide dismutase, (Vocero-Akbani et al., 
1999; Barka et al., 2000; Chellaiah et al., 2000; Kwon et al., 2000). Furthermore, the 
technique, using Tat-PTD, was reported to be capable of delivering biologically active 
proteins into the mouse by IP-injections, to all tissues, including the brain (Schwarze 
et al., 1999).
The main advantage of this internalisation procedure is the low toxicity and 
high uptake by all tested cell types. The cellular internalisation occurs at 4°C and 37°C 
and cannot be saturated, strongly suggesting a transduction mechanism that is energy- 
and receptor-independent (Joliot et al., 1991; Derossi et al., 1996; Derossi et al.,
1998). However, it is not known whether there is an upper size limit, and if 
internalisation rate and bioactivity are correlated with the complexity of the cargo. In
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addition, the highly positively charged residues may result in lack of solubility of the 
fusion proteins.
As a transcripton factor. Tat is also able to trans-activate other cellular genes, 
including those encoding cytokines like TNFo, 11-2 and 11-6 (Buonaguro et al., 1992; 
Scala et al., 1994; Westendorp et al., 1994), and cell survival-related proteins like p53 
and Bcl-2 (Li et al., 1995; Zauli et al., 1995). Several reports also showed an 
inhibitory effect of the full-length Tat protein on T lymphocyte activation, 
proliferation and gene transcription (Viscidi et al., 1989; Helland et al., 1991; Ensoli 
et al., 1993; Holloway et al., 2000). This, however, did not exclude the possible use of 
the Tat-PTD as an inert delivery vehicle for proteins into T cells. The cysteine-rich 
region of Tat mediates the formation of metal-linked dimers, and is essential for its 
function (Garcia et al., 1988; Ruben et al., 1989). The delivery vehicle Tat-PTD only 
contains the 11 amino acids basic region, and lacks the essential regions necessary for 
dimérisation and transcription activity. At the start of this project, the effect of Tat- 
PTD on T cells was largely unknown, and was thus the focus of initial experiments.
The short peptide, comprising of the 11 amino acids of Tat-PTD and a 9 
amino acid HA-tag, did not influence the basic expression levels of activation 
markers, CD4, CD8 and TCR, nor was any effect seen on basal levels of apoptosis in 
these in vitro T cell cultures. The presence of 10 pM Tat-PTD in the culture medium 
during priming with specific antigen or anti-CD3 did not result in any alteration of the 
expression levels of cell surface markers nor the kinetics of their expression compared 
with medium controls. In addition, no influence of Tat-PTD on T cell proliferation, 
and on kinetics and levels of secretion of the cytokines 11-2 and IFNy could be 
observed.
These results were not unexpected, since Tat-PTD consists only of the basic 
region of full-length Tat, which requires other domains for its suppressive activity on 
T cell activation and its influence on gene transcription. The absence of any influence
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of Tat-PTD on the parameters tested meant that it fulfilled the first criterion to serve 
as an inert vehicle for protein delivery into naive T cells.
Can Tat-PTD deliver large proteins across the naive T cell membrane?
The second criterion important for the potential usefulness of Tat-PTD was the 
capacity to deliver large protein fragments across the cell membrane of naive ex vivo 
T cells. Full-length Lck and protein domains from the signalling molecules Lck and 
ZAP70, involved in TCR-mediated proximal signalling processes, were genetically 
fused to Tat-PTD and expressed in Bl-21 E.coli. Sonication of bacterial pellets in 8M 
urea or 6M guanidine HCl allowed the disaggregation of all insoluble protein into a 
soluble form. The use of dénaturant produced the highest yield of protein for 
purification, especially since all tested fusion proteins were expressed in inclusion 
bodies. An additional effect of using a dénaturant was that purified proteins were 
unfolded, which enhanced their ability to transduce across the cell membrane for most 
previously reported Tat-fusion proteins (Nagahara et al., 1998). Only minor 
optimisation was required to purify high yields of fusion proteins that were pure by 
Coomassie Blue gel analysis from the denatured fraction.
The major pitfall experienced when preparing Tat-fusion proteins was the high 
occurrence of precipitation of the unfolded proteins after placing them into aqueous 
buffers. Since these fusion proteins were intended for treatment of ex vivo naive T 
cells, a very fragile cell type, any dénaturant present had to be removed, and the 
proteins had to be solubilised into a physiological buffer. The original protocol 
achieves this by rapid removal of the dénaturant, yielding Tat-fusion proteins with 
higher transduction efficiency than those prepared under native conditions (Nagahara 
etal., 1998).
Rapid removal of 8M urea by PD-10 desalting columns was successfully 
reported before, although it lead to inferior yields compared with ion-exchange
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chromatography (Vocero-Akbani et al., 2001). Trials with the fusion proteins 
generated in this study, however, failed to yield soluble protein during PD-10 
desalting. Removal of protein precipitation upon aggregation, by centrifugation or 
filtering, thereby reducing the precipitation cascade, did not improve the protein yield. 
Since some proteins may precipitate at high concentrations after elution, several 
dilution steps were introduced, which only marginally improved protein yields. The 
same was observed with attempts to reduce hydrophobic interactions by 
supplementing the buffers with glycerol, sucrose or glucose, by preventing ionic 
interactions with high salt concentrations and by enhancing protein solubility by the 
addition of the amino acids; arginine and glycine. The yield of soluble protein 
obtained with this method of desalting greatly depended on the properties of the 
protein of interest.
Initially, comparable results were obtained for all generated fusion proteins 
with rapid desalting strategies. Structurally the proteins share some homology, they 
are derived from highly conserved PTKs and share a highly conserved SH2 domain. 
None of the previously reported Tat-fusion proteins contained such a domain, and 
solubility conditions needed to be established empirically. Using a slow desalting 
method, it was found that the longer and the more complex the fusion partner, the 
more difficult it was to keep the proteins soluble, and the smaller the yield of soluble 
protein obtained. During the course of this project it proved to be impossible to obtain 
sufficient quantities of soluble Tat-Lck'^*, containing a SHI, SH2, and SH3 domain, 
and allowing further experiments, while the smallest construct, Tat-Lck^"^ consisting 
of the SH2 domain only, proved to be the most successful in initial trials using 
methods of slow desalting.
Since rapid desalting did not result in sufficient quantities of soluble fusion 
proteins, a slow desalting strategy was followed. A similar strategy was also applied 
to the purification of Tat-Ras, where 8M urea was removed via dialysis and dilution- 
steps (Hall et al., 2001; Myou et al., 2002). Sufficient amounts of soluble fusion 
proteins, for several experiments, could be obtained. However, a concern about using
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a slow desalting method was that proteins might re-adopt their native or partly native 
structure, which could compromise their transduction across the cell membrane.
The internalisation of partly denatured Tat-eGFP in several cell types was 
reported to be decreased in efficiency and speed compared with completely denatured 
fusion proteins (Caron et al., 2001). Rapid removal of the dénaturant creates 
denatured Tat-PTD fusion proteins that may have a higher potential of functional 
activity than those prepared under slow folding techniques. The absence of a 
biological response with some native Tat-fusion proteins may reflect this inefficiency 
of native protein to achieve required intracellular concentrations to show a response.
It was reported that, prior to internalisation, Tat-fusion proteins undergo an unfolding 
step (Bonifaci et al., 1995), which implies that proteins with higher order minimal 
structure and with high entropy levels are more efficiently transduced than low 
entropy correctly folded ones. This was also illustrated with the use of eGFP; not only 
was the internalisation process slower, the protein lost its fluorescence during the 
translocation process.
In this study, slowly desalted Tat-PTD fusion proteins containing 
Zap70(SH2)2 or Lck^^"^ were conjugated to the fiuorochrome FTTC. Transduction 
across the plasma membrane could be shown by FACS analysis whereby extracellular 
fusion protein was quenched with a low pH or by digestion with trypsin. As reported 
for other Tat-PTD fusion proteins, close to 100% of cells were transduced with FITC- 
conjugated fusion protein in this study. In addition, as indicated by the narrow width 
of the FACS histogram peak, all cells received similar amounts of fusion protein.
Subsequently, fusion protein uptake by ex vivo T cells was followed over 
several hours. The optimum intracellular concentration of FITC-labelled fusion 
protein was established around three hours of coculture, much slower than previously 
reported with other Tat-PTD fusion partners, where maximum levels of intracellular 
protein concentrations were reached between 5 and 60 minutes (Nagahara et al., 1998; 
Schwarze et al., 1999; Vocero-Akbani et al., 1999; Barka et al., 2000; Chellaiah et al..
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2000; Kwon et al., 2000; Hall et al., 2001; Myou et al., 2002). The results are in 
accordance with reports making use of a similar approach, whereby extracellular 
bound protein is quenched (Hall et al., 2001). Reports claiming more rapid 
transduction, however, did not exclude extracellular bound protein (Nagahara et al., 
1998; Vocero-Akbani et al., 1999). The observed delay in transduction corresponded 
with the onset of functionality of Tat-Zap70(SH2)2, which was only capable of co- 
precipitating TCRÇ and CD3e after an incubation time of at least 3 hours. For most 
previously described Tat-PTD fusion partners, functionality was observed correlating 
with the moment a maximum level of intracellular protein concentration was reached, 
except for eGFP, which reaches this only after 14 hours.
The delay in fusion protein crossing the cell membrane found in this study, 
compared with previous reports for other proteins might have reflected a different 
folding state, caused by the slow desalting method. The slow dilution method might 
prompt proteins to adopt a partly native structure or at least a more complex one than 
in the fully denatured state. Comparisons between denatured and native protein in 
their ability to induce biological responses have shown that denatured protein readily 
induced cellular responses at low concentrations, while native protein failed to do so 
even at the highest concentrations tested (Nagahara et al., 1998).
The protein transduction process in this study as reported by others was found 
to be concentration dependent (Nagahara et al., 1998; Schwarze et al., 1999; Vocero- 
Akbani et al., 1999; Barka et al., 2000; Chellaiah et al., 2000; Kwon et al., 2000; Hall 
et al., 2001; Myou et al., 2002). When the extracellular protein concentration is 
changed, Tat-PTD fusion proteins are reported to shift the equilibrium and 
subsequently transduce back out of the cells, as was also the case with fusion proteins 
tested in this study. This happens despite the fact that once inside the cell, denatured 
proteins can be correctly refolded by chaperones, and thus could shift the equilibrium 
due to a more complex structural state, thereby reducing the reverse transduction out 
of the cells. It is unknown what proportion of transduced, intracellular fusion protein 
adopts a correctly folded state. However, testing the functionality of Tat-Zap70(SH2)2
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in Jurkat cells by assessing their capacity to co-precipitate with TCRÇ showed it was 
rapidly lost upon washing, suggesting that not all transduced protein may have been 
correctly refolded.
Attempts to find a method allowing rapid desalting of the generated Tat-PTD 
fusion proteins continued, since the transduction rate across the plasma membrane of 
slowly desalted fusion proteins was found slow, as compared with previous reported 
proteins, and acquired protein yields were still low. Initial rapid desalting trials, the 
use of PD-10 desalting columns and fast dialysis, had failed due to high occurrence of 
protein precipitation, and small scale tests with ion-exchange columns also resulted in 
protein precipitation or, in the case of Tat-Zap70(SH2)2, to irreversible binding to the 
column. This problem of irreversible binding to ion-exchange chromatography 
columns was reported before for some Tat-fusion proteins (Becker-Hapak et al.,
2001), and might be due to a combination of the highly positive charged Tat peptide 
and the structure of the fusion partner. However, the method of rapidly desalting by 
ion-exchange was favoured above other techniques by other groups, reporting 
superior results (Nagahara et al., 1998). I therefore resorted to using Resource resin in 
batch form, whereby the use of FPLC or HPLC equipment could be avoided. The 
introduction of Q and S resin in batch format, and single elution steps, allowed 
successful solubilisation of high amounts of denatured Tat-PTD fusion proteins into 
aqueous buffer. This method was successful for all fusion proteins generated during 
this study. However, each protein still required empirical testing of the optimal 
solubilisation conditions, regarding choice of column material, ionic strength of the 
buffers and pH.
A potential concern of using rapidly desalted protein was that, although 
transduction may be more efficient, refolding and thus functionality may be 
compromised. Many proteins have been transduced under denaturing conditions after 
rapid desalting. However, for some it has been reported that they need to be purified 
from a soluble fraction to become efficiently refolded in vivo (Schwarze et al., 2000). 
This suggests that complete denatuation of some proteins leaves the Tat-PTD fusion
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protein in a state that has a high transduction efficiency but a poor rate of refolding. 
Rapidly desalted fusion proteins tested during this study indeed showed enhanced 
uptake efficiency. Maximum intracellular levels were reached, in accordance with 
previous reports, in about 30 minutes. However, data about the function of these 
proteins are currently outstanding, and will be the focus of further study. It is likely 
that an incubation period of several hours prior to manipulation of the transduced cells 
is still required. Others have shown that refolding of some proteins, even with high 
efficiency transduction rates, can take several hours whereafter functionality is 
observed (Nagahara et al., 1998; Caron et al., 2001). This presumably depends on the 
complexity of the fusion partner of interest.
Based on these data, Tat-PTD fulfilled its function as an inert delivery vehicle 
for large protein domains, which it was shown to be able to transduce across the T cell 
plasma membrane, in all cells with equal distribution. Furthermore, it was shown that 
Tat-Zap70(SH2)2 was functional 3 hours after coculture, indicating that fusion 
partners containing SH2 domains can be properly refolded. Although a rapid desalting 
method was established to solubilise denatured Tat-PTD fusion protein into aqueous 
buffer, and it was shown that these proteins transduce more efficiently across the 
plasma membrane compared with slowly desalted fusion proteins, data about 
refolding and function still need to be obtained. Since these parameters were 
established for slowly desalted fusion proteins, these were used in subsequent 
experiments.
The interest in transduction domains in recent years has led to the 
development of even more powerful peptides that might be able to boost the usage of 
this technique (Futaki et al., 2000; Wender et al., 2000), especially for large protein 
domains and full-length proteins. Although mutants in animals can provide useful 
data and insights into the importance of proteins, the resultant phenotype is a 
consequence of a complex developmental program and adaptive mechanisms so that 
the precise function of the affected molecules might be obscured. Transduction has 
already been effectively used at determining the regulatory role of small GTPases
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(Chellaiah et al., 2000). Constitutively active and dominant-negative forms can be 
generated and added to cell cultures, allowing experiments to be performed on 
primary cells that are otherwise difficult to manipulate, and avoiding labour intensive 
work of generating transgenic animals. It is, however, impractical to expect Tat- 
mediated delivery to work for eveiy protein, and to the right location.
Can TCR-mediated signalling and T cell differentiation be influenced by 
the introduction o f competitor proteins?
After differentiation and emigration from the thymus to the peripheral 
immune organs, T cells are functionally immature and have the capacity, upon 
encountering antigen, to develop into different functional subsets of effector T cells, 
each with their own cytokine profile. It is still poorly understood, however, what 
drives these cells into different response modes.
Activation and differentiation in the periphery is determined by at least three 
factors. The first part of the signal for T cell activation is delivered by the TCR/CD3, 
after interaction with peptide/MHC on APCs, and is influenced by the concentration 
of available peptide. The second part of the signal is provided by a number of 
costimulatory or accessory molecules, whose expression levels determine the extent 
of signal amplification. Both signals are influenced by the duration of the interaction 
between T cells and APCs, determining the amount of signal that can be accumulated. 
In recent years, evidence has accumulated that hierarchical thresholds for proliferation 
and differentiation determine the generation of various effector T cell modes (lezzi et 
al., 1998; Langenkamp et al., 2000; Langenkamp et al., 2002). The polarisation of 
Thl versus Th2 CD4^ T cells is clearly influenced by the nature of these two signals 
(Seder and Paul, 1994), and Treg/non-responsive or anergic cells are classically 
generated in the complete absence of the second costimulatory signal (Schwartz, 
1990). The mechanisms that account for the generation of these various effector T 
cells remain, however, unclear.
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The signalling cascades determining the final outcome of a T cell response are 
based on a number of biochemical events, with the interactions between two or more 
proteins. This interaction is an absolute requirement for transferring the extracellular 
signal to the nucleus where all signals are integrated, resulting in an appropriate 
response. This study tried to explore the possibility to influence the outcome of a T 
cell response by introducing signalling domains that can compete with endogenous 
signalling molecules. To this end, the Tat-PTD protein transduction system was 
successfully tested as an inert method to deliver large proteins into naive T cells.
The PTKs Lck and ZAP-70 are tyrosine phosphorylated as one of the earliest 
events after TCR stimulation. They are involved in recruiting signalling molecules to 
the TCR-signalling complex with their high affinity interaction domains. These high 
affinity domains, SH2 and SH3, are well defined and have highly specific substrates, 
allowing the generation of high affinity competitor proteins that are capable of 
blocking specific protein-protein interactions. This, together with the correlation of 
abrogated Lck and ZAP-70 tyrosine kinase activities in anergic T cells (Faith et al., 
1997), made Lck and ZAP-70 good candidates for interfering and altering TCR- 
mediated signalling in an attempt to drive T cells into different response modes.
Interfering with the function of ZAP-70 was attempted with two Tat-PTD 
fusion proteins, one containing a previously reported short peptide sequence inhibitor 
(Nishikawa et al., 2000), and one containing a ZAP-70 truncation mutant lacking the 
entire kinase domain, previously shown to function as a dominant negative mutant 
(Northrop et al., 1996; Qian et al., 1996).
The short peptide sequence inhibitor of ZAP-70 was identified using an 
affinity-based library screen, and although designed as an inhibitor of SH2 domain 
interactions, was found to act as an inhibitor at the catalytic pocket (Nishikawa et al., 
2000). A membrane-permeable version was made by fusing it to an Antp-based 
penetratin peptide and its ability to block T cell responses was investigated in Jurkat T 
cells. Upon CD3 cross-linking the peptide specifically diminished phosphorylation
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levels of proteins known to be ZAP-70 kinase substrates; PLCy and LAT. In addition, 
it was shown to inhibit 70% of 11-2 gene expression at a concentration of 10 pM. In 
this study, the identical peptide sequence was fused to the Tat-PTD sequence and 
tested on ex vivo naive T cells.
In contrast to the penetratin construct in Jurkat T cells, the peptide inhibitor 
fused to Tat-PTD did not show any influence on T cell proliferation, expression of 
surface markers and the secretion of the cytokines 11-2 and IFNy. This is unlikely to 
be due to the use of Tat-PTD. Although the mechanism of transduction across a lipid 
bilayer is currently unknown, both PTDs have been successfully used to transduce 
peptide sequences and share the presence of basic amino acids shown to be 
responsible for penetration of the membrane. It was established that the full-length 
Tat protein is internalised via the ubiquitous heparan sulphate proteoglycans (Tyagi et 
al., 2000), though more recently it was suggested that the short Tat-PTD is taken up 
by a route that does not involve heparan sulphates (Silhol et al., 2002), indicating that 
different mechanisms for cellular internalisation may exist.
The absence of an inhibitory effect of the small ZAP-70 inhibitor is more 
likely due to the use of ex vivo T cells and peptide inhibitor concentrations used. The 
reported 70% inhibition in an in vitro kinase assay was found around 10 pM peptide 
concentration, and not much inhibition may be expected in ex vivo cells at that 
concentration extracellularly since only a part of the added peptide will actually enter 
the cells. The concentration used to obtain 70% inhibition of transcriptional activation 
of a reporter construct for the 11-2 gene reported by Nishikawa et al. in Jurkat T cells 
was also 10 pM, by stimulating the cells with plate bound anti-CD3e and 10 ng/ml 
PMA. An additional problem with the use of ex vivo T cells was that doses above 5 
pM proved to be toxic and only peptide inhibitor concentrations up to 5 pM could be 
tested. The possibility remains that the inhibition in Jurkat cells was a feature of 
altered signal transduction pathways in a transformed cell line.
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Recruitment of ZAP-70 to the TCR is crucially dependent on its tandem SH2 
domain (Iwashima et al., 1994). It was previously shown that interfering with the 
recruitment of ZAP-70, via a PTPase-resistant ITAM peptide analogue (Wange et al., 
1995), or a kinase-truncated mutant (Qian et al., 1996), can specifically suppress 
TCR-mediated phosphorylation of endogenous ZAP-70 activation of NFAT, Vav and 
Erk phosphorylation and recruitment of Grh2. When using a CD8-Ç chimeric 
receptor, it was shown that the kinase-truncated mutant was constitutively bound to 
the hyperphosphorylated CD8-Ç chimera, suggesting that it competes for the same 
binding places as wild type ZAP-70. However, these data were all obtained using 
Jurkat T cells, which prohibited the study of T cell differentiation and response modes 
after altering TCR-mediated signals. Fusing the kinase-truncated ZAP-70 mutant to 
Tat-PTD, generating Tat-Zap70(SH2)2, allowed the assessment of the influence of 
this dominant-negative mutant on TCR-mediated signalling and T cell differentiation 
in ex vivo naive T cells.
For the use of large fusion partners to Tat-PTD, slowly desalted, kinetics of 
transduction time and functionality were established during this study. The time 
between the addition of fusion protein to the cells and reaching maximum intracellular 
protein levels and protein functionality, meant that experiments testing the influence 
of the presence of the Tat-PTD fusion partners on T cell priming and function were 
preceded by a 4 hour incubation period prior to stimulation.
In order to evaluate the effects of Tat-PTD fusion proteins on early signal 
transduction, calcium fluxes were studied as a first indication of altered TCR 
signalling processes. It had been reported that ZAP-70-negative mutants of the Jurkat 
T cell line fail to flux calcium in response to anti-CD3 monoclonal antibody 
(Williams et al., 1998). However, calcium mobilisation has been measured in T cell 
clones and naive CD4+ peripheral T cells under partial-agonist conditions that do not 
activate ZAP-70 (Sloan-Lancaster et al., 1994; Madrenas et al., 1995; Boutin et al., 
1997).
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In this report, Tat-Zap70(SH2)2 was shown to influence calcium fluxes in a 
concentration-dependent and anti-CD3 antibody dose-dependent manner. This 
indicates that Tat-Zap70(SH2)2 is capable of competing with endogenous ZAP-70, 
and altering the proximal signalling processes. Furthermore, this suggests that ZAP- 
70 function is regulated by the strength of TCR triggering, since high doses of anti- 
CD3 showed a full calcium flux in amplitude and speed, while lowering the anti-CD3 
concentration resulted in a delayed response with lower amplitude when using 2 pM 
Tat-Zap70(SH2)2, and abolished the calcium flux at 3 pM Tat-Zap70(SH2)2 
concentration. This might be the result of multiple binding sites for ZAP-70 at the 
TCR. The total of 10ITAM motifs allow, in theory, the recruitment of more or less 
ZAP-70 depending on the strength of signal. Tat-2^p70(SH2)2 may be able to block 
some of these sites, but not all, since a supra-optimal dose of anti-CD3 allowed a full 
calcium flux.
In order to further assess the influence of Tat-Zap70(SH2)2, a control protein 
will need to be generated. All SH2 domains have an arginine residue crucial for SH2 
domain function since it is responsible for making direct contact with the 
phosphotyrosine residue substrate (Eck et al., 1993). Substitution of this arginine 
residue by lysine will abolish SH2 domain function. In the case of ZAP-70, this 
residue is found at positions 37 and 191 (Hatada et al., 1995). Although the C- 
terminal SH2 domain shows the highest affinity, mutation of either single SH2 
domain decreases the Kd by > 100-fold (Bu et al., 1995), and will be sufficient to act 
as a disabled control protein.
The effect observed on calcium flux in this study demonstrates a potentially 
interesting phenomenon, since it seems to be influenced by the strength of TCR 
signalling. Full activation of ZAP-70 results in supplying the IS with LAT, PLCy, 
PKC0 and Grb2 (Blanchard et al., 2002). The latter is involved in activating Ras, Erk, 
INK and p38 via the Grb2/Sos pathway leading to antigen-driven growth and 
differentiation. Interestingly, RasGRPl was recently implicated in transducing low- 
grade TCR signals possibly necessary for T cell survival and differentiation (Priatel et
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al., 2002). The observation by Gong et al. (2001) led to the hypothesis that T cell 
selection is coupled to the utilisation of the RasGRPl and Grb2/Sos pathways and, 
hence, the activation of MAPKs (Yun and Bevan, 2001). This might be applicable to 
peripheral T cell differentiation; insufficiently strong signals will thereby activate Ras 
and Erk via RasGRPl leading to T cell anergy or altered effector functions, while 
strong signals will activate Ras, Erk, INK and p38 via the Grb2/Sos pathway leading 
to effector T helper cells. In addition, ZAP-70 was most recently implicated to 
directly target the dual-specificity PTPase VHR that can inactivate the MAPKs Erk2 
and INK (Alonso et al., 2003). VHR phosphoiylation by ZAP-70 may give the TCR 
control over the duration of the Erk2 and INK responses. The circumstances and 
kinetics of this are currently unknown, but since ZAP-70 plays a differential role in T 
cell anergy (Sloan-Lancaster et al., 1994), this may explain the differences in relative 
activation profiles of Erk and INK in these cells.
The protein-protein interactions regulating Lck’s activity and proximity to 
effectors, made it a likely candidate for spatial regulation during T cell activation.
Two truncated Lck proteins were fused to Tat-PTD, allowing the transduction of T 
cells, whereafter these fusion proteins can potentially compete for identical protein- 
protein interactions as endogenous Lck. Since the SH2 domain was described 
essential for the initiation of signalling events, it was fused to Tat-PTD (Tat-Lck^^^). 
However, the recruitment of Lck is known to be dependent on its N-terminal region 
(Kabouridis et al., 1997), and a kinase-truncated version, maintaining the N-terminus, 
SH3 and SH2 domains was fused to Tat-PTD. The dependency on its recruitment for 
activation allowed the generation of a disabled protein that contains the Tat-PTD and 
His-tag at the N-terminus, thereby prohibiting this protein from coming into proximity 
with its substrates.
Only the latter two, Tat-Lck^^"^ and Lck^^^^-Tat, were tested for their 
influence on T cell activation and differentiation. When BIO CD4^ T cells were pre­
treated with these fusion proteins, a distinct fusion protein dose-dependent alteration 
in calcium flux could be observed after anti-CD3 crosslinking. This pattern could only
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be observed when using Lck^^^^-Tat, which has a free N-terminus, while the pattern 
observed with Tat-Lck^^"^ was identical to medium controls. In contrast to Tat- 
Zap70(SH2)2, this alteration was not influenced by the concentrations of anti-CD3, 
suggesting that the effect is independent of TCR signalling strength. This is in 
accordance with Ehrlich et al. (2002), who failed to observe a difference in temporal 
and spatial patterns of Lck recruitment between strong and weak agonists.
Treatment with 1 pM Lck^^^^-Tat still resulted in a minor flux with similar 
timing as that of medium controls, but the amplitude was much reduced. Treatment 
with 2 pM Lck^^"^-Tat completely eliminated the initial spike in the calcium flux, 
although a gradual increase in intracellular free calcium levels could be observed at 
later time points. This may indicate that the initial signal from the TCR to intracellular 
channels (IPg-receptors) for rapid release of intracellular calcium stores is inhibited, 
while the slower plasma membrane calcium ATPases are allowed to raise intracellular 
free calcium levels. This might eventually result in a delayed, but possibly altered, 
stimulation of the treated T cells.
The alteration in calcium flux was indicative of altered TCR signalling, and 
encouraged the assessment of the effect of Lck^^"^-Tat on T cell differentiation and 
function. Since Tat-Lck^^"^ was unable to alter the calcium response upon TCR 
stimulation, this protein served as a disabled protein control in the next experiment. 
The loss of functionality observed with Tat-Zap70(SH2)2 after 1 hour when cells were 
washed after pre-treatment with the fusion protein, made it necessary, after the initial 
loading phase, to keep T cells in medium containing the Tat-PTD fusion proteins 
during T cell priming. Some fusion partners might need to be present for some time 
after the primary stimulus, depending on their mode of action. The tested proteins in 
this study were therefore only washed out after the first overnight incubation.
Upon stimulation with plate-bound anti-CD3 and anti-CD28 for 4 hours, 
MACS-selected CD4^B10 T cells were assessed during the first three days for their
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proliferative response and their expression of surface markers. The Tat-Lck^^"^ 
conditions showed identical results to the medium control, as expected.
Treatment with 1 pM Tat-Lck^^"^, despite showing an altered calcium flux, did not 
show an alteration in the proliferative response, or in the expression of surface 
markers. Treatment with 2 pM Lck^^^^-Tat, on the other hand, showed a distinct 
effect on T cell proliferation, which was as low as that seen in unstimulated cells. 
Some alterations were observed in the expression of CD69, CD25 and CD44, and 
their up-regulation as compared with anti-CD3- and anti-CD28-stimulated controls 
was delayed. CD69 expression also never reached maximum levels, and the cells were 
initially smaller, not reaching the full blast stage. However, at 6 days after the initial 
stimulus, cells treated with 2 pM Lck^^^^-Tat were increased in size, and showed 
upregulation of CD69, CD25 and CD44. If one relates this to the calcium flux data, 
these results indicate a delayed and altered T cell activation. This was also reflected in 
the cytokine profile at this stage. CD4^ T cells pretreated with 2 pM Lck^^^^-Tat 
showed a 60% decrease in the number of 11-2 producing cells, suggesting a functional 
difference between these and control conditions.
Challenging the primed cells with plate-bound anti-CD3 and anti-CD28 for a 
second time in the absence of any fusion proteins should highlight the polarisation of 
effector T cells. The cells pretreated with 2 pM Lck^^"^-Tat during their primary 
stimulus showed increased expression levels of CD44 and CD25 compared with 2 pM 
Tat-Lck^^"^ and medium controls. This suggests that the signal transduction 
machinery was changed during the primary stimulus resulting in an altered response 
upon subsequent stimulation. The cytokine profile showed that the majority of these 
cells (56%) failed to produce 11-2 and IFNy, in contrast to the control conditions, in 
which over 90% of the cells produced 11-2 and over 50% IFNy, indicating that the 
response mode of the cells pretreated with 2 pM Lck^^^^-Tat during their priming 
was significantly altered. The control cells showed a typical Thl profile that was 
expected after anti-CD3/CD28 stimulation. Cell populations producing the Th2 type 
cytokines 11-4 and 11-10 were absent in these conditions. Interestingly, cells in the 2
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pM Lck^^^^-Tat condition failed to produced 11-4 but a population of 23% produced 
11- 10.
The absence of a proliferative response upon stimulation, and the failure to 
produce 11-2 and IFNy, shows strong similarities with anergic T cells that arise from 
incomplete T cell activation (Schwartz, 1996). While anergy results from partial 
stimulation, it is considered to be an active signalling process requiring triggering of 
the TCR and the mobilisation of calcium (Macian et al., 2002). By using Lck^^^^-Tat, 
recruitment of endogenous Lck and thus Lck function is partially blocked. This results 
in incomplete T cell stimulation, which fails to show the initial spike in calcium 
mobilisation, but allows a more gradual increase in intracellular free calcium levels. 
Functional uncoupling of the TCR and Lck activation was previously observed in 
human anergic CD4+ T cells (Fujimaki et al., 2001). Measurements of calcium 
transients in single cells have shown that weak agonist peptides elict lower levels of 
calcium mobilisation than strong agonosts (Rabinowitz et al., 1996; Sloan-Lancaster 
et al., 1996a). Experiments in the presence of the extracellular calcium chelator 
EGTA may block the induction of the phenotype found in this study, and give an 
indication of the importance of extracellular calcium mobilisation in the induction of 
the observed phenotype.
In addition to T cell anergy, the prolonged higher levels of the surface marker 
CD25 after primary stimulation and increased levels of CD25 after restimulation 
observed during this study using Lck^^"^-Tat, indicates similarities with in vivo Treg 
cells (Read and Powrie, 2001). Several groups have shown that CD4^CD25^ T cells 
are hyporesponsive and fail to produce 11-2. Accumulating data suggest that these 
anergic or T^g cells, instead of being functionally inert, may develop a phenotype 
with functional importance in negative regulation of naive T cells. This regulation 
could be passive, by competing with normal naive T cells for survival factors, or local 
cytokines or ligand binding. On the other hand, regulation could be the outcome of an 
active mechanism. Some of these cells have been reported to produce 11-10 upon 
restimulation (Groux, 2001; Shevach, 2002), known to inhibit T cell functions (Akdis
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and Blaser, 2001). It is currently unclear if the cells produced in the presence of 
Lck^^^^-Tat in this study resemble these regulatory cells, and if they possess any in 
vitro or in vivo suppressive activity. This will, however, be the focus of continued 
research.
Further experiments in the near future will be aimed at defining the molecular 
mechanism behind the induction of the observed phenotype by Lck^^*^^-Tat. The role 
of endogenous Lck, which may be essential for a low or altered signal, may be 
determined by using the inducible Lck knock-in system (Legname et al., 2000). In 
these mice it is possible to stop the expression of Lck at a desired moment in time. 
This enables comparison between T cells still harbouring Lck and those that have lost 
its expression. Treatment of these cells with Lck^^"^-Tat will allow assessment of 
whether endogenous Lck activity is required to induce the phenotype observed in 
treated CD4^ BIO T cells during this study and if Lck is involved in the altered 
pathways maintaining this state.
This study has established that the N-terminal region of Lck is an absolute 
requirement for altering TCR-mediated signalling by using Tat-Lck^^"^, which has a 
blocked N-terminal region, and was unable to alter TCR signalling. In addition to 
directing Lck^^^^-Tat to the IS, the N-terminal region may compete with endogenous 
Lck for binding sites at the CD4 coreceptor, thereby reducing the amount of recruited 
wild type Lck upon TCR triggering. The SH2 domain in Lck^^^^-Tat may also be 
important for competing for protein-protein interactions with endogenous Lck, since it 
is essential for the formation of the trimolecular complex containing Lck, CD4 and 
CD3 (Rudd et al., 1991), and for interaction with ZAP-70, leading to its subsequent 
phosphorylation and activation. The role of the SH2 domain in Lck^^^^-Tat can be 
demonstrated by using the R154K mutant, which has a non-functional SH2-domain 
(Straus et al., 1996). Alternatively, the SH3 domain, which is responsible for 
interactions with the coreceptor CD28 (Holdorf et al., 1999), might play a role. T cell 
anergy can be induced when T cells are stimulated in the absence of CD28 
stimulation. The SH3 domain has been shown to be a link between TCR-mediated and
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CD28-derived signals, and to determine Lck activity in the IS (Holdorf et al., 2002). 
The influence of this domain can be demonstrated by removing it from the fusion 
protein construct.
More distal events determining the fate of Lck^^^^-Tat treated T cells and their 
involvement in altered signalling pathways may reflect findings in previous reports 
studying T cell anergy. Biochemical studies with Lck^^^^-Tat-treated, stimulated and 
rechallenged cells will assess levels of TCR, Lck, Fyn and ZAP-70 phosphorylation, 
and the activation levels of the three MAPKs with help of phospho-specific antibodies 
giving insight into which pathways are altered as a result of Tat-Lck^^"^ treatment.
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